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Breast cancer is the most common cancer among women worldwide. The current gold 
standard for breast cancer screening is triple assessment using clinical examination, 
histological assessment and imaging (a combination of X-ray mammography and ultrasound). 
However, this approach limits the understanding of the subtypes and progression of the 
disease in terms of biochemical changes. Vibrational spectroscopy has demonstrated its 
potential to provide diagnostic information. Raman and FTIR spectroscopy can facilitate the 
prediction of the biochemical progression for different diseases in a rapid non-destructive 
manner. Raman and FTIR spectroscopy was used to characterise and differentiate normal 
breast and breast cancer as well as different subtypes and grades of breast cancer. Tissue 
microarrays (TMAs) are valued in cancer research due to the minimal tissue requirements and 
excellent correlation with whole tissue sections. TMAs containing breast cancer and normal 
breast samples were analysed with Raman and FTIR spectroscopy. The cancerous samples 
include different grades and subtypes and represent similar tribal origins in Nigeria. A total of 
578 samples were analysed with Raman spectroscopy, while a total of 273 samples were 
analysed with FTIR. Biochemical changes were detected for luminal, HER2+, and triple 
negative breast cancer for grade I, II and III. Spectral data revealed key differences in the 
concentration of biochemical compounds, such as, lipids, nucleic acids and proteins. Principal 
component analysis (PCA) was able to identify differences that lead to accurate and reliable 
characterisation of normal breast tissue, and different subtypes and grades of breast cancer. 
Linear discriminant analysis (LDA) confirmed 86% sensitivity and 89% specificity for the Raman 
spectroscopy results and 92% sensitivity and 86% specificity for the FTIR results. The identified 
differences represent a stepping stone towards a complete understanding behind the nature 
of different subtypes and cancer progression. In summary, vibrational spectroscopy showed a 
good potential in characterising and identifying new spectral markers. These findings provide 
an insight into different subtypes of breast cancer and the chemical pathway to the cancer 
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CHAPTER 1. INTRODUCTION 
 
The incidence of breast cancer (BC) has risen significantly in the past years. Nowadays BC is 
the second most frequent cancer among women.[1] Evidence suggests that early detection 
and diagnosis are among the most important factors for a favourable prognosis. Once a 
tumour is detected and it is suspected to be cancerous, biopsy is the typical procedure to 
follow. Currently histopathological assessment of biopsy samples remains the gold standard 
for diagnosis. However, several drawbacks such as subjectivity of the technique, time delay, 
tissue trauma, patient stress and the need of further invasive procedures still remain. 
As part of the diagnosis, the receptor status is assessed. Oestrogen receptor (ER) and Human 
epidermal growth factor receptor 2 (HER2) are compulsory to assess. Progesterone receptor 
(PR) is optional, but it also forms part of this status. These 3 receptors are used to target the 
cancer cells in addition to chemotherapy. Triple negative breast cancer (TNBC) is a subtype of 
BC in which hormonal and HER2 receptors are not expressed and therefore its current 
treatment is limited to chemotherapy. Black and Hispanic young women present a higher 
incidence of TNBC in comparison with other ethnicities and age groups. In addition, this 
subtype is aggressive, and it is related to a poor prognosis. It is clear that a better 
understanding of breast cancer, its heterogeneity and molecular drivers is needed in order to 
develop effective targeted treatments and therapies.  
Vibrational spectroscopy has been used to study different tissues and the progression of 
several diseases including cancer. The use of vibrational spectroscopy techniques such as 
Raman and FTIR spectroscopy could be a significant asset in the field of oncology research. 
The use of vibrational techniques could allow identifying chemical changes in the breast tissue 
related to the presence, development, and progression of breast cancer and therefore 
facilitating our understanding of the disease. The patient status includes clinical data and 
pathological parameters such as laterality, tumour size, type, grade and stage of BC. The 
spectral data managing through a combination of statistical analysis and chemometrics could 
allow the inclusion of patient status and as consequence a better characterisation of BC. 
AIMS AND OBJECTIVES 
1. Raman spectroscopic analysis of human breast cancer and normal breast biopsies on tissue 
microarrays (TMA) 
2. Analysis of spectroscopic results with multivariate analysis employing Principal Component 
Analysis (PCA) and cluster analysis and Linear Discriminant Analysis (LDA) to distinguish 
specific cancer related changes.  
3. Fourier-transform infrared (FTIR) spectroscopic analysis of human breast cancer and normal 
breast biopsies on tissue microarrays (TMA) 
4. Chemometric analysis using statistical analysis:  Principal Components Analysis (PCA), Linear 
Discriminant Analysis (LDA) and Cluster analysis to distinguish specific cancer related changes. 
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CHAPTER 2. LITERATURE REVIEW 
2.1 CANCER OVERVIEW 
Cancer is a disorder of cells that ends up in the formation of a tumour, which is considered a 
mass of cells with abnormal proliferation. The lack of capacity to follow normal differentiation 
and growth processes distinguishes a tumour cell from a normal cell. In the cell cycle, there 
are 3 well-known checkpoints to diverge out or programme to death these abnormal cells. 
Unfortunately when cancers arise these checkpoint are compromised due to disruptions or 
key proteins alterations in the cell cycle.[2] 
According to the Globocan2018 statistics performed by the International Agency for Research 
on Cancer in charge of the World Health Organization, 18.1 million cancer cases were 
predicted to be diagnosed worldwide in 2018. In this year 9.6 million deceases were predicted 
on the same report.[1] These numbers reveal that this disease is a leading cause of death 
among different populations, affecting people of a wide range of ages in developed and 
developing countries. According to the World Cancer report 2014, 22 million of cancer cases 
will exist within the next two decades.  
Early detection has been the measure taken around the globe to decrease cancer patient´s 
mortality by giving treatment at early stages. Some of the risk factors for cancer have been 
well identified, but some others remain unproven making it difficult to stablish successful 
prevention programs.  
2.2 BREAST CANCER  
When cancer cells form a tumour in the breast epithelial tissue this cancer is known as breast 
carcinoma.[3] Carcinoma is a term that could be used for any epithelial cancer. However, if 
the cancer origin is a gland tissue the term given is adenocarcinoma.[2] Breast cancer is 
considered a heterogeneous malignancy, not only because of its morphological and physical 
characteristics, but also at the molecular level. All these variations affect the progression and 
prognosis of the cancer, in addition to determine the treatment options suitable for its 
particular characteristics. [4], [5] 
According to the Global Cancer Statistics 2018 report, breast cancer is the second most 
frequent cancer worldwide.[1] As consequence of its tremendous heterogeneity the 
understanding, study and research of this disease is vital to improve and develop efficient and 
specific treatments.[6] The understanding of the specifics and general aspects of BC is 
essential to aboard this public health problem. Identifying all the risk factors, facilitating easier 
and faster detection techniques, and offering cancer specific therapies remain priorities in 
health research.[7] 
2.3 BREAST STRUCTURE 
The breast is a combination of several tissues located on the top of the pectoralis major 
forming protuberances at the chest level. Enlargement of the female breast occurs during 
puberty. The mammary gland undergoes several changes before, during and after pregnancy 
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and nursing. The breast gland development occurs during pregnancy, with the milk production 
purpose followed by its atrophy when the nursing process is ceased.[8] The breast undergoes 
several hormonal changes through the puberty, pregnancy, lactation, and after 
menopause.[9] Owing to these regenerative and remodelling processes, several diseases can 
arise in the breast tissue.[10] 
As it can be seen in Figure 1, the breast is formed of the nipple, lobes and their duct system, 
adipose tissue, suspensory ligaments and connective tissue stroma. The lobes contain the duct 
system and can be found in a radial form around the nipple. The duct system is formed by 
collecting ducts, lactiferous sinus, segmental duct, sub-segmental ducts, terminal ducts and 
lobules. The nipple has around 8-24 collecting ducts represented by orifices, which represent 
a lobe each. In the nipple smooth muscle fibres surround the lactiferous ducts with the 
purpose of erecting the nipple for suckling. Due to its circular arrangement contracting and 
emptying the lactiferous sinuses is possible.[10] External to the ducts and lobules there is 
connective tissue known as stroma. The stroma contains collagen, fibroblast, plasma cells, fat 
cells, blood vessels, lymphocytes, foam cells, and sometimes pigment-laden histiocytes and 
multinucleated stromal giant cells. The stroma occupies an intra- and inter- lobular position. 
This structure is a combination of adipose and fibrous tissue and it is the responsible for the 
bulky shape in women breast. The adipose component of the stoma it is usually located in the 




Figure 1. (A) Structure of the adult female breast. (B) Duct system within a lobe.  
The function of the collecting ducts resides in draining the mammary lobe ducts to the nipple. 
The accumulation of milk during lactation is in charge of the lactiferous sinus. The lactiferous 
sinus can be found right after the collecting duct in the duct system. The segmental duct 
divides into sub-segmental ducts that end in terminal ducts. The terminal duct is in charge of 
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draining the lobule. Each lobe can host around 20-40 lobules. These lobules are arranged in a 
grapelike cluster form. Each lobule is formed by 10-100 acini. Modified from [8], [10], [12] 
The terminal duct lobular unit (TDLU) consist on a lobule and its corresponding terminal duct. 
The TDLU is where most diseases processes arise due to the changes suffered by the epithelial 
cells and lobules under hormonal stimulation.[10]  
The lymphatic channels of the breast drain in their majority to the axillary mammary nodes. 
There are 3 levels of nodes. The importance of the breast relation with the lymphatic channels 
resides in the possibility of cancer metastases to the lymphatic system.[8] 
2.4 EPIDEMIOLOGY 
In 2018 was determined that breast cancer had a 24% incidence among all cases of women´s 
cancer, converting it in the most common cancer among women. It has also been reported 
that nearly 2.1 million cases will be diagnosed in 2018. [1]  
With a total of 630,000 deaths in 2018, breast carcinomas had the first mortality rank among 
all types of cancers in females. The incidence and mortality in different regions of the world 
can be seen in Figure 2, Figure 3, and Figure 4. 
 
Figure 2. Incidence and mortality rates for breast cancer. [1] 





Figure 3. Global representation of the most common type of cancer incidence in 2018 by country among 
females. The numbers of countries represented in each ranking group are included in parenthesis the legend. 
[1] 
 
Figure 4. Global representation of the most common type of cancer mortality in 2018 by country among 
females. The numbers of countries represented in each ranking group are included in parenthesis the legend. 
[1] 
The lower rates of breast cancer incidence correspond to younger ages (<50), increasing as 
the age does. The incidence of breast cancer rates also differs by ethnicity and race. BC 
incidence for white women is higher than for black and South Asian women. The incidence for 
women younger than 40 years is higher for black population than for white background 
women. However, for women older than 40 this tendency is reversed. The mortality for black 
women suffering from breast cancer is higher in comparison with white patients.[13]–[16]. 
According with the Cancer incidence and survival by major ethnic group, England, 2002 - 2006 
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report, in England young Asian women (15-64 years) have a lower survival rate at 3 years in 
comparison with white ethnicity women. This same report showed that Black women 
between 15-64 years presented a reduced survival at 1 and 3 years compared to white 
women. The survival comparison of black and white women older than 64 years showed no 
significant differences.[13] The same tendency has been demonstrated by different studies 
and programs such as  the population-based Surveillance, Epidemiology, and End Results 
(SEER) Program, and the Disease Control and Prevention’s National Program of Cancer 
Registries (NPCR) in USA among many others around the globe. [16], [17] 
In accordance with reports from patients in UK and USA, young black women are more likely 
to be diagnosed with tumours associated with the worst prognosis, such as triple negative 
breast cancer. In addition to the influence of the ethnicity, race, tumour type, and cancer 
stage; the biologic variations in the tumour, socioeconomic factors, time of detection, access 
to healthcare and treatment services play a vital role in breast cancer survival. [14], [17] The 
rates in mortality in countries deprived of early detection programs or standardized guidelines 
to handle and report breast samples is significantly higher than in developed countries with 
rigid protocols and programmes. An example of this is Nigeria among other African countries, 
where education and training in pathologic reporting needs to be promoted.[18] 
2.5 AETIOLOGY 
Several breast cancer risk factors have been recognised including, age at menarche and 
natural menopause, birth rate, pregnancy age, lactation histories, the menstrual cycle 
patterns, ovarian activity, the use of hormone therapies as contraceptives and menopausal 
hormone use, obesity, diet patterns, genetics, tobacco use and alcohol intake.[10], [19], [20]  
Different studies have suggested that the BC aetiologies may be as heterogeneous as the 
disease. For example reproductive factors such as early menarche, nulliparity and delayed 
childbearing represent risk factors for hormone receptor-positive tumours, but not for 
hormone receptor–negative cancers.[21] 
2.6 FUTURE PREDICTIONS 
The International Agency for Research on Cancer has predicted an important increase of BC 
rates in the following years. The expected number of breast cancer cases and mortality for the 
next two decades are displayed in Figure 5. Based on these figures a 46% increase of BC cases 
will be occur by 2040 in comparison with 2018, while an increment of 58% in mortality is 
expected.[22] 




Figure 5. Breast cancer incidence and mortality prediction worldwide for females of all ages. Based on the 
Globocan IARC online analysis prediction tool. 
2.7 BREAST TUMOURS CLASSIFICATION 
Tumours are masses formed by cells with abnormal characteristics such as atypical 
proliferation. These could be classified as benign or malignant. Benign tumours are formed by 
abnormal cells, but they are not identified as cancerous. On the contrary, the malignant 
tumours are formed by cancer cells. If these cells are contained or limited to the ducts without 
invading the basement membranes the tumour is known as in situ. The most common cases 
are ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). When the cancer cells 
invade the basement membranes and adjacent fat/stroma this is regarded as invasive 
carcinoma.  The commonest examples are infiltrating ductal carcinoma (IDC) and infiltrating 
lobular carcinoma (ILC). Invasive tumours have the possibility of invading surrounding tissue, 
for epithelial tumours the invasion through the blood vessels and lymphatic system bring high 
chances of carrying malignant cancer cells to other tissues causing secondary tumours. This 
process is better known as metastasis.[2]  
Reliable and consistent tumour detection techniques have been used for tumour detection. 
Breast screening is carried out using a triple assessment including imaging, X-ray 
mammography and ultrasound, clinical examination and histopathological assessment.[23] 
Tumour detection can be done rapidly and effectively using imaging. However, determining 
the nature of the tumour and tumour assessment requires the use of invasive labour-intensive 
and rigid protocols. If a detected lesion presents with characteristic that suggest cancer, a 
sample must be taken. The tumour sample is obtained using a thin needle to retrieve the 
tissue. Needle core biopsies have some limitations such as insufficient material retrieval, 
sampling errors, and risk associated with the procedures.  
Biopsy schedule, long waiting for results, and missampling are reasons for uncertainty, anxiety 
and emotional and physical stress in patients.[24] Unfortunately, real-time diagnosis cannot 
be performed with the current techniques. As consequence intraoperative margin evaluation 
during tumour removal represents an extra challenge for surgeons. Until this day, there is only 
one Food and Drug Administration (FDA) approved device for intraoperative margin 
assessment. This device is named MarginProbe and works based on differences in the 
electromagnetic wave reflection among normal and cancerous tissue. The most important 
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limitation lies in the fact that although this device provided a 75% sensitivity its 46% specificity 
is still very low.[25] Histological examination remains the gold standard for confirming the 
diagnosis and for margin assessment. 
Breast tumours may be classified based on their histological characteristics according to the 
WHO classification of tumours of the breast.[26] In order to achieve a better understanding 
of the invasive and non-invasive tumour nature a simple schematic representation of breast 
cancer progression is shown in Figure 6. In the UK the Royal College of Pathologists reporting 
guidelines are used to identify the tumour type and perform the classification.  
 
Figure 6. Breast cancer progression. (A) Normal breast tissue. (B) Ductal carcinoma in situ, proliferation of 
abnormal (epithelial and stromal) cells. (C) Invasive carcinoma, base membrane and myoepithelial cells partial 
degradation allowing cancerous cell invasion into ECM. 
Diagnosis and assessment of tumours is doing by microscopic evaluation. These tasks have as 
an objective to determine the existence and type of cancer and provide oncologists with 
enough information to select the treatment needed by that specific subject. The type of 
treatment is determined based on the histoprognostic index, the histological parameters and 
the molecular profile. To achieve this, tumour staging, and grading are required. The staging 
evaluates the spread of the tumour. According to internationally accepted staging protocols 
clinical characteristics such as the size of the neoplasm and near lymph nodes status must be 
considered. The stage is assigned based on the scores obtained by the TNM system. This 
approach includes 3 different aspects to assess: T for Primary Tumour, N for Regional Lymph 
Nodes and M for Distant Metastasis. A simplified representation of the TNM system based on 
the Royal College of Pathologists reporting guidelines is presented in Table 1. [27] Based on 
this, there are four stages of breast cancer, with the stage 1 being the earliest state of 
malignancy and stage 4 being metastatic. [26] The possible stages and how are they calculated 
based on the TNM systems are represented in Table 2.  
Table 1. TNM classification of tumours of the breast based on the Royal College of Pathologists reporting 
guidelines. [27] 
Primary tumour (T) 
T0  No evidence of primary tumour  
Tis  Carcinoma in situ /DCIS/LCIS  
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T1  Tumour ≤20 mm in greatest dimension  
T2  Tumour >20 mm but ≤50 mm in greatest dimension  
T3  Tumour >50 mm in greatest dimension  
T4  
Tumour of any size with direct extension to the chest wall and/or to the skin (ulceration or 
skin nodules) [NB. Invasion of the dermis alone does not qualify as T4]  
Nodes (pN) 
pN0  No regional lymph node metastasis identified histologically  
pN1  
Micrometastases OR  
Metastases in 1–3 axillary lymph nodes AND/OR  
Metastases in internal mammary nodes with metastases detected by sentinel lymph node 
biopsy but not clinically detected  
pN2  
Metastases in 4–9 axillary lymph nodes OR  
Metastases in clinically detected internal mammary lymph nodes in the absence of axillary 
lymph node metastases.  
pN3  
Metastases in ≥10 axillary lymph nodes OR  
Metastases in infraclavicular (level III axillary) lymph nodes OR  
Metastases in clinically detected ipsilateral internal mammary lymph nodes in the presence 
of one or more positive level I, II axillary lymph nodes 
OR  
Metastases in >3 axillary lymph nodes and in internal mammary lymph nodes with 
micrometastases or macrometastases detected by sentinel lymph node biopsy but not 
clinically detected OR  
Metastases in ipsilateral supraclavicular lymph nodes.  
Distant metastases (M) 
M0  No clinical or radiological evidence of distant metastases.  
M1  
Distant detectable metastases as determined by classic clinical and radiographic means 
and/or histologically proven >0.2 mm  
 
Table 2. Breast tumour stage based on the Royal College of Pathologists reporting guidelines. [27] 
Stage T N M 
0 Tis N0 M0 
IA T1 N0 M0 
IB 
T0 N1mi M0 
T1 N1mi M0 
IIA 
T0 N1 M0 
T1 N1 M0 
T2 N0 M0 
IIB 
T2 N1 M0 
T3 N0 M0 
IIIA T0 N2 M0 
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T1 N2 M0 
T2 N2 M0 
T3 N1 M0 
T3 N2 M0 
IIIB 
T4 N0 M0 
T4 N1 M0 
T4 N2 M0 
IIIC Any T N3 M0 
IV Any T Any N M1 
 
Tumour grading evaluates how similar/different the cancer cells appear in comparison with 
normal cells. The tumour grade is established using histological and cytological criteria. The 
cancer grade reflects the tumour morphology and its proliferative capacity. [2], [28] In the UK 
the Nottingham criteria is used to assess the tumour grade. The Nottingham criteria is based 
on the scoring of gland (acinus) formation, nuclear atypia/ pleomorphism, and mitosis count 
from 1 to 3 depending on a specific qualitative evaluation. When the scores from acinus 
formation, nuclear atypia, and mitosis count are added the total score must be in the range 
of 3-9. Depending on the score the grade is assigned as indicated in Table 3. 
Table 3. Tumour grading according to the Nottingham criteria and the Royal College of Pathologists 
reporting guidelines. [27] 
Score Grade 
3, 4, 5 I Cancer cells resemble normal cells. Slow growth 
6, 7 II 
Cancer cells look clearly different to normal cells. Higher 
proliferation 
8, 9 III 
Abnormal look. Spread more aggressively, Higher 
proliferation. 
 
Breast tumours are also assessed to identify the receptor status. The biomarker receptor 
status identification is performed to score the oestrogen receptor (ER), and the human 
epidermal growth factor (HER2) protein overexpression. The progesterone receptor (PR) can 
also be assessed, but it is not compulsory. According to the receptor status, tumours can have 
different clinical behaviour, response to endocrine treatment an anti her2 therapy and 
different metastatic probability. Owing to this fact the identification of biomarker receptor 
status is an imperative factor to consider in clinical decision-making.[29] 
A classification based on immunopathologic characteristics assessing the biomarker receptor 
status is an important task to provide an accurate diagnostic. Scoring of PR, ER and HER2 is 
performed through immunochemistry methods (IHC) and Fluorescence In Situ Hybridization 
test (FISH).[29] Several research groups have contributed to the tumour subtype classification 
including markers such as Ki-67 and PCNA (related to cell proliferation), 
cytokeratins5/6/14/17 and epidermal growth factor receptors. Considering contributions 
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from different literature Table 4 shows the breast cancer subtypes by molecular profiling and 
IHC. [29]–[32] 
Table 4. Subtype classification based on IHC/FISH. 
Subtype Features 
Luminal A (ER+ /PR+ & Ki-67<14%) 
Luminal B (ER+ /PR+ & Ki-67≥14%) 
Luminal/HER2 (ER+/PR+/HER2+) 
HER2 enriched (ER-/PR-/HER2+) 
Basal-like (ER-/PR-/HER2-  & EGFR + and/or CK5/6 +) 
Triple-negative (TN) (ER-/PR-/HER2-  & EGFR- & CK5/6 -) 
 
In the UK the histopathological assessment is very active and functional due to an external 
quality assurance programme. The implementation of the programme has supported the 
delivery of high-quality care to breast cancer patients. However, the use of strict protocols is 
inconsistent around the world with variations in the results being reported. These variations 
are caused by differences among fixation times, methods, staining times and antigen 
retrieval.[33] Constant measures are taken to improve the reporting of breast samples. For 
example, exploring new technologies to complement the current histopathological 
assessment gold standard. 
Molecular classification has been achieved in high resolution by using microarray-based gene 
expression profiling. When unsupervised analysis has been performed for different types of 
BC, the ER status has proven to be the most critical discriminator. However, clear clusters have 
been obtained identifying several receptor status subtypes.[29], [31], [34], [35] Based on the 
identification of specific gene sequence on different BC subtypes, disease progression 
(information related to proliferation rates, high/low grade tendency, metastatic spread 
patterns and prognosis) can be better understood through the molecular changes occurring 
and underlying the biology of BC.[29], [30] Although gene signatures confirmed that the 
receptor status classification offers a good reference to suggest treatment, it has also 
confirmed the heterogeneity of the disease and it has helped expand the subtype 
classification with other three subgroups: claudin-low, molecular apocrine and interferon. The 
molecular subtype features are display in Table 5. This table has been modified from Alizart 
et al. [29] 










Luminal A HER2- Low 
Luminal cytokeratin +; E-cadherin 
+/- 
Luminal B HER2-/+ High 
Luminal cytokeratin +; TP53 
mutations 




HER2 HER2+ High TP53 mutations 
Basal-like HER2- High 
Basal cytokeratin +; TP53 
mutations; 
DNA repair loss; EGFR +/- ; KIT +/- 
Molecular 
apocrine 
HER2- High Androgen receptor þ 
Claudin-low HER2- High 




HER2- High STAT 1 
 
Different studies involving different cohort sizes had been performed reporting a similar 
classification. However, consensus and concordance about the classification is non-existing. 
Although several studies with big cohorts had been carried out involving gene profiling, the 
molecular subtyping is not standardized. The variability showed by molecular subtyping 
reflects that further evidence is required before implementing them in routine use.  In 
addition, the time and costs of those technique and tumour sampling will represent a 
limitation to its application into clinic.[29], [34]. Recently, molecular tests have been approved 
by the National institute for Health and Care Excellence (NICE) for the routine pathway of 
breast cancer management in selected patients including EndoPredict (EPclin score), 
Oncotype DX Breast Recurrence Score, Prosigna, MammaPrint and IHC4+C. [36] 
Taken together, these classifications suggest that there is an association between the 
hormonal receptor status, treatment and prognosis. Positive hormonal receptors are used to 
target the cancer cell and treat the disease with endocrine or aromatase inhibitors therapy 
following surgery. It has been shown that the use of adjuvant systemic therapy has a positive 
effect on reducing breast cancer mortality and recurrence in selected patients.[37], [38] 
Therapy for negative hormonal receptors differs from positive hormone cases in a number of 
important ways. Triple negative breast cancer (TNBC) has no receptors to be targeted 
therefore therapy is limited to chemotherapy, radiation and surgery.[39] The limited therapy 
options, the aggressiveness of an only cytotoxic approach treatment and the TN phenotype 
itself have made the study of TNBC increasingly important in the oncology area.[40] 
2.8 TRIPLE NEGATIVE BREAST CANCER /PHENOTYPE (TNBC) 
This type of breast cancer is characterized by tumours with negative expression of 
progesterone receptor (PR), oestrogen receptor (ER) and that does not overexpress Human 
epidermal growth factor receptor 2 (HER2), hence its name. These triple negative (TN) 
tumours represent the 10-20% of breast tumours. TN Tumours are usually larger and with 
higher grades in comparison with those corresponding to other BC subtypes. [41], [42] TNBCs 
are resistant to hormonal therapies maintaining chemotherapy as the only course of action 
for its treatment.[43] This molecular subtype is considered biologically aggressive and its 
heterogeneity hinders the molecular target identification in order to develop treatments. [42] 
2.8.1 CLASSIFICATION  
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TNBC can be subdivided in two types, the basal and non-basal type. To be considerate as triple 
negative the basal type must have a coral basal phenotype which consist in the triple negative 
profile and the expression of one or more of the basal cytokeratins such as cytokeratin 5 (CK5), 
cytokeratin 6 (CK6), cytokeratin 14 (CK14), cytokeratin 17 (CK17) and epidermal growth factor 
receptor (EGFR), . On the contrary the non-basal TNBC does not express any of these receptors 
and maintains the ER-/PR-/HER2- phenotype. Basal-like TNBC represents 70-90% of TN 
phenotype, while 75% of basal-like tumours are TN. It is highly relevant to indicate that basal-
like tumours can also express positive hormonal receptors (HR) or HER2, however these would 
not be considered as TN tumours. Some features of TNBC are displayed in Table 6.[41], [43]–
[45] The identification of these TN phenotypes is performed using IHC with HER2 FISH analysis. 
Some evidence from molecular studies reflects that TNBC encompasses other molecular 
subtypes such as basal-like, Claudin-low, interferon-rich and normal-breast like.[43], [44] 
Table 6. Features and characteristics associated to TNBC phenotype. 
Basal-like TNBC 
Core basal phenotype (TN and expression of any CK5/6, CK14, CK17 and EGFR) 
Arise from luminal progenitor compartment, or from normal basal cells. 
Abnormal chromosome X inactivation  
Node-negative likely 
TNBC (ER-/PR-/HER2- ) 
Incidence risk increased by societal and genetic factors 
Cell surface profile similar to the breast cancer stem cells CD44+CD24- and ALDH1A1 
expression. 
A subset may represent a BRCA1 germline mutation tumours 
Relationship between the survival probability and primary tumour size. 
Tumour presents as high grade, increased mitotic count, scarce stromal content, central 
necrosis, lymphocytic response visible in stroma.  
Patient characteristics:  Young age at diagnosis, mutation carriers 
Tumour characteristics: Usually ductal or mixed histology and high grade 
Treatment/prognosis; Poorer prognosis, chemotherapy sensitive, no targeted therapy and high 
risk of early relapse 
 
Gene expression (GE) profiling reveals the heterogeneity of the TNBC subtype. Six TNBC 
subtypes with different ontologies and unique profiles were identified by Lehman et al when 
587 TNBC cases were profiled and cluster analysis was performed.[42] This classification is 
shown in Table 7. 
Table 7. TNBC subtypes displaying unique gene expression (GE) and ontologies. Distinct gene ontologies are 
associated with each TNBC subtype. 
TNBC Subtype Top gene ontologies for TNBC subtypes 
Basal-like BL
1 
Heavily enriched in cell cycle and cell division components and 
pathways  
Expression of genes associated with proliferation.  
Elevated DNA damage response pathways  
Increased proliferation and cell-cycle checkpoint loss in 
consistency with elevated expression of the DNA damage 
response genes  





Growth factor signalling and receptor gene expression as well as 
glycolysis/gluconeogenesis.  
This subtype has features suggestive of basal/myoepithelial origin.  
Immunomodulatory (IM) Enriched immune cell processes/signalling.  
Core immune signal transduction pathways.  
Immune cell-surface antigens, cytokine signalling, complement 
cascade, chemokine receptors and ligands, and antigen 
presentation. 
Mesenchymal (M) Heavily enriched in components and pathways involved in cell 
motility, ECM receptor interaction, and cell differentiation 
pathways. 
M and MSL share features with metaplastic breast cancer, 
characterized by mesenchymal/sarcomatoid or squamous features 
and its chemoresistance. 
Mesenchymal stem–like 
(MSL) 
Enrichment of genes for cell motility, differentiation, and growth 
pathways. Unique to the MSL express growth factor signalling 
pathways.  
Genes involved in angiogenesis. 
Low levels of proliferation genes in comparison with M, 
accompanied by enrichment in the expression of genes associated 
with stem cells, numerous HOX genes, and mesenchymal stem 
cell–specific markers. 
Luminal androgen receptor 
(LAR)  
Characterized by androgen receptor (AR) signalling.  
Although this subtype is ER negative, gene ontologies richly 
express hormonally regulated pathways including steroid 




TN tumours including basal-like TN account for 10-20% of BC cases. TNBC has a higher 
incidence in young black, African, Indian and Hispanic women in comparison with other ethnic 
groups of young age. [42], [44], [46]–[49] The Carolina Breast Cancer Study (CBCS) reflect that 
the group at higher risk to present basal-like TNBC are premenopausal African–American 
women. In this group the tumour incidence comprises 27-47% of all the cases. On the contrary 
the group of postmenopausal non-African–American women is at a lower risk of basal-like 
TNBC, with only 14% of these tumours among all cases.[43] When age is considered as 
predictor of hormonal receptor status, women younger than 40 years are predicted as 
candidates for TN status.[50] 
Among African American female population, TN basal-like cancer patients have an earlier 
relapse and overall survival in comparison with other subtypes. This tendency is increased if 
the patient is in a pre-menopausal stage.[14] The higher predominance of TNBC has been 
demonstrated in studies involving a dominant black population in African countries with BC 
incidence in young population. For example, Titloye et al reported that >80% of a total of 835 
tumours belonged to patients younger than 50 years old. This study determined that the 
predominant subtype among Nigerian breast samples was the high-grade TN phenotype, 
including basal-like TNBC. In accordance with studies performed with other African population 
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samples, the TN phenotype proves to have an important incidence among young black 
women.[50]–[53] 
The risk factor for TNBC have not been identified clearly due to the heterogeneity of the 
disease. However, Parity, full-term pregnancy at young age, suppressing lactation drug use, 
and interrupted breastfeeding after multiple births proved to be more influential as risk 
factors for basal-like breast cancer. While long breastfeeding on multiple pregnancies has 
been reported to reduce risk of basal-like breast cancer, but not luminal A. [14], [43], [54] 
2.8.3. TNBC PROGNOSIS AND TREATMENT 
Basal-like TNBC has been associated to poor prognosis by molecular characterisation and 
translational studies. This subtype showed high recurrence scores and expressed an activated 
wound response signature. This signature is related to a shortened overall survival and distant 
metastasis-free survival .[43], [55] TNBC is associated with a higher risk of central nervous 
system and viscera metastasis (mainly brain and lungs, 30% and 40%), in comparison with 
bone metastasis (40%) which is more common in non-TNBC. Additionally, lower survival rates 
during the 5 years after diagnosis are associated to TNBC in comparison with other BC 
subtypes, while the distant relapse possibility decrease after it.[47] 
The lack of hormone receptors and HER2 targeted agents preclude the use of hormonal 
therapy as adjuvant therapy. Thereby adjuvant chemotherapy and neoadjuvant 
chemotherapy approaches are the treatment options offered to women with TNBC. It has 
been demonstrated that some TN tumours are highly sensitive to chemotherapy. As result 
they present excellent outcomes once there is no residual disease after the neoadjuvant 
chemotherapy treatment. The presence of residual disease after chemotherapy 
administration is associated with an unfavourable outcome. [44] 
Recent research has suggested the association between TNBC and the BRCA1 gene 
mutation.[56], [57]The similitudes and relationship found with BRCA1 mutated cases arise the 
therapy possibilities. Patients with this germline mutation present a deficient break repair of 
double-stranded DNA. The use of platinum salts, antiangiogenic agents and DNA repair 
strategies such as Poly(adenosine diphosphate–ribose) polymerase (PARP) enzyme inhibitors 
for TNBC with BRCA1 dysfunctional pathways have demonstrate beneficial outcomes.[43], 
[44], [58] In order to overcome the TNBC drug resistance and find friendlier adjuvant 
therapies, the understanding of its heterogeneity is vital. 
2.9 BREAST CANCER HETEROGENEITY 
Breast cancer is a highly heterogeneous disease. There can be several variations among and 
within BC cases. Intratumour heterogeneity can occur not only at different parts of the tumour 
itself, but also as an evolution over time.[59] Breast tumours can present with different 
histological types, subtypes, grades, and at different stages. This diversity of factors has an 
impact on the progression risk and the resistance to treatment. [5] 
The relevance of the histological characterisation can be considered limited if we take into 
consideration that more than 70% of BC cases are classified as invasive ductal carcinoma of 
no special type (NST) and present different clinical behaviour.[59] As mentioned in the 
Chapter 2. Literature review 
37 
 
previous section, the determination of the tumour phenotype may be a better indicator for 
treatment selection.  
Wider and deeper characterisation of BC tumours, using techniques such as molecular 
profiling and whole-genome sequencing, can provide translational knowledge to assist with 
BC management. BC characterisation offers advantages such as predicting responses to some 
therapies and further research on targeted therapies, but this is not a straight forward task. 
[5], [32], [33]  
Molecular profiling of breast cancer samples has demonstrated that there are variations in 
the genetic composition of tumours. Further genetic characterisation can provide more 
information on BC growth rate, signalling pathways, cellular composition and proliferation 
rates.[31], [32] There are suitable treatments to destroy the cancer cells based on their 
molecular subtype. However, there is not consensus on the classification of the different 
molecular subtypes. 
Cancer progression is a representation of treatment failure and is defined by the growing and 
spread of cancer after treatment.[60] Disease progression indicates phenotypic changes. 
These changes involve modification at the morphological, molecular and functional level. 
Several processes such as angiogenesis, inflammation, immune and hormonal responses take 
place during the cancer progression.[61], [62] All these processes can be tracked and research 
through the biochemical changes caused at cellular and tissue level.[63]–[65] Hereafter, if 
those biochemical changes can be identified a better understanding of the aggressiveness and 
metastatic potential of BC at different time-points can be achieved.[66] 
The development and use of personalised and tailored therapies remain a must in cancer 
management. The use of “one-fits-all” approaches is impossible due to the high heterogeneity 
of the disease. The implications of the tumour heterogeneity at intra- and inter-tumour level 
are displayed in Table 8 which was adapted from Zardavas et al. [59]  
Table 8. Clinical implications of tumour heterogeneity in breast cancer. 
Type of 
heterogeneity 
Clinical implications Potential solution 
Intertumour 
Need for patient stratification 
High-throughput molecular profiling technique 
Molecular classifiers 
Need for therapy selection/clinical 
development of targeted agents 
Innovative trial designs: 
Master protocols 
Basket trials 
Adaptive trial design 
N-of-1 studies 
Intratumour 
Need to define the phenotype of 
the recurrent disease 
Metastatic biopsy 
Molecular evolution of the disease 
Repeated tumour biopsies 
Geographically separated biopsies 
Liquid biopsies 
Identification of driver events 
Next-generation sequencing 
Bioinformatic tools and algorithms 




Animal models/functional validation 




Emergence of treatment 
resistance 
Combination of targeted agents 
Exploiting passenger events 
 
A Biomarker is defined as an objective, usually quantifiable characteristic of biological 
processes such as diseases. These markers work as reliable predictors of absence or presence 
of diseases. [67] Biomarkers are sought after to facilitate diagnosis, decide treatment, obtain 
prognostic factors, and predict cancer progression.[68], [69] Additionally, a finer classification 
will benefit those groups whose prognosis cannot be forecasted by conventional parameters.  
The characterisation of the different subtypes can lead to a better understanding of the 
pathways responsible for the outcome, development, spread patterns, and metastases. The 
diagnoses, treatment, and development of drugs and adjuvant regimens will be facilitated and 
simplified. In addition, the discovery of new markers can help to develop new detection 
techniques and support potential drug discovery.  
2.10 VIBRATIONAL SPECTROSCOPY 
Vibrational spectroscopy comprises techniques where samples are exposed to 
electromagnetic radiation causing the stable vibrational states of the matter to change to an 
excited state. In order for this to occur the quantum radiation (energy applied) must be higher 
or equal to the excitation energy.[70] The chemical nature and structure of the analysed 
specimen, in addition to the applied energy is strongly related to the excited states produced 
in the compound.[71] Therefore vibrational spectroscopy allows identifying the chemical 
composition of a wide range of materials and tissues. 
Owing to the high detail in the spectra obtained with vibrational spectroscopy, biochemical 
changes can be detected in tissues. These changes can be related to diseases and can be easily 
detected with these characterisation techniques. Vibrational spectroscopy has demonstrated 
potential to provide diagnostic information in addition to facilitate the prediction of 
biochemical progression on different diseases in a rapid non-destructive manner.[70], [72] 
Mid-infrared FTIR and Raman spectroscopy (RS) are the most popular techniques in this area 
and will be revised briefly in this section. 
2.10.1 RAMAN SPECTROSCOPY (RS) 
When electromagnetic energy in the near-IR, visible or near-UV range is applied to a sample 
2 types of scattering are expected: elastic or Rayleigh and inelastic or Raman. As its name 
suggest the elastic scattering maintains the same frequency as the incident photon. On the 
contrary a loss or gain in energy in comparison with the incident photon occurs in the Raman 
scattering.[70] RS bases its fundament on inelastic scattering and polarizability changes. The 
polarizability change is produced by vibrations when the molecules are irradiated.[73] 
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When light interacts with the electron cloud and bonds of the analysed specimen an excitation 
of the vibrational states occurs. Once the molecule relaxes it emits a photon. The photon’s 
frequency is shifted in comparison with the excitation wavelength owing to the change in 
state. If the scattered photon ends at a less energetic state it is known as Stokes shift or red-
shifted and has a lower frequency. If the photon finish at a more energetic state during the 
scattering the shift it is known as anti-Stokes or blue-shift and has a higher frequency. A 
representation of this it is shown Figure 7. The energy needed to promote the change in the 
vibrational state is the difference between the incident and scattered photon. The difference 
in frequency between the incident and the Raman-scattered lights is known as Raman shift. 
This shift is specific for each individual molecule. Owing to this specificity Raman spectroscopy 
allows the characterization of the chemical composition through the identification of chemical 
bonds and functional groups. [70] 
 
Figure 7. Types of light scattering in terms of energy; maintained (Raleigh), loss due vibration (Stokes), or gained 
by vibration (anti-Stokes), and intensity versus frequency. 
Additionally, Raman spectroscopy can provide information about the quality, quantity of 
certain species and some structural properties such as orientation and symmetry.[74] 
Raman spectroscopy has several advantages for use in biological analysis. RS is considered less 
invasive and the sample preparation is minimum or not required, avoiding the use of reagents. 
In vivo and ex vivo analysis is possible when special accessories such as external probes are 
used. In addition, the depth and spatial high resolution offered by this spectroscopy technique 
provide accurate qualitative and quantitative results.[74] 
The analysis of small volumes of sample has been facilitated through the merge of Raman 
spectroscopy and confocal microscopy. A diagram and brief functioning explanation are 
shown in Figure 8. 




Figure 8. Schematic representation of confocal Raman microscope. A representation of the incident beam is 
coming from the laser (1) and being expanded (2). After this the laser goes through mirrors and optical 
arrangements to pass through a filter (3) before arriving to the objective and interacting with the sample. The 
inelastic Raman scattering is collected though the objective and passed through the filter. Once there is sent 
through a slit to the grating (5) before arriving to the spectrograph. Once in the spectrograph the beam is 
imaged. 
2.10.2 FTIR SPECTROSCOPY 
Nowadays infrared spectroscopy is the most widely spread spectroscopy technique. Its 
popularity is attributed to its outstanding capacity to provide qualitative and quantitative 
information regarding chemical analysis. FTIR spectroscopy offers extensive sample 
techniques possibilities, rapid analysis, and its fast running speed.[71] 
There are 3 regions of infrared (IR), the near infrared (NIR), the mid infrared (MIR) and the far 




Figure 9. Infrared regions and excitations caused by them. 
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When a sample is exposed to infrared radiation excitation in the vibrational modes occurs. 
The molecular vibration causes a change in the dipole moment of the molecules. When this 
change occurs the absorption of energy is obtained and processed. This absorption is 
dependant of the coincidence between the molecular vibrations and the frequencies of the IR 
radiation.[73] 
As this technique is dependent on the dipole moment changes, it is imperative that dipole 
conditions exist in the sample to be IR active.[70] 
Fourier transform infrared (FTIR) spectroscopy is a type of IR spectroscopy in which a 
mathematical process involving Fourier Transform is used for data processing. FTIR 
spectroscopy generates an interferogram as result of the measure of the radiation absorbed 
with and without the sample. The infrared source produces the radiation, passing through the 
interferometer to interact with the sample and then being detected. The detector identifies 
the amount of energy absorbed, then this is amplified, filtered and processed using Fourier 
Transform.[75] The infrared spectrum is a plot of radiant absorbance or transmittance versus 
frequency (cm-1). Figure 10 shows the components of the FTIR Instrumentation. 
 
Figure 10. Schematic representation of FTIR instrument. 
 
2.10.3 FTIR AND RAMAN SPECTROSCOPY COMPARISON 
Raman and FTIR are complementary techniques. As both arise from different phenomena, 
they provide different information. Both techniques have demonstrated to be suitable to 
analyse samples in different states, and to facilitate quantitative analysis and sample 
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fingerprint elucidation. A comparison of both techniques it is shown in Table 9 which has been 
adapted from Larkin et al, 2011 and Rehman et al, 2013. [70], [73] 
Table 9. FTIR and Raman spectroscopy comparison. 
Features Raman FTIR 
Physical effect 
Scattering 
Vibrational state relaxation/ 
Polarisation change.  
Absorption 
Radiation frequency/molecular 
dipole moment change.  
Sample preparation Minimum or not required Required in majority of cases 
Problems 
Fluorescence can be an issue in 
this technique. 
Samples without remaining water 
are needed owing to its strong 
signal 
Materials 
Wide range of synthetic and 
natural materials in different 
states (liquid, gas, solids) 
Natural and synthetic dry 
materials, excluding non-aqueous 
samples. 
Resolution 
Varies depending on laser, usually 
around 0.05-8 µm 
Varies with beam splitters, usually 
around 1-20 µm 
Frequency range 4000-50 cm-1 Mid-IR: 4000-400 cm-1 
Best vibrations 
Best at symmetric vibrations of 
non-polar groups.  
Strong for covalent bonds 
Best at asymmetric vibrations of 
polar groups.  
Strong for ionic bonds 
 
A brief description of some techniques and accessories related to these techniques can be 
found in Table 10.[76] 




Fourier transform infrared spectroscopy in the mid-IR 
Transmission and 
reflection based 
Sample is analysed onto a ZnSe or Si sample carrier. 
Attenuated total 
reflectance (ATR) 
Sample is in contact with an ATR crystal. It provides accurate information 
about the chemical composition of the sample (in contact with the crystal). 
Imaging 
The equipment is attached to a microscope system. It allows mapping analysis 
of areas, points and lines. 
Raman spectroscopy 




Laser power must be selected according to needs and sample. Visible lasers 




Enhancement of signal is based on the resonance. Excitation of this type is in 
resonance with the electronic transition. Achieve 104 signal enhancement 
over normal Raman scattering 
Surface enhanced 
Requires using metal surfaces/colloidal solutions/electrodes. Enhancement is 
achieved by electromagnetic enhancement effect and chemical enhancement 
(which is a charge transfer mechanism). In addition to enhance the signal by 
103-106, it has a fluorescence quenching effect. 
 
2.11 USE OF VIBRATIONAL SPECTROSCOPY FOR BC ANALYSIS 
The use of vibrational spectroscopy allows the characterisation at biological level content. 
Biological characterisation provides further information about cell biology processes such as 
cell cycle, differentiation, transcriptional nature, and apoptosis.  
Breast cancer models had been studied with Raman spectroscopy. A vast number of studies 
have focused on describing the spectral fingerprint of breast tissue. Lipids and proteins have 
been identified as the main differentiation between normal and cancerous breast tissue. A 
major presence of certain lipids such as fatty acids like triolein and oleic acid characterise the 
normal breast while a dominant presence of protein has been reported in cancerous tissue. 
The protein plays an important role not only in cancerous tumours but also in other types of 
lesions such as fibrosis and benign neoplasms. [74], [77], [86]–[90], [78]–[85] 
Grading of breast cancer samples has been attempted successfully using RS. Rehman et al 
reported changes in important biomolecules, such as, nucleic acids, proteins and fatty acids. 
Changes in intensities and peak shifts were observed helping to determine different grades. 
High nuclear grade (HNG) DCIS was characterised by a higher content of lipids represented by 
fatty acids and acylglyceride peaks, while low nuclear grade (LNG) DCIS samples were protein-
rich [89]. These results support the presence of this lipids as energy reservoirs. [91]–[94]. In 
addition, the lipid contain has proved to have an effect on the membrane fluidity and 
therefore on the preparation of the ECM. When the ECM was analysed with Raman 
spectroscopy the surrounding connective tissue presented peaks suggesting an 
overproduction of proteins. Paidi et al reported the preparation of the ECM based on changes 
associated with collagen and proteoglycan components. [95], [96] 
RS allowed disclosing biochemical variations between cancerous and normal cell lines by using 
Chemometric analysis. Talari et al analysed two cancerous cell lines (ER+/PR+ and TN) and one 
normal cell line. This study characterised the chemical differences among cell lines using a 
Raman confocal microscope system. Cell lines differentiation was achieved with statistical 
analysis. Disease status related to lipid metabolism was portrayed based on the different lipid 
vibrations intensities. An increase in the fatty acids in the cancerous cells suggested cancer 
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progression. Content increment was represented by the corresponding peak intensity 
increasing. In addition, this intensity increment was a sign of rapid cell proliferation due to low 
lipid degradation (caused by lipid peroxidation).  Amide groups are structural-functional 
groups of proteins and nucleic acids; therefore, the amide content can provide a good insight 
into the protein and nucleic acids levels. High levels of amides represent a hallmark of cancer 
cells. Principal component analysis of the finger print region suggested a large variation among 
both cancer cell lines. The variation was consistent with the heterogeneity of the disease. 
Therefore, narrower spectral regions were evaluated to identify components that allowed 
differentiation. As result of this, the concentration of proteins and amino acids was suggested 
to be the main difference between malignant and normal cells in agreement with the lack of 
significant difference in the lipid concentration between the triple negative subtype and the 
normal cell line. These results were used to stablish a predictive model using linear 
discriminant analysis which yielded 100% sensitivity and 91% specificity. Talari results 
confirmed that RS has the capacity not only of differentiate among cancer and normal cells, 
but also among BC subtypes.[74]  
The analysis of biopsies using Raman spectroscopy has been exploited due to the enhanced 
resonance of phospholipids and carotene derivatives caused by the use of visible lasers. The 
contribution of these components decreases when carcinoma samples are analysed allowing 
its identification.[78] Haka et al. used Raman spectroscopy to distinguish among benign and 
cancerous breast lesions. This research group used a set of ex vivo samples from 58 subjects. 
A total of 130 spectra were taken with an optical fibre Raman probe system. The diagnosis 
was based on results obtained with the Shafer-Peltier et al spectroscopic model of breast 
tissue.[97] This model uses basis spectra of morphological structures expected in the breast 
tissue to compare with the spectra obtained from the breast tissue sample. The basis spectra 
include cell nucleus, collagen, epithelial cell cytoplasm, fat, β-carotene, calcium 
hydroxyapatite, calcium oxalate dihydrate, cholesterol-like lipid deposits, and water. Based 
on the relation between signal intensity and chemical concentration fit coefficients were 
obtained for each sample. The basis spectra have a value equal to 1 representing the 100%, 
while the sample will have a value >1 for the same component. This fit coefficient will 
represent the contribution of that specific substance or structure in the sample. The obtained 
coefficients were used to stablish the lesion chemical makeup. By using maximum likehood 
estimation the sample probability of representing a benign or malignant lesion was 
determined. The fit coefficients of this study for different lesions allowed identifying some 
chemical changes related to different breast pathologies. The results of this research indicate 
that normal breast is mainly composed of fat while an increase on the collagen content was 
found in all abnormal breast samples. The collagen increment is consistent with the 
proliferation of fibroblast and collagen overproduction caused during scaring in breast 
pathologies. In infiltrating carcinoma, the collagen increment is a consequence of the invasion 
of stromal tissue by cancerous cells which promote the proliferation of fibroblast. In cancerous 
and benign tumours, the fit coefficient corresponding to cell nucleus and epithelial cell 
cytoplasm increased, in concordance with the neoplasm trademark of nuclei enlargement and 
abnormal cell proliferation. The comparison between the nuclear-to-cytoplasm ratios 
reflected that the ratio corresponding to the carcinoma was significantly higher differentiating 
cancer from benign neoplasm. This study suggests that precancerous lesions can be diagnosed 
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by considering the intermediate nuclear-to-cytoplasm ratio. However, this statement might 
not be strictly true as low grade cancers will also present a low ratio. Another significant 
component that allowed the nature differentiation among tumours was the fat. As the nature 
of the tumour become malignant the infiltration of cancerous cells occurs in between fat cells. 
On the contrary, the benign tumour pushes the fat tissue aside to expand the lesion. By cross-
validating the results of this study with the pathologist diagnosis, the use of this Raman 
spectroscopic model had 86% accuracy, a specificity of 96% and a sensitivity of 94%. These 
results indicated the potential of this technique to be incorporate to clinical diagnosis after 
further optimization.[98] A few years later the same group used a new set of samples to 
validate the model. In this occasion a specificity of 93% and a sensitivity of 84% were achieved, 
therefore the potential of Raman spectroscopy for diagnoses was confirmed.[86] 
Haka research has suggested that applying the principles of their proposed diagnosis model 
the diagnosis of BC can be performed clinically by incorporating optical fibres into biopsy 
needles or even to develop a transdermal technology. This suggestion is based on the fact that 
Raman spectroscopy can provide information to an immediate diagnosis of cancer. It is 
important to mention that the weakness of the signal in comparison with other techniques 
such as fluorescence spectroscopy and the use of safe laser powers must be overcome by a 
careful and appropriate system design.[86], [98] 
When fit coefficients are used in spectroscopic models, several factors must be taken into 
consideration. For example, the affectation of chemotherapy drugs and re-excision surgery, 
that leaded to false negatives in Haka et al validation research. The use of fresh or frozen 
tissue has a minimum change in the density-scattering relation. However, it needs to be 
optimized. [86] 
Raman spectroscopy has demonstrated to be a powerful technique to characterise the 
chemical progression of BC. Oncogenic cellular senesce and proliferation has been 
characterised by identifying changes in the configuration of unsaturated lipid isomers (-cis and 
–Trans respectively).[99] As senescence/proliferation is a key process for cancer development 
this information can improve and support the diagnosis process. 
Intensive research in breast oncology has been perform employing infrared spectroscopy. For 
example, different breast pathologies such as hyperplasia, fibroadenoma and carcinoma were 
analysed by Eckel et al using FTIR spectroscopy. The amide region was identified as 
differentiator for these three diseases and normal breast. Shifts to lower frequencies in the 
3000-3600 cm-1 region was characteristic of the malignant samples. This fact has been backed 
up by other groups.[100]–[102] In addition, in the cancerous tissue the -helix amide I 
frequency increased while the -sheet for the same amide band increased.[102] The FTIR 
study of the secondary structure and conformational changes of proteins might offer 
indication on the progression from normal to cancerous epithelial tissue.[103], [104] The 
fibroadenoma was differentiated by the significantly higher absorbance ratio for the bands at 
3300 and 3075 cm-1. The A1680/A1657 absorbance ratio allowed to establish a trend based on 
intensities where carcinoma, fibroadenoma, hyperplasia and normal breast were decreasing 
in intensity as listed. The content of collagen determined using the A1657/A1204 and A1657/A1278 
absorbance ratios increased in intensity as listed in normal, hyperplasia, carcinoma and 




Ling et al found a decrease in the intensity of the symmetric and antisymmetric vibrations of 
the -CH2, (-CH2)n , and C=O vibration in the cancerous samples in comparison with normal 
breast. Moreover, a shift of the P=O or P-O-C bands towards lower wavenumbers was 
identified in the cancerous sample.[100]  
Several useful ratios had been used to differentiate benign and cancerous lesions. Some 
examples are the following presented a significant difference (P < 0.05):  for proteins and its 
structure A1640/ A1550 and A1160/A1120; for lipid and protein content A1640/A1460 and A1550/A1460; 
for lipid structureA1460/A1400; and finally for nucleic acids content A1310/A1240.[101]The 
methylation ratio determined by A2958/A2853 has also been used as a carcinoma biomarker. This 
ratio increases when the cancerous epithelia are analysed. On the contrary, a decrease on the 
A2958/A2853 ratio is found when the stromal component of cancerous samples is analysed and 
compared with the connective tissue of normal breast samples. Hypomethylation can act as 
an indicator of cancerous processes. This methylation behaviour can be explained by 
hypomethylation of DNA, an increase of malignant epithelial cells and the decrease of protein 
fibres in cancerous cases.[105] Also, the area under the band at 2925 cm-1 has been reported 
as a biomarker with a sensitivity and specificity of 100 % when normal and cancerous samples 
are being compared.[104] 
Analysis of BC with FTIR had been carried out with accessories such as Attenuated total 
reflectance (ATR). Rehman et al characterised DCIS and IDC processed breast samples with 
different grades. This study confirms the considerable contribution of DNA, lipids, proteins 
and fatty acids into the FTIR spectrum. Spectra obtained in this study revealed difference in 
positioning and intensity of the peaks suggesting biochemical and compositional changes 
among the cancerous and normal tissues. Different spectral ranges able to identify the grade 
were clearly identified in this research. For example, 1,250 to 960 cm−1 which represent 
changes in collagen, glycogen, ribose, phosphodiester and DNA. The intensity at different 
peaks such as 1030 cm-1 also serves as an indicative of grade. Higher grades had an overall 
increased intensity in comparison with low grade samples. In addition to this, the appearance 
of new peaks such as at 1055 cm-1 as the grade increase represent spectral evidence of 
identification among different types and grades by using FTIR spectroscopy. An interest 
highlight of this study is the suggestion of the validation of the technique and its efficacy to 
support diagnosis disregarding samples age.[106] 
The BC microenvironment has also been studied with FTIR. Kumar et al focused their analysis 
on the extra cellular matrix (ECM) owing to its importance as supporter for growth, 
progression, invasion and metastasis of the tumour. In this study section of BC, samples were 
analysed by FTIR imaging considering the cancer area, and the collagen close to- and far -from 
the cancer tumour. As major findings three bands were identified as markers, the band at 
1653 cm-1 with an increased intensity in the epithelial cell in comparison with its content in 
both ECM-areas and two bands at 1640 and 1630 cm-1 which ratio suggests a progression in 
the collagen as it goes away from the cancerous area. These results propose the use of these 
bands to identify cancer-induced changes in the collagen/stroma component.[107] 
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Devi et al analysed frozen /dried samples of different breast pathologies including BC with 
FTIR. The following bands were used as markers as they differentiated among benign and 
malignant tissue, 538, 853, 935, 1005, and 1080 cm-1. In agreement with the literature a higher 
content of collagen was found in cancerous samples. Furthermore, once more differentiation 
of benign and malignant lesion was confirmed.[102], [108], [109] 
Vibrational spectroscopy has been used extensively to characterise and study different 
process related to BC, a brief summary of relevant findings in this field involving BC and 
vibrational spectroscopy can be found in Table 11. 
Table 11. Summary of Breast cancer findings using Raman and FTIR spectroscopy. 
Findings Technique Reference 
Malignant tissue spectra have a lack of proteins 
peaks 
FTIR-Raman [110] 
Shifts related to malignancy development Near-IR Raman [78] 
Lipid vs protein dominance in normal and 
abnormal tissue 
Near-IR Raman [80] 
Senescent/proliferating state of BC cells by 
configuration in lipids 
Micro-Raman [99] 
Calcification identification Near-IR Raman [111] 
Cancer dominated by arachidonic acid metabolism 
products vs monounsaturated oleic acid and 
derivatives from normal tissue 
Raman imaging [112] 
Feasibility of Raman spectroscopy for in vivo 
intraoperative margin assessment 
Optical fibre Raman 
probe 
[113] 
Suggest relevant peak intensity ratios of serum 
spectra for breast cancer diagnosis 
Raman imaging [114] 
Non-invasively detection and identification of 




Malignant samples have excess of lipids whereas 
benign present excess of proteins 
Near-IR Raman [90] 
Biochemical assessment of heterogeneous lymph 
node features 
Raman imaging [116] 
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Higher DNA duplication activities in tumorigenic 




Proliferation biochemical changes in mammalian 
cells 
Optical fibre Raman 
probe/ FTIR 
[118], [119] 
Spectroscopic detection of early neoplastic 




Spectral range to identify differences among 
different DCIS and IDC grades 
ATR FTIR/ [89], [106] 
Micro-Raman 
Protein bands patterns according to breast 
pathology 
FTIR [102] 
Breast cell cancer growth/cell cycle phases ATR FTIR [120] 
Cancer-induced modifications in collagen FTIR imaging [107] 
Benign vs cancerous characteristic peaks FTIR [108] 
Global effects of miRNAs in MCF7 breast cancer 
cells 
ATR FTIR [121] 
Fibroblast behaviour under cancer stimuli FTIR Imaging [122] 
BC samples analysis and formalin-fixation and FTIR Imaging [123] 
Paraffin-embedding effect on spectra 
Spectral differentiation among different BC stages Fibre optic 
evanescent wave 
Fourier transform IR 
(FEW-FTIR) 
[124] 





Sentinel lymph node (SLN) cancer metastases 
analysis 
FTIR [126] 
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Specific absorption peaks for breast cancer tissues Synchrotron 




Spectral characterization of whole tissue sections 
including cancer and its microenvironment 
FTIR Imaging [109] 
ECM spectral study in 3D BC models FTIR Imaging [128] 
 
2.12 CHEMOMETRICS/ MULTIVARIATE DATA ANALYSIS 
The term Chemometrics is defined by the application of mathematical and statistical analysis 
to chemical data to extract and obtain useful information efficiently. Usually the large number 
of data requires the use of computationally intensive methods.[129] Due to its analytical 
nature several components in one single sample can be detected by using spectroscopic 
techniques. When chemical data is analysed there are several variables to be considered. 
Approaches such as Consider One Separate variable at a Time (COST) are not an efficient way 
to process the data to obtain accurate information. The data managing in a multivariate form 
will always be preferred.[130] 
Analytical characterisation techniques such as spectroscopy measure several variables, and as 
a consequence yields multivariate data. Once this data is processed using different statistic 
methods different approaches can be achieved. For example discrimination or classification 
of the obtained data in order to obtain differences among samples or finding similarities to 
help its classification.[131], [132] 
Data reduction is the aim of using computational multivariate analysis in spectroscopic 
characterisation. This aim is intended due to the great number of values obtained, such as 
thousands of intensity values.[131] 
2.12.1 UNSUPERVISED ALGORITHMS (PCA & CA) 
These types of algorithms are used when the process of data exploration is done without prior 
expectations. The result of this process is the formation of clusters and gradients providing 
information on similitudes and differences.[132] Principal component analysis (PCA) and 
Cluster analysis (CA) are examples of this type of algorithms as they do not know the groups 
prior to the analysis.[131] 
PCA is a multivariate analysis in which a set of related variables are reduced into a smaller set 
of uncorrelated variables.[133] This algorithm is used when correlation exist between the 
variables, allowing to reduce the amount of data. As its name indicates the PCA aim is to find 
principal components. This is achieved by obtaining a principal component (PC) value as 
function of the given variables linear combination and coefficients used to avoid correlation 
between the new variables. PC1 shows the greater variation among the data set, followed by 
PC2, PC3, etc. On the contrary, as the PC score increases the variation decreases. The PCs 
result from the covariance matrix, which is a matrix obtained from the measures of the joint 
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variations. Nevertheless, the correlation matrix can also be used for this purpose, having the 
zero mean variable standardization and unit variance as consequence. The need for 
standardization occurs when different scales are used or when there is a big difference 
between the variance and the domination of a PC will be compromised. The standardization 
will ensure that equal weight would be carried by all variables allowing their comparison. Once 
the PCA data processing has been done, the number of groups identified can be used to 
explain the chemical structure difference among the analysed samples. [131] 
PCA not always provide a good separation between groups; in those cases, other methods 
such as cluster analysis can be used to search for specific groups. Cluster analysis divides the 
specimens into groups of the same class. This grouping is made based on the closeness in the 
variable space based on the Euclidean distance, which is known as the distance between two 
points in an n-dimensional space. The standardizing of the data can also be used for cluster 
analysis, and has the same effect than in PCA, the use of a common scale without one variable 
domination.[131] 
The clustering process can be represented in a dendrogram illustrating the stages of 
clustering, plotting the observations against the distance or the similarity. The similarity is 
considered a function of the Euclidian distance and the maximum distance.[131] 
2.12.2 SUPERVISED ALGORITHMS (LDA) 
These algorithms are used when a previous classification is known. Linear discriminant 
analysis (LDA) is an example of supervised algorithms and is considered a dimension reduction 
method. To distinguish among the different classes a unique label or output value is assigned 
to each of them. After this step, known as training stage, the data is better known as labelled 
observations. This algorithm has as goals to discriminate the data by using classification rules 
(classifiers) that will intend to separate the data to its maximum capacity, and to classify new 
unlabelled data using previous processes.[134], [135] Due to class prediction is the aim of this 
technique and certain rules are defined prior analysis these algorithms are known as 
supervised and are used for validation of chemometric models. 
The optimization of LDA allows to reduce the distance between different classes and to reduce 
it between components in the same class.[135] Through this method and some variations the 
classification of data corresponding to microarrays, and several spectroscopic techniques 
analysing different tissues has been done successfully.[136]–[139] 
2.13 TISSUE MICROARRAYS (TMA) 
Tissue microarrays (TMAs) have been integrated in cancer research due to their many 
advantages and effective use of limited tissue. TMAS are blocks that contain many paraffin-
embedded tissue core samples. Owing to the large number of samples contained in the TMA, 
a rapid, efficient and cost-effective analysis can be performed.[140] This methodology allows 
to analyse hundreds to thousands cases in single sets.  
TMAs can be arranged by clinical information association and have demonstrated to be a valid 
technique to confirm clinic-pathologic correlations in comparison with whole tissue sections. 
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This kind of arrangement allows analysing samples of tumour biopsies at different stages, and 
has been also used to validate the expression of protein biomarkers.[141] 
TMA analysis of different carcinomas has been done in the last years validating this technique 
for cancer diagnosis and research.[142]–[144] The advantages and limitations of this 
technique are shown in Table 12. 
Table 12. Tissue microarrays (TMA) advantages and limitations for tissue analysis. 
Advantages Disadvantages 
Small cores are representative of whole tissue 
sections (WTS).[140], [141] 
Issues related to the size, number, spacing and 
layout of cores.[140] 
Time and cost effective. Allows resource-efficient 
use.[140], [145] 
Trained and experienced histotechnologists are 
required to prepare and analyse the samples in 
order to include relevant lesions.[140] 
Efficient and reliable platform for sub-classifying 
breast cancers into relevant subsets.[141] 
Some tissues (breast, colon, and skin) are 
resistant to being punched, which require extra 
careful preparation.[146] 
Can reproduce clinico-pathologic correlations 
shown by standard sections and controls.[141], 
[145] 
There is not standardization on preparation 
methods (eg. storing and transferring 
temperatures). [146]  
High throughput profiling.[140] 
Duplicate cores are needed to achieve valid 
results representative of WTS.[143] 
Multiple analyses of large number of 
samples.[140], [145] 
Other tissues for orientation purposes are 
recommended.[144] 
Improvement of reproducibility, speed and 
reliability of interpretation as consequence of 
having all the samples in one slide.[145]  
  
Comparison of adjacent sections by staining of 
consecutive slide.[145] 
  
Virtually all tissues are suitable for TMA.[144]  
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CHAPTER 3. MATERIALS AND METHODS 
This study was performed using tissue microarrays (TMAs) containing a large number of breast 
cancer samples and normal breast tissue. The cancerous cohort corresponds to breast 
samples from Nigerian patients. The samples in use were obtained under the Ethical approval 
REC No. 06/ Q1206/180. An example of the TMA aspect is displayed in Figure 11. 
 
Figure 11. TMA appearance, H&E stained TMA (left) and dewaxed TMA for spectral analysis (right). 
The TMAs include an orderly arrangement of duplicate circular cores. These samples were 
removed from hundreds of different breast tumours, normal breast tissue. Other tissues were 
used as controls and for orientation. After selecting and removing the punched samples from 
donor blocks, they were transferred into one empty recipient paraffin blocks as described 
before.[50] Blocks were then sectioned on glass, calcium fluoride slides and MirrIR slides. The 
TMAs were provided by Dr Abeer Shaaban, Consultant pathologist at University Hospitals 
Birmingham NHS Foundation Trust. 
3.1 TMA ASSESSMENT 
Six TMAs containing breast cancer samples and one TMA containing normal breast sections 
were received in duplicates. Theses samples were received with the following information: 
histological tumour type, grade, ER and HER2 status, and patient sex and age at diagnosis. 
The TMAs nomenclature and intended number of samples and orientation cores in each slide 
are shown in Table 13. All the TMAs in this study were received in glass slides. TMA´s A2, B2, 
C2 and normal were additionally received in a second substrate. The additional TMA NGB A2 
and normal were placed in calcium fluoride slides. Calcium fluoride is transparent in FTIR and 
therefore this set was used for this analytical purpose. On the other hand, the additional NGB 
B2 and C2 TMA´s were placed in MirrIR slides. A MirrIR slide (Kevley Technologies, 
Chesterland, Ohio, USA) is a glass slide coated with a thin Ag/SnO2 layer working as a reflective 
substrate which is inert and transparent to visible light. When working on infrared reflection 
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mode this substrate reflects almost completely making it perfect for tissue analysis with FTIR 
spectroscopy.   
Table 13. Tissue microarrays conforming the study cohort. Shaded TMA´s were received in two different 






















378 252 126 
MirrIR FTIR 
NGB D2 Glass Raman 315 188 127 
NGB F2 Glass Raman 273 154 119 





376 268 108 
CaF2 FTIR 
 
The samples cores have 5µm thickness and 0.6 mm diameter. The samples were taken from 
different tumours from different patients. Different human and bovine tissues were used to 
help with the orientation. An orientation grid example can be found in Figure 12. This grid in 
combination with images of the duplicated slides were used to ensure the proper orientation 
and identification of samples. 
In all the slides, duplicates of each tumour were placed next to each other. Duplicated slides 
representing the same sections were used for this study; one slide was used for the 
spectroscopic analysis after dewaxing and the other one for H&E staining. The staining was 
done to identify the cancerous and normal epithelia. Figure 13 shows a schematic 
representation of the use of the duplicate sets. 
 
Figure 12. Orientation grid example. Highlighted cells indicate orientation cores and white cells represent breast 
samples. 
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Figure 13. Use of duplicate sets for spectroscopic analysis and area identification. 
 
3.2 SAMPLES INFORMATION 
Samples from tumours and normal sections were used for spectroscopic analysis. A total of 
578 samples were analysed with RS (499 breast cancer tumours and 79 normal breast 
sections) while a total of 273 samples (245 breast cancer tumours and 28 normal breast 
samples) were analysed with FTIR. Seven TMA’s were analysed with RS, while four TMA’s were 
analysed with FTIR. The difference in samples analysed is due to tissue availability in FTIR 
transparent substrates. 
. 
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Ductal NST (no-special-type) carcinoma was the dominant histological subtype representing 
87.3% of the cancerous cases. The mean patient´s age at diagnosis was 48.62 ± 12.41 years. 
The clinicopathological features of the Nigerian patients and the normal breast samples are 
presented in Table 14. 
Table 14. Clinicopathological features of the studied cancerous and normal tissue. Values expressed as n (%), 
unless otherwise indicated. 
Mean age, years 48.62 (SD 12.41) 
Mean tumour size 63.33 mm (SD 1.24) 
Raman (n=578) FTIR (n=273) 
Cancerous samples 499 (86.33%) Cancerous samples 245 (89.74%) 
Normal breast 79 (13.66%) Normal breast 28 (10.25%) 
Histological grade 395 Histological grade 205 
I 31 (7.84%) I 22 (10.73%) 
II 153 (38.73%) II 69 (33.66%) 
III 211(53.41%) III 114 (55.61%) 
Molecular subtype 395 Molecular subtype 179 
Luminal 121 (30.63%) Luminal 64 (35.75%) 
HER2+ 21 (5.31%) HER2+ 15 (8.38%) 
TNBC 253 (64.05%) TNBC 100 (55.86%) 
 
3.3 DEWAXING AND H&E STAINING OF PARAFFIN SECTIONS 
One of the TMA in each duplicate set was used for spectroscopic analysis and the second one 
was used for area identification. The slide intended for spectroscopic analysis was used after 
dewaxing. In order to achieve free-wax samples, the modified Mian et al dewaxing protocol 
for Raman analysis of tissue was used.[147] The modification in the protocol involved reducing 
the exposition time in xylene based on the thickness of the breast samples. In addition, the 
rehydration of samples was performed using the organic phase, industrial methylated spirit 
(IMS), first and moving on to the aqueous solutions in order to wash all the xylene. The 
chemicals and exposition times used for the dewaxing process is show in Table 15. 
Table 15. Dewaxing protocol for spectroscopic analysis set. 
Time Chemical 
10 min Xylene 
5 min 100% IMS 
5 min 70% IMS 
5 min 50% IMS 
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The second slide of the set was used to identify the cancerous and normal epithelia and 
components of the breast tissue. To allow this identification, Haematoxylin and Eosin (H&E) 
staining was performed after wax removal with Xylene for 5 min, and hydration of the tissue 
sections in 100% (1 min), 70% IMS (30 s) and distillate water (1 min).  The orientation slides 
were stained in Harris haematoxylin solution for 1.5 minutes and washed in running tap water 
for 4 minutes. After this, the slides were counterstained in eosin solution for 5 minutes and 
dunked in tap water twice. The staining process was followed by dehydration through 70% 
and 100% IMS (30s each). As a final step, the slides were cleared in Xylene for 10 min and 
mounted with xylene based mounting medium. Furthermore, the staining helped with the 
identification of the orientation cores and general spatial awareness within the TMA.  
3.4 ADEQUACY OF CORES FOR INCLUSION 
When the TMAs are prepared, the loss of cores and the folding of samples during sectioning 
can be observed. These issues can be related to the tissue type, and the preparation of the 
sample´s variables such as thickness or drying. The core retention can be affected by poor 
process and by the tissue nature. Considering all this, it is important to define the terms used 
on this study. 
 Core loss: include all the missing samples on the TMAs and cores with less than 10% of 
the original core size remaining. Owing to the orientation template and the grid 
positioning of the cores, it is easily identifiable which cores are missing. 
 Incomplete core: There are considered incomplete cores those whom maintain less than 
50% of the original core size, but more than 10%. 
 Complete cores: cores with sample quantity greater than or equal to 50% of the original 
core. 
The eligibility criteria for Raman and FTIR analysis required cores to have: 
 An H&E stained core and its dewaxed duplicate. 
 In the NGB TMA´s, identifiable cancerous areas by using the H&E stained slide. 
 A complete or incomplete core. 
As it was previously indicated, the samples are presented as duplicates; since core loss can 
exist only for one of these duplicates the spectroscopic analysis was performed for all the 
samples that meet the inclusion criteria. 
3.5 AREA IDENTIFICATION 
Once one slide of each duplicate set was stained using the H&E protocol previously reported 
the TMAs were scanned. The comparison of the H&E and the light sample was performed to 
identify the regions where the spectra needed to be taken. In the cancerous samples, the 
cancerous epithelium was the area of interest while in the normal breast the normal 
epithelium was the one analysed. In some cancerous samples, infiltration of cancerous cell 
into stroma was present. However, the analysis of these cancerous cells was not performed 
as it lies outside the scope of this research.  
A tutorial on morphology of normal mammary tissue, in situ and invasive cancer including its 
various types was received to ensure the adequate differentiation between normal and 
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cancerous tissues. This tutorial was conveyed by Dr Abeer Shaaban, Consultant pathologist in 
the Histopathology University Hospitals Birmingham NHS Foundation Trust department at 
Queen Elizabeth Hospital Birmingham. A subsequent joint analysis of TMAs including difficult 
cases revealed excellent concordance. 
The identification of the cancerous areas and the normal tissue was performed for all the 
samples where they existed both, the H&E stained sample core and its dewaxed analogue 
sample.  
3.6 VIBRATIONAL SPECTROSCOPIC CHARACTERISATION 
3.6.1 RAMAN SPECTROSCOPY DATA ACQUISITION 
Raman spectroscopy was used only in TMA´s placed in glass as indicated in Table 13 and Figure 
13. Raman spectra were collected using a Thermo Scientific high performance DXR confocal 
Raman microscope. Once the cancerous epithelial cells in the NGB TMA´s and the normal 
epithelium in the normal TMA were identified with the help of the H&E images, 20 random 
points within each area were analysed with the conditions displayed in Table 16 as it is 
illustrated in Figure 14. Each random point spectrum took 150 seconds, and the 20 sample 
points were completed in 50 minutes. The sample points represented in Figure 14 were 
obtained with 50X long work distance objective and a 3D spatial resolution of  1 µm (x, y) and 
2 µm depth resolution. Each core shown in Figure 14 took 10s to image  
Table 16. Raman spectroscopy analysis conditions. 
Raman conditions 
Laser wavelength 532 nm diode laser 
Alignment and calibration Polystyrene standard 
Objective 50x long work distance (LWD) 
Laser power 10 mW 
Aperture 50 µm pinhole 
Exposure time 10 s 
Number of exposures 15 
Number of background exposures 512 
Corrections Fluorescence polynomial 6 
 
 




Figure 14. Example of area identification and random points selection for spectral analysis of an invasive ductal 
carcinoma. (i)H&E for area identification, (ii) Light image of core for spectroscopic analysis (iii) Random points 
selected for spectral acquisition in the cancerous area (red). 
Considering the thickness of the samples, glass was sometimes detected in the spectra. The 
software Omnic for dispersive Raman (Thermo Scientific, USA) was used to subtract the glass 
contribution and to obtain averages of each sample, duplicate or single cores depending on 
availability.  
3.6.2 FTIR SPECTROSCOPY DATA ACQUISITION 
FTIR spectral acquisition was collected only in the CaF2 and MirrIR slides as indicated in Table 
13 and Figure 13. Spectral collection was performed using an iN10 MX Nicolet Infrared Imaging 
Microscope using the reflection mode. Twenty spectra were collected randomly from the 
cancerous epithelia in the NGB samples and from the normal epithelia in the normal TMA. The 
conditions used for spectra collections are shown in Table 17 and the point selection is 
illustrated in Figure 14. Using the UltraFast Mapping mode, a 1.2 × 1.2 mm area took 4.5 
minutes to scan, with a spatial resolution 25 µm and a spectral resolution of 8 cm-1. 
Table 17. FTIR spectroscopy analysis conditions. 
FTIR conditions 
Mode Reflection 
Background standard Gold plate 
Beamsplitter KBr 
Number of scans  16 
Spectral range 675-4000 cm-1  
Resolution 8.0 cm-1 
Detector Liquid nitrogen cooled MCT-A 




3.6.3 DATA ANALYSIS 
The statistical data analysis was performed using Unscrambler X 10.2software (Camo 
software, Oslo, Norway). Unsupervised (PCA & Cluster analysis) and supervised multivariate 
approaches (LDA) were used in data analysis. The data was pre-processed using baseline, 
Savitzky-Golay smoothing and standard normal variate (SNV) corrections. 
Principal component analysis (PCA) was performed on the spectral regions showed in Table 
18 for Raman spectroscopy and in Table 19 for FTIR spectroscopy. The dots presented 
throughout the score-plots represent the average spectrum of the spatial points collected for 
a specific sample. 
Table 18. Spectral regions used for Raman spectroscopic analysis. 




Aminoacids and nucleic acids 980-600 
Lipids 3100-2680 
Hydroxyproline and proline 960-810 
 
Table 19. Spectral regions used for FTIR spectroscopic analysis. 
Spectral region Spectral range (cm-1) 
Lipids 3500-2550 
Proteins  1700-1500 
Nucleic acids 1250-1000 
Fingerprint 1450-600 
 
Linear discrimination analysis (LDA) was used to validate the chemometric model over the full 
spectral range. Five samples from each group were left out at each pass until the total number 
of spectra of each type were predicted. 
Sensitivity of this model was calculated using correctly classified false positive, false negative 
and true negative. Formulas used for calculation of sensitivity and specificity are: 
 
Sensitivity =  
True positive














Results and  
discussion 
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CHAPTER 4. FTIR ANALYSIS OF NORMAL BREAST AND BREAST CANCER 
 
The results presented in this section include the FTIR spectral analysis of 3 tissue microarrays 
containing African breast tumours from similar tribal origins in Nigeria including different 
grades and subtypes and one TMA containing normal breast sections. 
Twenty spectra were obtained from the epithelial tissue of each sample. A total of 245 
cancerous tumours (359 cancerous sections) and 28 normal breast (37 normal breast sections) 
were analysed with FTIR spectroscopy. The average spectra of the cancerous epithelia named 
cancerous area (CA) and the normal epithelia which will be referred to as normal breast (NB) 
are presented in Figure 15. 
When compared, the spectral profile of both tissue types presented characteristic bands 
associated with the presence of carbohydrates, lipids, nucleic acids and proteins as shown in 
Figure 15. The variance presented in the spectroscopic data has been plotted and shown in 
Figure 16. The spectral bands and their assignments are listed in Table 20 with the assignments 
taken from Movasaghi et al and Rehman et al [148], [149]. Overall, the bands found in the 
cancerous area spectrum are shifted towards lower wavenumbers in comparison with the 
normal breast bands. This downshift has been reported in cancerous samples by different 
research groups. [102], [105], [106] 
Furthermore, differences in the intensity of peaks were identified between normal and 
cancerous tissue as it can be seen in Figure 17. The cancerous area spectra had a higher overall 
intensity which suggested biochemical changes associated with the disease. The increased 
intensity in C-H bands can be considered as an indicator of an increase of cellular components 
such as lipids, nucleic acids and proteins.  
 
Figure 15. FTIR average spectra of cancerous area (CA) and normal breast (NB). 
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Figure 16. FTIR average spectra of Breast cancer (CA) and normal breast (NB), variance is represented with grey 
shadow. 
Table 20. FTIR spectral bands of cancerous area (CA) and normal breast (NB) spectra averages with 









nN‒H (protein)  
N‒H stretching of amide A 
and O‒H stretching of 
carbohydrates 
3305  Amide A band 
3065 C2C–H2 aromatic stretching 3075 
CH stretching band of the 
phenyl rings 
2955 
 Asymmetric stretching 




symmetric stretching of CH3 
2919 
Stretching C–H. Cholesterol 
ester. CH2 asymmetric 
stretching: mainly lipids, 
with the little contribution 
from proteins, 
carbohydrates, nucleic acids 
2922 
Asymmetric stretching 
vibration of CH2 of acyl 
chains (lipids) 
2873 
CH3 symmetric stretching: 
protein side chains, lipids, 
with some contribution from 
carbohydrates and nucleic 
acids 
2873 
CH3 symmetric stretching: 
protein side chains, lipids, 
with some contribution from 
carbohydrates and nucleic 
acids 




Stretching C–H  
ns CH2, lipids, fatty acids. CH2 
symmetric stretching: mainly 
lipids, with the little 
contribution from proteins, 
carbohydrates, nucleic acids 
2852 
Symmetric stretching 
vibration of CH2 of acyl 
chains (lipids) 
Stretching C–H. ns CH2, 
lipids, fatty acids 
CH2 symmetric stretching: 
mainly lipids, with the little 
contribution from proteins, 
carbohydrates, nucleic acids 
1653 
Amide I absorption 
(predominantly the C=O 
stretching vibration of the 
amide C = O) 
Protein amide I absorption 
C = O, stretching C=C uracil, 
NH2 guanine 
Peptide amide I 
C=O stretching of amide I 
Amide I (protein) 
Amide I α-helix 
1663 
Amide I band. n(C = C) cis, 
lipids, fatty acids. C=O 
Cytosine, uracil 
1536 
 Stretching C = N, C = C. 
Amide II 
1545 
Protein band. Amide II (dN-
H, nC–N). Peptide amide II 
1451 
Methylene deformation in 
biomolecules. Polyethylene 
methylene deformation 
modes. CH3 symmetric 
deformations. Asymmetric 
CH3 bending modes of the 
methyl groups of proteins. 
CH2 bending: mainly lipids, 
with the little contribution 
from proteins 
1450 
Asymmetric CH3 bending of 





modes. CH3 symmetric 
deformations. Asymmetric 
CH3 bending modes of the 
methyl groups of proteins. 
CH2 bending: mainly lipids, 
with the little contribution 
from proteins 
1390 
 Stretching C–O, deformation 
C–H, deformation N–H 
1400 
Extremely weak peaks of 
DNA and RNA arise mainly 
from the vibrational modes 
of methyl and methylene 
groups of proteins and lipids 
and amide groups. 
Symmetric CH3 bending 
modes of the methyl groups 
of proteins. Symmetric 
stretching vibration of COO− 
group of fatty acids and 
amino acids. Symmetric 
bending modes of methyl 
groups in skeletal proteins 




δ(CH), ring (polysaccharides, 
pectin) CH2 wagging. 
Collagen 
1334 
δ(CH), ring (polysaccharides, 
pectin) CH2 wagging. 
Collagen 
1308 Amide III   
1233 
Overlapping of the protein 
amide III and the nucleic acid 
phosphate vibration.  nPO2− 
asymmetric  
1234 
Composed of amide III as 
well as phosphate vibration 
of nucleic acids. PO2− 
asymmetric (Nucleic acid) 
1172 
CO‒O‒C asymmetric 
stretching: ester bonds in 
cholesteryl esters.  
Stretching modes of the C‒
OH groups of serine, 
threonine, and tyrosine 
residues of cellular proteins. 




Vibrational modes of 
collagen proteins‐amide III 
1071 
Symmetric phosphate [PO2− 
(sym)] stretching. Nucleic 
acid band 
1080 Nucleic acid band 
1066 
C‒O stretching of the 
phosphodiester and the 
ribose. PO2− symmetric 
stretching of nucleic acids 
1033 
n(CC) skeletal cis 
conformation, n(CH2OH), 
n(CO) stretching coupled 
with C‒O bending. Stretching 
C‒O ribose 
969 
C‒N‒C stretch: nucleic acids, 
C‒N‒C stretch: nucleic acids 
972 
nPO4 of nucleic acids and 
proteins 
 
Likewise, as seen in Figure 17C the shifting and increased intensity in the 1500-1700 cm-1 area 
associated with nucleic acids and amide stretchings might suggest changes in the 
conformational structure of proteins in the cancerous tissue. [106]  
The band associated with the asymmetric stretching of CH2 of acyl chains (lipids) was shifted 
to a lower wavenumber (2922.2 to 2918.7 cm-1) on the cancerous area. This shift is related to 
an increment of trans- lipids conformations. A higher content of the trans- conformations 
translates into a higher order in lipids by decreasing the flexibility of the acyl chain. Studies by 
Spector et al. had reported the cell shape change based on the lipid order. Therefore, a change 
in the cell shape by modifications on the cell membrane fluidity can support and promote 
malignant activities as well as signalling pathways associated with carcinogenesis. [121], [150]  




Figure 17.  FTIR characterisation of cancerous area (CA) and normal breast (NB). (A) General region (4,000-675 
cm-1), (B) High wavenumber region (3,500- 2,550 cm-1), (C) Amide region (1,700-1,500 cm-1), and (D) 
Fingerprint region (1,450-600 cm-1). 
The intensity of peaks at 1334, 1204, and 1033 cm-1 is considerably higher in the normal 
breast in comparison with the cancer area. These peaks have been attributed to collagen 
vibrations and seem to appear sharper and stronger for normal tissues. Low content of 
collagen can be suggested as part of the FTIR spectral profile of breast cancer samples. 
Additionally, the shift from 1160 cm-1 to 1171 cm-1 in the cancerous area has been reported 
as an increase of the cancerous cells in malignant tissue. This band is characteristic of C–O 
stretching of the parenchymal cells phosphorylated proteins. [105] On the other hand, this 
band is also associated with the CO‒O‒C asymmetric stretching of ester bonds in cholesteryl 
esters. The increased intensity at 1171 cm-1 on the cancerous area might be an affectation on 
the cell membrane fluidity in addition to the highest cholesterol requirement reported on 
malignant tissue. [121] 
Different absorbance ratios have been used as biomarkers for different biochemical changes. 
For example, the A2958/A2853 ratio can provide an insight on methylation, A1657/A1204 and 
A1657/A1278 indicate the collagen content relative to the protein content, A1640/ A1550 and 
A1160/A1120 give information on proteins and its structure, A1640/A1460 and A1550/A1460 indicate a 
ratio of lipid to protein content, while A1310/A1240 provide information on the nucleic acid 
content. When deconvolution of spectra is performed the following ratios can be obtained: 
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A3300/A3075 gives an idea on how dense and close-packed structural the tissue is, whilst 
A1657/A1635 reflect the content of α-helix and β-sheet domains in tissue proteins. The ratios for 
the cancerous area and the normal breast are presented in Figure 18. 
 
Figure 18. Selected absorbance ratios of cancerous and normal breast tissue. 
The first ratio, A2958/A2853 has a stretch relationship with the grade of methylation. The ratio of 
the methyl stretching band to the methylene band was smaller for the cancerous tissue in 
comparison with the normal breast. This reduction in the ratio from normal to malignant 
tissue has been explained through the DNA hypomethylation and the overall increase of 
malignant cellular content. In addition, it has been suggested that a reduction of protein fibres 
in the cancer tissue. [105] This finding can be supported by the ratios representing the content 
of collagen relative to the total content of protein, (A1657/A1204 and A1657/A1278),  which are 
higher for the normal breast tissue.   
Once the deconvoluted IR spectra for the CA and NB amide area was obtained the 
deconvoluted peaks for α-helix (1657 cm-1) and β-sheet (1635 cm−1) protein structures were 
clearly identified as seen in Figure 19. In agreement with the downshift presented in the CA 
spectrum, both peaks presented a shift towards lower wavenumbers (1659 and 1632 cm-1) in 
comparison with the normal breast (1666 and 1635 cm-1). Moreover, the β-sheet cancer peaks 
presented a higher intensity in components with the normal breast. This increased intensity 
explains the CA broader Amide I peak. The A1657/A1635 ratio showed a higher quantity of α-helix 
conformation in the normal breast in comparison with cancerous tissue. These behaviours 
indicated changes in the number of hydrogen intermolecular bonds in the secondary 
structural conformation. [102] It can be suggested that β-sheet structural proteins are more 
present in cancer tissue and that structural changes form an important part of the 
carcinogenesis process. Studies focused on the analysis of breast tumour microenvironment 
had reported β-sheet conformations surrounding the cancerous epithelia and changing 
towards an α-helix conformation as they move far from the tumour. [107] 
As product of the deconvolution of the FTIR spectrum of normal breast, a band located at 
1593 cm-1 was identified only in the normal tissue. This band is associated with the vibrations 
of the C-C stretch of the phenyl ring. [149] The identification of the deconvoluted band 
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addition, the high content of collagen visible in the normal breast sections can contribute 
towards this vibration. 
Based on the A1657/A1204 and A1657/A1278 ratios, a lower content of collagen relative to protein 
content has been found in the cancerous samples. Therefore, the presence of collagen in the 
normal breast samples seems to be dominant while a higher content of proteins constituting 
the malignant epithelia is present in the cancerous samples.  
 
Figure 19. (A) Stacked deconvoluted peaks of FTIR spectra in the amide area (B) Overlaid comparison of 
spectra presented in (A). 
The stretching band of C-OH in the cancerous tissue is shifted towards a higher wavenumber, 
1171.5 cm-1, while the band representing the same effect on the normal breast is presented 
at 1160 cm-1. This shift is caused by the increased non-hydrogen bonded C-OH groups in the 
cancer tissue reflecting the phosphorylation of the cellular proteins. The phosphorylation of 
the C-OH groups in proteins is characteristic of the carcinogenesis process. In this process, the 
–OH groups are replaced by larger phosphate groups. By breaking this hydrogen bonds some 
of the structures like the β-sheets no longer exist leaving behind unordered structures. [103] 
When the A1640/A1460 (Amide I/Lipids) and A1550/A1460 (Amide II/Lipids) ratios were compared 
both of the cancer ratios were higher. This result implies a lower content of lipids relative to 
the protein content for the cancer tissue, whereas the opposite trend is true for the normal 
breast epithelia. 
The cancerous cohort represents a heterogeneous group of cases, therefore, a comparison of 
several spectra for both cases can provide a better insight of the malignant behaviour and all 
Chapter 4. FTIR analysis of normal breast and breast cancer 
69 
 
the biochemical processes associated with the cancer progression. For this end, the results of 
the multivariate analysis are presented in the next sections. 
4.1 GENERAL REGION (4,000-675 CM-1) ANALYSIS OF NORMAL BREAST AND BREAST 
CANCER 
Principal component analysis was applied to the spectral general region. Each dot in the score 
plot presented in A of Figure 20 represents the average spectrum of all the spatial random 
points taken from either a normal breast (blue dot) or a breast cancer tumour (red dot). Good 
separation was obtained with principal component 3 and 5, accounting for 15% of the variance 
as it can be seen in the score plot presented in Figure 20A.  
A clear grouping can be seen for the cancerous area and the normal breast. CA and NB samples 
are presented at opposite sides of both principal components axis. The peaks responsible for 
the separation of cancerous and normal tissue on the score plots are 3275, 2963, 2916, 2849, 
1669,1633, and 1530, cm-1.  
The first peak located at 3275 has been correlated to the N‒H stretching of amide A in 
proteins and nucleic acids. [102] This peak seems to indicate a higher vibrational activity on 
the cancerous area in comparison with the normal breast. In the previous section, an overall 
downshift in the cancer area spectral profile was mentioned. This is the case for the amide A 
peak which went from 3304 cm-1 in NB to 3281 cm-1 in CA. This downshift might result from 
an increase on the hydrogen bonds of secondary structures in proteins. [151] In addition, 
important differences in intensity and broadness can be detected with the naked eye when 
spectral profiles are compared. These differences suggest that the cancerous areas contain a 
significant amount of extracellular components such as proteins and nucleic acids, which are 
necessary to promote and sustain the abnormal characteristic proliferation of cancerous cells. 
These findings are in agreement with previous reports. [102], [149] 
The peak presented at 2963 cm-1 is associated with the asymmetric stretching vibration of 
CH3 of acyl chains in lipids, but also with some contribution from nucleic acids and 
carbohydrates. [121], [149] Based on the positive peak found in the PC-2 loading and the 
positive location of the cancerous samples in the PC-2 axis in the score plot, a higher content 
of acyl chains in the cancerous area can be assumed. The increased content of unsaturated 
bonds in the lipid components in the cancerous tissue has been previously reported to have 
an effect on cell adhesion molecules in the cell membrane, as well as interactions between 
cell adhesion molecules and lipid components in the membrane. In addition, changes in the 
conformational structure of proteins have affectation on the physical behaviour of the cell 
membrane and therefore on the membrane fluidity. All these changes will modify the 
permeability of the membrane and how it will respond to its physical environment and 
radiation. [152], [153] 
The peak at 2916/2918 cm-1 presented in both principal components –PC3 and PC5–  has 
been associated with the asymmetric stretching of CH2 bonds mainly in lipids. The next peak 
identified - 2849 cm-1- is also attributed to stretching vibration of lipids but asymmetrically. 
Little contribution from proteins, carbohydrates, and nucleic acid has also been reported for 
both peaks. This vibration has been closely related to the stretching in cellular membrane 
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lipids. [106], [149]  Based on the location of the majority of the CA point in the score plot a 
higher content of the lipids in the cancerous areas can be assumed. During carcinogenesis 
important lipid modification on the cellular membrane take place. These changes are reported 
to affect the permeation and the transport of metabolites considerably. Also, the accelerated 
and constant production of lipids is needed to fuel the malignant metabolism. [154]  
Within the analysis of the whole spectral range, three peaks associated with amide vibrations 
and its different conformations were identified as biomarkers for the classification of breast 
cancer and normal breast. These peaks are 1669, 1633, and 1530 cm-1 and represent the 
amide I α-helix (1669 cm-1) and amide I β-sheet (1633 cm−1) domains in proteins and the Amide 
II vibration comprising the N–H bending and C–N stretching predominantly in α-helix (1530, 
cm-1). [102] The scattering of cancerous samples on the score plots toward the negative axis 
in PC-3 suggested that the malignant areas presented more vibrations associated with the 
amide I β-sheet conformation and the amide II vibration in comparison with the normal 
breast. Furthermore, PC-5 reinforced the previous finding by confirming that normal breast 
presented less active amide I α-helix vibrations associated with the 1669 cm-1 peak in 
comparison with CA samples.  
When the PCA model created using the whole spectral range was validated using Linear 
discriminant analysis (LDA) a sensitivity of 92% and specificity of 86% was confirmed.  
Cluster analysis was obtained for the cancerous area and normal breast samples. The analysis 
was set up to recognize 10 clusters to facilitate separation as it can be seen in Figure 21. The 
fourth cluster presented in plot D is formed by most of the normal breast samples. However, 
some of the normal samples are located on B, E, and H. The infiltration of normal samples into 
cluster mainly formed by cancer samples confirmed the heterogeneity of our cohort. The 
cancerous samples analysed with this method represented different grades and subtypes, and 
as a result, present different characteristics that might resemble the normal tissue. Therefore, 
the clustering of both type of samples.  
4.2 ANALYSIS PER REGION OF NORMAL BREAST AND BREAST CANCER 
The previous analysis of the general region offered peaks responsible for the separation of 
cancer and normal samples. These peaks were located among the higher wavenumber, amide 
and fingerprint regions. Further analysis in each region was carried out to identify more 
biomarkers and these are presented in the following sections. 




Figure 20. Principal component analysis of the general region (4,000-675 cm-1). (A) Score plot using PC-3 and PC-5 accounting for 15% of the variance, (B) Average 
spectral profile for breast cancer and normal breast. Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in 
C&D, (C) PC-3 Loading, (D) PC-5 loading.




Figure 21. Cluster analysis of Cancerous area (CA) and Normal breast (****NB****). The analysis was set up to identify ten groups presented from A to J. 
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4.2.1 HIGHER-WAVENUMBER REGION (3,500–2,550CM−1) ANALYSIS OF NORMAL BREAST 
AND BREAST CANCER 
Principal component analysis was used to identify changes and variations in the higher-
wavenumber region. The best separation of cancerous and normal breast areas was found 
using PC-1 and PC-4 which were accountable for 82% of the variance as it can be seen in Figure 
22. 
The peaks located at 3264, 3173, 2930, 2903, 2861, 2842 cm-1 were identified as responsible 
for the grouping of the cancerous area and normal breast.  
The first peak at 3264 cm-1 was reported in the general region analysis and attributed to the 
N‒H stretching of amide A in proteins and nucleic acids. The band at 3173 has been reported 
as N-H stretching bands with cis configuration. The amide A band of proteins is presented 
around 3000 cm-1 with a characteristic shoulder at 3130 cm-1 representative of a secondary 
amide. This shoulder presents Fermi resonance from the combination of the N-H stretching 
with either the trans- or cis-conformation of the secondary amide overtone. [155] The normal 
tissue presented a lower contribution of the 3173 peak, whereas the cancerous area samples 
equally distributed among both PC-4 axes as it can be seen in Figure 22A. This spreading 
behaviour indicates a dynamic behaviour among the cancer samples in our cohort.  
The bands located at 2930 and 2842 cm-1 are attributed to both antisymmetric and 
symmetric CH2 stretching of hydrocarbon chains. These assignments are mainly correlated 
with long chains characteristic of lipids like ceramides, glycolipids and phospholipids. [156] 
Ceramides act as precursors for regulators of cell growth, proliferation and motility. [157] In 
the average spectra presented in Figure 22B, clear differences in position, intensity and width 
can be appreciated. It can be suggested that important changes in the conformation of lipids 
are taking place during carcinogenesis as the cancerous samples present higher contributions 
on these peaks in comparison with the normal breast samples. Changes in the lipid 
conformation and affectation on the lipid membrane fluidity during carcinogenesis had been 
widely reported by different research groups. Lipid modifications promote the signalling and 
stimuli to facilitate processes such as proliferation and cell adhesion. [158]–[160]  
Furthermore, the peaks positioned at 2903 and 2861 cm-1 provided further information on 
the CH3 symmetric stretch, and aliphatic C-H stretching in fatty acids and lipids. Both 
contributions were higher in the cancerous tissue confirming modification on the lipid 
metabolism. Breast cancer has shown high rates of production of novo lipids. Lipids play vital 
roles in different phases of tumorigenesis. Their involvement in the membrane synthesis and 
membrane saturation directly affect the cell growth, cell proliferation and the resistance to 
oxidative stress. Other important components are the lipid droplets. The lipid droplets are 
formed by triacylglycerides and cholesterylesters. Fatty acids are moved from the lipid store 
and are used as a source of energy through β‐oxidation. Besides, cancer cells seem to present 
higher numbers of lipid droplets compared with normal tissue. The activated storage of 
triacylglycerides in lipid droplets has been suggested to work as fuel source after re-
oxygenation during intermittent hypoxia. Fatty acids also promote redox balance supporting 
a high-glycolytic rate. In addition, lipids form the structural basis of paracrine hormones and 
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growth factors which promote tumour growth, neovascularisation, invasion, and metastatic 
spread. [160] 
4.2.2 AMIDE I AND AMIDE II (AMIDE I/II) REGION (1,700-1,500 CM−1) ANALYSIS OF 
NORMAL BREAST AND BREAST CANCER 
The principal component analysis of the spectral region from 1700-1500 cm-1 showed good 
separation and grouping when PC-2 and PC-3 are compared, as shown in Figure 23A. The 
average spectral profile of the analysed cancer area and the normal breast are presented in 
Figure 23B. These profiles present three peaks each. However, as in other regions these peaks 
are the product of the convolution of different spectral contributions as presented in Figure 
19. When the loadings were analysed the following peaks were identified as responsible for 
the separation and grouping of both sample types: 1668, 1646, 1612, 1568, 1552, and 1528 
cm-1. 
The first peak located at 1668 cm-1 seems to indicate the normal breast shifted peak assigned 
to α-helix found in proteins. Accordingly, the contribution of this band is higher for the normal 
breast. Half of the cancerous samples are located in the PC-3 negative axis. The location of 
these samples suggests a dynamic behaviour regarding conformational changes in proteins at 
different stages of carcinogenesis. The samples in the mentioned location presented a higher 
intensity on the band positioned around 1646 which is mainly associated with β structures 
and unordered random coils. This changes in intensity and the spread of samples on both axes 
suggests a transition from α-helix structures into β-sheet structures as cancer progress. [102] 
Cancer epithelia presented higher  1612 cm-1 intensities in comparison to normal epithelia. 
This band is representative of adenine vibration in DNA. [149] Therefore, a higher content of 
nucleic acid content is assumed and is considered in agreement with the increased cellular 
content expected in abnormal proliferation. In addition, the peak identified at 1568 cm-1 
seemed to have a higher contribution for all the normal breast samples and half of the cancer 
area samples.  
The 1568 cm-1 peak has been assigned to amide II but also to C=N of adenine and guanine. 
Once again, the cancer samples demonstrate different behaviour having less and more 
content of amide II and pair bases than the average while the normal breast proved a constant 
increased behaviour probably because of the stromal collagen. High cell density characteristic 
of accelerated proliferation and invasive processes can be suggested for the samples located 
on the positive access of PC-3. 
Amide II also is represented by the peak at 1552 cm-1 which is characteristic by the C-N 
stretching and the N-H bending of the amide II. [161] The contribution of this peak is higher 
in all the normal breast samples. This band is characteristic of the collagen component in the 
stromal area. It has been suggested that the stromal component has been included in the 
spectral analysis due to the low cell density (in comparison with CA) in the normal epithelium.  
Stretching characteristic of C=C and C=N specific for guanine and adenine nucleic bases 
represented by the band found at 1528 cm-1 (deconvoluted spectra) presented higher 
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intensities in half of the cancerous samples. This behaviour suggested a higher cell density, 
but also a higher cell components content characteristic of active proliferation. [74] 
4.2.3 FINGERPRINT REGION (1,450-600 CM−1) ANALYSIS OF NORMAL BREAST AND BREAST 
CANCER 
When principal component analysis was applied to the fingerprint region, a clear separation 
and grouping were achieved. Cancer and normal breast samples were placed on different axis 
on PC-4 and PC-5 accounting for <2% of the variance as it can be seen in Figure 24. 
The peaks located at 1427, 1385, 1366, 1332, 1236, 1194, 1051, and 882 cm-1 were identified 
in the loading plots as responsible for the grouping and separation of CA and NB samples.  
The band at 1427 cm-1 has been assigned to CH2 vibrations in lipids, especially fatty acids. 
[149] The cancerous area analysed presented higher intensities for this band suggesting an 
active lipid metabolism and transformations. This behaviour is in agreement with the results 
previously reported in the higher wavenumber region.  
The stretching of C-O, deformation of C-H and N-H is represented by the 1385 cm-1 peak. 
[149] The vibrations represented by this peak are mainly associated with proteins and nucleic 
acids. This band has a higher contribution in the cancerous samples suggesting either higher 
cell contents or higher cell density. [106] A higher cell density is characteristic of higher grades 
and can explain the spreading of the cancerous samples. Similar behaviour was detected with 
the peak at 1366 cm-1 which is representative of the same vibrations. A shoulder 
representative of this band can be appreciated in the spectral profiles shown in Figure 24B. 
Figure 24B showed important differences in the 1332 cm-1 peak. This band has been reported 
as a collagen-specific peak and an increased intensity has been attributed to higher contents 
of collagen. [162] This peak presented higher intensities in the normal breast samples. 
Collagen-specific vibrations like this reinforced the idea of the stromal spectral acquisition 
when the normal breast was analysed. Furthermore, the band at 1194 cm-1 also represent a 
vibrational mode of collagen, amide III.  
The assignment located at 1236 cm-1 has been correlated with the phosphodiester 
asymmetric stretch in nucleic acids, but also is representative of amide III and CH2 wagging 
vibrations of collagen. [105] When the contribution of this peak was evaluated all the normal 
breast and half of the cancer samples presented higher intensities than the rest half of the 
cancerous samples and the average intensity. The collagen found and included in the normal 
breast analysis is responsible for the integration of the normal samples in this category due to 
the amide III vibration. This amide III peak arises from the C–N stretching and N–H 
deformation. [163] On the other hand, the 1236 cm-1 band is highly representative of nucleic 
acids content. The cancer samples that presented higher intensities of this peak are suggested 
to present higher cell density and cell component. This band is representative of two different 
contributions, and both sample types present different biochemical behaviour. Hence the 
difference in the spectral profile presented in Figure 24B.  
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The band located at 1051 has the highest contribution in the cancer area samples according 
to their positions in the score plot in Figure 24A. This peak is assigned to the C-O-C stretching 
of DNA and RNA and the combination of the C-O stretching and C-O bending. [149] A clear 
visual representation of the relevant contributions of this band can be appreciated in the 
average spectral profile of the cancerous sample in Figure 24B. This peak suggested a higher 
content of nucleic acid components which characterise malignancy and aggressive behaviour. 
[164] 
 




Figure 22. Principal component analysis of the higher wavenumber region (3,500 -2,550 cm-1). (A) Score plot using PC-1 and PC-4 accounting for 82% of the 
variance, (B) Average spectral profile of the higher wavenumber region for breast cancer and normal breast. Dotted lines represent the peaks found as responsible 
for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-4 loading.  




Figure 23. Principal component analysis of the amides region (1,700-1,500 cm-1). (A) Score plot using PC-2 and PC-3 accounting for 17% of the variance, (B) Average 
spectral profile of the amides region for breast cancer and normal breast. Dotted lines represent the peaks found as responsible for the separation based on the 
loadings presented in C&D, (C) PC-3 Loading, (D) PC-2 loading. 




Figure 24. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-4 and PC-5 accounting for <2% of the variance, (B) 
Average spectral profile of the amides region for breast cancer and normal breast. Dotted lines represent the peaks found as responsible for the separation based 
on the loadings presented in C&D, (C) PC-4 Loading, (D) PC-5 loading. 
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CHAPTER 5. FTIR ANALYSIS OF BREAST CANCER 
5.1 COMPARISON OF THE SPECTRAL DATA OF DIFFERENT SUBTYPES WITHIN A SPECIFIC 
GRADE.  
The results and discussion presented in this section include the FTIR spectral analysis of 2 
tissue microarrays containing African breast tumours from similar tribal origins in Nigeria 
comparing different grades and subtypes. 
A total of 359 cancerous samples were analysed with FTIR spectroscopy. Two comparison 
types were performed, the first one comparing different subtypes within one grade and the 
second one comparing the spectral data of different grades within a specific subtype.  
5.1.1 GRADE 1 ALL SUBTYPES 
When compared, the average spectral profile of grade 1 samples presenting luminal, HER2+ 
rich and triple negative breast cancer (TNBC) subtypes showed differences enough to see with 
the naked eye as presented in Figure 25 and Figure 26. 
 
Figure 25. FTIR average spectral profile of grade 1 samples presenting triple negative (TNBC), luminal 
and HER2+ subtypes, variance is represented with grey shadow. 




Figure 26. FTIR average spectral profile of grade 1 samples presenting triple negative (TNBC), luminal and HER2+ 
subtypes. (A) General region (4,000-675 cm-1), (B) High wavenumber region (3,500-2,550 cm-1), (C) Amide region 
(1,700 -1,500 cm-1), and (D) Fingerprint region (1,450-600 cm-1). 
5.1.1.1 HIGHER WAVENUMBER (3,500-2,550 CM-1) ANALYSIS OF GRADE 1 SAMPLES ALL 
SUBTYPES 
The comparison of the different subtypes of grade 1 spectral profiles showed overall 
differences in absorbance and peak ratios. However, considerable shifts cannot be 
appreciated with a naked eye. Therefore, principal component analysis was used in the higher 
wavenumber (3,500-2,550 cm-1) showing grouping and separation based on the subtype as it 
can be seen in Figure 27.  
The peaks located at 3278, 3053, 3015, 2968, and 2920 cm-1 were identified as responsible for 
the sample separation. 
The first peak located at 3278 cm-1 is characteristic of amide A stretching. [165] The HER2+ 
rich presented higher intensity than the average of this peak followed by TNBC and luminal 
grade 1 samples. Complementarily, the same trend is repeated with amide B. This peak is 
located at 3053 cm-1 and it is mainly associated with the N-H stretching of proteins. 
In Figure 27B, the dotted line representing the peak located at 3015 cm-1 which showed a 
slight shoulder that became easily visible in the grade 1 HER2+ spectrum profile. This band has 
been associated with olefinic =CH stretching. [121] This shoulder became less clear in TNBC 
and luminal grade 1 samples. Higher content of the olefin =CH stretching was identified in 
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HER2+ grade 1 according to the score plot presented in Figure 27A followed by TNBC and 
luminal grade 1 samples. 
The peak found at 2968 cm-1 associated with fatty acids and certain contribution of CH3 
symmetric stretching of side chain lipids, and nucleic acids. [149]The location of the samples 
on the PC-2axis revealed that TNBC showed a higher overall contribution of lipids based on 
this peak, whereas grade 1 luminal and HER2+ samples presented a more dynamic trend.  
Finally, a peak at different wavenumber (2920 and 2927 cm-1) but correlated with the same 
assignment was found in both loadings. For discussion purposes, the location will be referred 
to as 2920 cm-1. This peak is representative of fatty acids by representing the asymmetric 
stretching of CH2 and CH3 in lipids. [121] The changing behaviour of this band in the spectral 
profile of all subtype grade 1 samples indicate that the role play by fatty acids is of vital 
importance in the early cancer cases. On the other hand, the differences in intensity and shape 
of these peaks indicate the varying content of fatty acids.  
5.1.1.2 AMIDE REGION (1,700-1,500 CM-1) ANALYSIS OF GRADE 1 SAMPLES ALL SUBTYPES 
When the amide region of grade 1 samples was analysed with principal component analysis 
showing good grouping for all three subtypes and good discrimination of HER2+ rich samples. 
An important shift can be appreciated in the spectral profiles HER2+ as it can be seen in Figure 
28B. The bands responsible for the grouping of the subtypes are 1674, 1635, 1613, 1523 cm-
1. 
The peak found at 1674 cm-1 representing C=O stretching, usually presented in guanine and 
deformation of N-H in-plane [149] evidenced similarities between luminal and TNBC grade 1 
samples. However, the shift presented on the HER2+ subtype spectral profile is responsible 
for the distribution of those samples in the opposite axis of PC-2 suggesting higher absorbance 
of this peak. On the other hand, based on the location of the peak in the luminal and TNBC 
shifted spectral profile might suggest an increased content of unordered random coils and 
turns. [102] 
Structural changes in the proteins presented on these cancer cases were responsible for the 
discrimination of the samples. The peak located at 1635 cm-1 has been associated with β-
sheet structures of amide I and its presented as a shoulder. [166] The contribution of this peak 
is similar in the luminal and TNBC. The grade 1 HER2+ samples are spread on the opposite axis, 
suggesting lower absorbance of this peak. Hence, less content of β-sheet structures. 
Furthermore, the spectral profiles of the grade 1 luminal and TNBC showed wider amide I 
bands in comparison with the grade 1 HER2+ as a result of the low contribution of the β-sheet 
shoulder. The previous statement is validated by the peak at 1523 cm-1 which also represent 
the β-sheet but of amide II vibrational modes. [102] The higher contribution of this band on 
the hormonal subtypes can be easily appreciated with the naked eye as a shoulder that seems 
missing in the HER2+ subtype.  
Peaks found in the amide region also provide insights into the nucleic acids biochemical profile 
of the cancer cases. This is the case for the peak located at 1613 cm-1 which represent the N-
H adenine vibrations in DNA. [167] Luminal and TNBC grade 1 samples presented higher 
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intensities of this band, also affecting the width of the convoluted band, in comparison with 
HER2+ grade 1 samples. The similitude between the hormonal subtypes suggests a similar 
nucleic acid production behaviour at lower grades, whereas a slower overproduction of 








Figure 27. Principal component analysis of the higher wavenumber region (3,500-2,550 cm-1). (A) Score plot using PC-2 and PC-4 accounting for 13% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for grade 1 TNBC, luminal, and HER2+. Dotted 
lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-4 loading.
Chapter 5. FTIR analysis of breast cancer 
85 
 
5.1.1.3 FINGERPRINT REGION (1,450-600 CM-1) ANALYSIS OF GRADE 1 SAMPLES ALL 
SUBTYPES 
The fingerprint region principal component analysis revealed differences among the three 
subtypes in the grade 1 samples. However, a relative separation of the samples was achieved 
(Figure 29) The listed peaks were identified as differentiators of all three subtypes: 1394, 1233, 
1162, 1114, 1067, 952 cm-1.  
Important similarities between the luminal and TNBC subtype spectral profiles can be 
appreciated in Figure 29B. Most of the assignment associated with the differentiating peaks 
correspond to nucleic acids vibrations. Higher absorbance was detected on the samples 
representing the luminal and TNBC subtypes. For example, 1394 cm-1 representing the 
stretching of C-N in cytosine and guanine [167].The peak at 1233 cm-1 reflecting the PO2- 
asymmetric stretching of nucleic acids [164] presented higher intensities for the positive and 
negative hormonal subtypes. However, the peak presented in the HER2+ spectral profile is 
sharper and better defined suggesting important contributions of the nucleic acids in grade 1 
HER2+ cancerous cases. Other nucleic acids peaks were also identified, the band at 1114 cm-
1 associated with the phosphate groups in RNA [167], the peak at 952 cm-1 reflecting the C-
O and C-C vibration in deoxyribose, which also has been reported as DNA vibrations of tumour 
cells. [164] Finally, the peak located at 1067 cm-1 corresponding to PO2- symmetric stretching 
of nucleic acids. The luminal and TNBC samples spectral profile presented higher intensities, 
but also a wider peak at this wavenumber.  
The activity and contribution of proteins were also identified as an important differentiator 
on the grade 1 cancerous cases. The peak located at 1162 caused by the C-O stretch mode 
of C-OH groups of serine, threonine, and tyrosine of proteins presented in the HER2+ spectral 
profile revealed a better-formed peak in this wavenumber possibly reflecting structural 
changes for this biochemical component. Besides, essential eukaryotic protein serine and 
threonine phosphatase regulate important cellular functions involved in carcinogenesis such 
as cell division and the synthesis of proteins, and glycogen metabolism highly involved in 
survival during hypoxic conditions. [168] The activity of proteins was also evidenced in the 
luminal and TNBC subtype which presented higher intensities. However, this peak seemed 
less clear and diluted by neighbour contributions.  




Figure 28. Principal component analysis of the amides region (1,700-1,500 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 97% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for grade 1 TNBC, luminal, and HER2+. Dotted lines 
represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loading




Figure 29. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-2 and PC-7 accounting for 97% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for grade 1 TNBC, luminal, and HER2+. Dotted lines 
represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-7 loading. 
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5.1.2 GRADE 2 ALL SUBTYPES 
When compared, the average spectral profile of grade 2 samples presenting luminal, HER2+ 
rich and triple negative breast cancer (TNBC) subtypes showed differences enough to see with 
the naked eye as presented in Figure 30 and Figure 31. Grade 1 luminal and TNBC samples 
presented similar spectral profiles and the same trend was detected in grade 2 samples in our 
cohort.  
 
Figure 30. FTIR average spectral profile of grade 2 samples presenting triple negative (TNBC), luminal and HER2+ 
subtypes, variance is represented with grey shadow. 
5.1.2.1 HIGHER WAVENUMBER (3,500-2,550 CM-1) ANALYSIS OF GRADE 2 SAMPLES ALL 
SUBTYPES 
The principal component analysis of the higher wavenumber region revealed groups but not 
a completely visible separation as can be seen in Figure 32. Five peaks were detected as a 
differentiator among groups. The peaks were located at 3151, 3024, 2948, 2914, and 2848 
cm-1. 
The shoulder found at 3151 cm-1 associated with the symmetric stretching of N-H [149] is 
presented with higher intensities in the luminal and TNBC. The intensities presented in the 
HER2+ grade 2 samples indicate that overall the contribution of this peak is lower than the 
average in comparison with the other two subtypes suggesting that the hormonal subtypes 
have higher protein production at this grade.  




Figure 31. FTIR average spectral profile of grade 2 samples presenting triple negative (TNBC), luminal and HER2+ 
subtypes. (A) General region (4,000-675 cm-1), (B) High wavenumber region (3,500-2,550 cm-1), (C) Amide region 
(1,700-1,500 cm-1), and (D) Fingerprint region (1,450 -600 cm-1). 
The band placed at 2948 cm-1 represent the C-H stretching that can be presented in a variety 
of biomolecules. [149] TNBC grade 2 samples presented a better grouping maintaining at the 
centre of the PC-1 axis and demonstrating more uniform biochemical changes in this subtype 
in grade 2 cases. Less C-H stretching vibrations were revealed by the lower intensities in the 
HER2+ grade 2 samples. Variations on this peak are more active in the luminal and TNBC 
reflecting more biochemical activity on these subtypes in comparison with HER2+ cases.  
Vibrations related to lipids, cholesterol and creatine were identified twice with the peaks 
located at 2914 and 2848 cm-1. These bands only showed higher intensities in the luminal 
and TNBC subtype, whereas the HER2+ subtype samples are all located in the lower than 
average area. This finding suggests that a more active lipid metabolism take place in the 
hormonal subtypes in grade 2 samples in comparison with the HER2+ subtype. 
 
 




Figure 32. Principal component analysis of the higher wavenumber region (3,500-2,550 cm-1). (A) Score plot using PC-1 and PC-3 accounting for 81% of the variance, 
(B) Average spectral profile of the higher wavenumber region for grade 2 TNBC, luminal, and HER2+. Dotted lines represent the peaks found as responsible for the 
separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-3 loadings. 
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5.1.2.2. AMIDE REGION (1,700-1,500 CM-1) ANALYSIS OF GRADE 2 SAMPLES ALL 
SUBTYPES 
Clear grouping and separation were achieved among the grade 2 samples when the amide 
region was analysed with principal component analysis as presented in Figure 33A. The PC-1 
seems to differentiate HER2+ samples by discriminating them on the positive axis.PC-1 helped 
identified the band at 1635 cm-1 associated with β-sheet structures (presented as a shoulder) 
[102] and 1524 cm-1 which represent the C=N stretching in guanine. [167] HER2+ rich samples 
presented higher intensities for these peaks, which might indicate more content of β-sheet 
secondary structures in comparison with the other subtypes and changes associated with the 
overproduction of nucleic acids. Additionally, an important upshift can be appreciated in the 
amide region of the HER2+ grade 2 spectral profile presented in Figure 33B.  
On the other hand, PC-5 distinguished between TNBC samples, mostly in the positive axis, and 
luminal samples spread in the negative axis. The loading associated with this principal 
component identified the following peaks as responsible for the separation: 1667, 1612, and 
1559 cm-1. 
The band located around 1667 and 1559 cm-1 presented higher intensities on the luminal 
grade 2 samples and half of the HER2+ grade 2 cases. These bands are representative of amide 
I β-turns of proteins and α-sheet amide II.[102] The differentiation of subtypes based on 
structural changes suggest structure alterations most likely due to the replacement of β-
sheets with α- and random coils as suggested by Rehman et al. [106] Furthermore, the peak 
located at 1613 cm-1 associated with C=C and C=O vibration in uracil [167] presented higher 
intensities and therefore a major contribution in the TNBC grade 2 samples and half of the 
HER2+ grade 2 samples. These results suggest that TNBC grade 2 cases focus on the 
overproduction of genetic material to promote proliferation, whereas luminal grade 2 
samples present considerable structural changes in their proteins. Structural changes in 
proteins are expected upon ligand binding in order to promote and facilitate different 
functions such as signalling. [169]  
5.1.2.3. FINGERPRINT REGION (1,450-600 CM-1) ANALYSIS OF GRADE 2 SAMPLES ALL 
SUBTYPES 
When principal component analysis was applied to the fingerprint region of the grade 2 
samples a separation among luminal and TNBC was achieved using the PC-5, while the 
separation and grouping of the HER2+ grade samples were achieved using the PC-3 (Figure 
34).  
PC-5 identified the 1377 cm-1 and 1024 cm-1 peaks presented higher intensities in the TNBC 
and lower intensities in luminal and HER2+ grade 2 samples. These peaks are representative 
of C-H deformation and C-O stretching associated with glycogen.  
In order to supply energy and provide glucose homeostasis, glucose is stored in cells as 
glycogen. Under stress processes such as hypoxia, cancer cells adapt to maintain and promote 
tumour growth. Glycogen plays a vital role in hypoxic conditions promoting cell survival. 
Furthermore, the glycogen metabolism has been proposed as the tumour and tumour 
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microenvironment energy source also having implication in treatment, chemotherapy and 
radiation, response. [168] The higher contribution of glycogen on the TNBC grade2 samples 
might be an indication of an accelerated proliferation process suggesting a more aggressive 
behaviour, which is characteristic of the TNBC subtype.  
On the opposite, PC-5 helped to identify higher absorbance of the peaks located at 1242 and 
1180 cm-1 on the luminal and HER2+ grade 2 samples. The first band is correlated with PO2- 
asymmetric stretching in nucleic acids [164], while the 1180 cm-1 peak is associated with 
cholesterol ester vibrations. [149] These findings suggest considerable changes and 
overproduction of genetic material in the luminal and HER2+ grade 2 samples. Whereas, the 
cholesterol ester vibrations might be related to changes in the cell membrane fluidity, which 
has been reported to require high contents of cholesterol on malignant tissue. [121] The lipid 
activity is highly relevant in several cellular activities. The variation in quantity and 
conformations affect the membrane fluidity having control of ligand-receptor interaction, 
endocytosis and antigen presentation which facilitate invasive processes. [157] 
Principal component 3 provided an insight into the components presented with low intensities 
in the HER2+ grade 2 samples. These component are represented by the bands located at 
1196, 1149, 1018, and 958 cm-1. The 1018 cm-1 peak was interpreted as a shift of the 
previously described peak presented at 1024 cm-1 and therefore will not be discussed. The 
contribution at 1196 cm-1 is assigned to the phosphate (P=O) band on phospholipids, [121] 
and the lower intensity presented in the HER2+ grade 2 samples might indicate less active 
lipid changes in the membrane having less affectation in the fluidity of the membrane. The 
band located at 1149 cm-1 associated with the glycogen absorptions cause by the C-O and C-
C stretching and the C-O-H deformation motions [149] confirmed a less active participation of 
the glycogen and its metabolism for the HER2+ subtype in grade 2 samples. This situation 
indicates less stress in the HER2+ cases, for example, no hypoxia or pre-hypoxia processes and 
overall less nutrient/energy requirement. [168] As a final point, the C-O deoxyribose 
vibrational mode [149] in the HER2+ grade 2 samples presented at 958 cm-1 showed 
noticeable differences in the spectral profiles in Figure 34B. This senescent contribution and 
in the spectra in combination with the findings presented in PC-3 suggested a less active 
proliferation in HER2+ grade 2 cases.  




Figure 33. Principal component analysis of the amide region (1,700-1,500 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 83% of the variance, B) Average 
spectral profile of the higher wavenumber region for grade 2 TNBC, luminal, and HER2+. Dotted lines represent the peaks found as responsible for the separation 
based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-5 loading.




Figure 34. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-3 and PC-5 accounting for 5% of the variance, (B) Average 
spectral profile of the higher wavenumber region for grade 2 TNBC, luminal, and HER2+. Dotted lines represent the peaks found as responsible for the separation 
based on the loadings presented in C&D, (C) PC-3 Loading, (D) PC-5 loading. 
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5.1.3 GRADE 3 ALL SUBTYPES 
The average spectral profile of grade 3 samples presenting luminal, HER2+ rich and triple 
negative breast cancer (TNBC) subtypes showed clear differences that can be appreciated with 
the naked eye as presented in Figure 35and Figure 36. Grade 1 and grade 2 luminal and TNBC 
samples presented similar spectral profiles. However, the grade 3 samples in our cohort 
showed more similitudes on the TNBC and HER2+ rich subtypes. Differences among the three 
subtypes will be discussed in the following sections. 
 
Figure 35. FTIR average spectral profile of grade 3 samples presenting triple negative (TNBC), luminal and HER2+ 
subtypes, variance is represented with grey shadow. 
5.1.3.1 HIGHER WAVENUMBER (3,500-2,550 CM-1) ANALYSIS OF GRADE 3 SAMPLES ALL 
SUBTYPES 
The principal component analysis of the higher wavenumber revealed a separation between 
luminal and TNBC grade 3 samples. In addition, a clear grouping of sample points can be seen 
in all three subtypes as it can be seen in Figure 37. 
Principal component 1 identified the following peaks as responsible for the separation of the 
hormonal subtypes: 3023, 2971, 2896, and 2896 cm-1. For all these peaks, a higher 
contribution represented by higher intensities were identified in the TNBC placing the luminal 
in the opposite trend with the HER2+ samples lying in between.  
The band at 3023 cm-1 representing aromatic C-H stretchings while the band at 2835 cm-1 
is representative of the N-H stretching both accounting for amino acids and nucleic acids 
vibrations. [149] The peak located at 2971 cm-1 represents the asymmetric stretching of CH3 
from fatty acids, in combination with the symmetric stretching of the CH3 located at 2896 
cm-1 [170] demonstrate the highly active lipid activity in TNBC grade 3 samples. The 
accumulation of fatty acids in TNBC suggest aggressive malignant activities that need to be 
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fuel through these lipid components. When the spectral profile of the three subtypes are 
compared (Figure 37B), important contributions of the 2917 cm-1 band are recognised on all 
the subtypes with important differences in the sharpness of the shoulder-shaped peak. The 
differences in the acuteness of the shoulder suggest important changes in the chemical 
composition of the fatty acids which is indicative of their participation towards more invasive 
processes. 
 
Figure 36. FTIR average spectral profile of grade 3 samples presenting triple negative (TNBC), luminal and HER2+ 
subtypes. (A) General region (4,000-675 cm-1), (B) High wavenumber region (3,500-2,550 cm-1), (C) Amide region 
(1,700-1,500 cm-1), and (D) Fingerprint region (1,450-600 cm-1). 
Principal component 2 revealed a better dispersion of the TNBC and HER2+ samples 
suggesting a heterogeneous behaviour in the TNBC and HER2+ grade 3 samples. On the 
contrary, a clear grouping along the PC-2 axis can be seen for the luminal subtype in Figure 
37A. The loading associated with PC-2 showed the peaks located at 3326, 2965, 2919, and 
2870 cm-1 as responsible for the grouping.   
The peak located at 3326 cm-1 has been reported as an asymmetric N-H stretching vibration 
corresponding to amide A. [102] The 2965 cm-1 has been interpreted as the asymmetric 
stretch CH3 in fatty acids and was discussed previously as the 2971 cm-1 band. The peak located 
at 2919 cm-1 represents the cholesterol ester vibrations. [149] The TNBC samples showed a 
wide range of dispersion on the PC-2 axis confirming variable contribution of these peaks. The 
luminal samples presented intensities closer and higher to the average, whereas the HER2+ 
tended to distribute equally on both sides. The last peak was presented at  2870 cm-1 and 
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represent the CH3 symmetric stretching of the protein side chain, and lipids with some 
contribution from carbohydrates and nucleic acids. [149] 
5.1.3.2. AMIDE REGION (1,700-1,500 CM-1) ANALYSIS OF GRADE 3 SAMPLES ALL 
SUBTYPES 
Principal component analysis of the amide regions showed good grouping for luminal and 
HER2+ grade 3 samples as presented in Figure 38 when PC-1 and PC-2 were used. The higher 
intensity in the peak located at 1636 in luminal grade 3 associated with structural changes 
suggested several adaptations towards β-sheets conformations. HER2+ grade 3 samples 
presented the lowest contribution of this secondary structure conformation blue shifted while 
the TNBC showed lower and higher than the average absorbance of this particular 
conformation, this can be appreciated in the spectral profile presented in Figure 38B. Thus, a 
reduction of the α-helix structure and increase in β-sheet structure can be assumed; this 
statement is consistent with the formation mechanism of β-sheet structures and are reflected 
in the amide peak shape. [171] Amide conformational changes have been proposed as part of 
the carcinogenesis pathological adaptations. [172]  
Similar overall behaviour has been found for the 1526 cm-1 band corresponding to the C=N 
guanine vibration. This band suggests that luminal grade 3 samples present consistent higher 
than the average absorbance while TNBC showed higher and lower intensities and HER2+ 
samples kept in the lower absorbance axis. Changes in the conformation of guanine have been 
reported as part of the carcinogenesis process. These RNA changes affect primary, secondary 
and tertiary structures and therefore disturb the reparative mechanisms of the cell and tissue. 
[167] 
Principal component 2 identified the peak representing Amide I located at 1661 cm-1 and the 
adenine vibration in DNA represented by the 1607 cm-1 peak. The vibration associated with 
the amide I is higher in absorbance for the TNBC and HER2+ grade 3 samples and can be 
appreciated in the spectral profiles presented in Figure 38B. The lowest contribution of amide 
I was presented in the luminal grade 3 samples; however, this can be explained by the red 
shift towards lower wavenumbers of this band in the luminal subtype. The second band 
associated with adenine vibrations presented higher intensities in the luminal grade 3 
samples. This statement is in agreement with combine adenine and guanine adaptations 
reported by Dovbeshko et al. [167] TNBC samples showed a split behaviour with scattered 
samples among both axes, whereas the HER2+ showed the lowest intensities for this 
particular band suggesting lower nucleic pair bases modification in grade 3 samples 
5.1.3.3 FINGERPRINT REGION (1,450-600 CM-1) ANALYSIS OF GRADE 3 SAMPLES ALL 
SUBTYPES 
The analysis of the fingerprint region revealed a good grouping but poor separation of 
different subtypes of grade 3 samples. Principal component 1 and 4 showed the best results 
accounting for 58% of the variance. Nucleic acids were responsible for most of the peaks 
identified with these two PCs.  
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Principal component 1 revealed that luminal grade 3 samples showed higher intensities in the 
peaks located at 1382 cm-1 associated with dCH3, stretching of C-O, and C-H and N-H 
deformation, 1222 and 1115 cm-1 representing asymmetric and symmetric stretching of 
phosphate groups in RNA, 1159 cm-1 associated with the C-O stretching of proteins and 
carbohydrates, and finally 1059 cm1 which is a representative peak of the triad nucleic acids 
bands by representing the C-O stretching of phosphodiester in ribose. [149] Half of the HER2+ 
grade 3 samples showed higher and lower intensities than the average. On the contrary, the 
TNBC grouping at the opposite side of luminal samples suggests lower contents of nucleic 
acids in comparison with the positive hormonal receptor subtype.  
Similar biochemical behaviours were identified using the peaks highlighted by principal 
component 4 as responsible for the sample’s grouping. The bands located at 1227 and 1065 
cm-1 were previously discussed as 1222 and 1065. For these specific peaks, a better spreading 
of sample points was identified for HER2+ grade 3 samples affecting its spectral profile showed 
in Figure 39B. TNBC showed the best grouping by keeping closer to the Y-axis representing 
absorbance values closer to the average while luminal samples tended to distribute in the 
higher than the average intensity values region. Important contributions of nucleic acids 
components are expected on grade 3 samples, as important changes associated with poor 
differentiation and accumulation of genetic material for cell division and proliferation is 
considered a hallmark of high grades. In addition, changes in peak shape by the addition of a 
shoulder like the one presented at 1115 indicate a modification in the structural components 
of RNA which might facilitate invasive processes, but also affecting cell reparative 
mechanisms. [167] 
 




Figure 37. Principal component analysis of the higher wavenumber region (3,500-2,550 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 94% of the variance, 
(B) Average spectral profile of the higher wavenumber region for grade 2 TNBC, luminal, and HER2+. Dotted lines represent the peaks found as responsible for the 
separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loading.




Figure 38. Principal component analysis of the amide region (1,700-1500 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 98% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for grade 3 TNBC, luminal, and HER2+. Dotted lines 
represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loadings. 




Figure 39. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-1 and PC-4 accounting for 58% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for grade 3 TNBC, luminal, and HER2+. Dotted lines 
represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-4 loading. 
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5.2 COMPARISON OF THE SPECTRAL DATA OF DIFFERENT GRADES WITHIN A SPECIFIC 
SUBTYPE.  
5.2.1 LUMINAL SAMPLES ALL GRADES 
When compared, the average spectral profile of luminal samples representing grade 1, 2, and 
3 showed differences enough to see with the naked eye, as presented in Figure 40 and Figure 
41. The higher wavenumber and fingerprint regions spectral profiles showed similitudes 
between grade 1 and 2 luminal samples, whereas the amide region showed that luminal grade 
2 and 3 are more alike. The discussion of these specific areas is presented in the following 
sections.  
 
Figure 40. FTIR average spectral profile of luminal samples representing grade 1, grade 2, and grade 3 cases, 
variance is represented with grey shadow. 
5.2.1.1. HIGHER WAVENUMBER (3,500-2,550 CM-1) ANALYSIS OF LUMINAL SAMPLES ALL 
GRADES 
Principal component analysis was used in the higher wavenumber (3,500-2,550 cm-1) showing 
good grouping and separation based on the grade as it can be seen in Figure 42. The group of 
peaks located at 3027 and 3023 cm-1, 2923 and 2925 cm-1, and 2849 and 2854 cm-1 were 
identified in both PC-1 and PC-6 respectively. All these peaks are associated with lipid 
vibrations such as asymmetric stretching vibrations of CH2 of acyl chains, CH3 symmetric 
stretching, and stretching vibrations of CH2 and CH3 of phospholipids, cholesterol, and 
creatine. These bands showed higher intensities and contributions in grade 2 cases, followed 
by a stable grade 1 group placed closer to the average and reduced intensities in grade 3 cases. 
These results suggest a reduction in the lipid components as adopting an aberrant cell form 
with poor differentiation and reduced similarity to normal cells. 





Figure 41. FTIR average spectral profile of luminal samples representing grade 1, grade 2, and grade 3 cases. (A) 
General region (4,000-675 cm-1), (B) High wavenumber region (3,500-2,550 cm-1), (C) Amide region (1,700-1,500 
cm-1), and (D) Fingerprint region (1,450-600 cm-1). 
Changes in the lipid components of grade 2 cases with luminal subtype might suggest cell 
membrane adaptations and changes which might affect the fluidity of the membrane in order 
to promote invasive processes. [172] Changes in the lipid metabolism have affectation not 
only in the structural aspect of membranes but also energy homeostasis, signalling and 
important cellular processes such as motility, proliferation, differentiation and cell growth. 
[160] Thus, lipid modifications are expected in grade 2 samples leading to a more aggressive 
behaviour than the grade 1 cells that resemble the closest to normal cells by changing the 
membrane fluidity and providing the energy resources for malignant activities. Tumours 
synthesise fatty acids de novo and actively look for its synthesis at early stages and its storage 
in lipid droplets. [173] Therefore, increased content of lipids is expected and has been 
confirmed in grade 1 and 2 luminal cases.  
Complementarily, overexpression of antioxidant has been reported in several cancer cases 
accelerating and increasing the lipid peroxidation significantly in the malignant tissue. [174] 
Lipid peroxidation has been associated with the transformation and growth of tumours [175] 
to the point that drugs such as Tamoxifen have been used as a treatment by reducing the 
peroxidation in lipids. [174] As a consequence of the high oxidative processes, the lipid 
content tends to decrease as a product of its degradation as it has been identified in grade 3 
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luminal samples. Once a hypoxia state has been reached and there is a low content of lipids 
due to peroxidation cancer cells turn into glycogen as an energy source. [160]  
Additionally, the peak located at 3293 cm-1 representing the amide A vibration associated 
with the N-H stretch was identified by PC-6. Grade 3 luminal cases presented a higher 
contribution of this band followed by grade 2 and 1. This vibration suggested that a higher 
content of proteins and nucleic acids were present in grade 3 samples probably representing 
the aberration and poor differentiation associated with higher grades.   
5.2.1.2. AMIDE REGION (1,700-1,500 CM-1) ANALYSIS OF LUMINAL SAMPLES ALL GRADES 
Principal component analysis was applied to the amide region of luminal samples representing 
grade 1,2, and 3 giving as a result a good grouping and differentiation using PC-3 and PC-4, as 
shown in Figure 43. The peaks located at 1689, 1595, and 1564 presented higher intensities 
in grade 1 luminal samples followed by grade 2 and 3 and were identified by PC-3. These bands 
are associated with base carbonyl stretching and ring breathing mode in nucleic acids, the 
methylation of nucleotides, and the ring base vibration in nucleic acids, respectively. The 
methylation of DNA has been reported in the early stages of carcinogenesis. This process can 
modify the genetic activity and has been proposed as a hypothesis for oncogenic 
transformations. [176]Therefore, its higher contribution in grade 1 luminal samples is highly 
relevant. The hypermethylation in breast cancer has affectation in the activity of genes in 
charge of steroid receptors, cell adhesion and matrix metalloproteinases inhibitors. The 
Oestrogen receptor (ER) gene in normal cells is unmethylated, whereas in ER positive cell lines 
present an important elevated methylation degree. [176]  
The existence of methylated nucleotides in low grades serve as a representation of initial 
malignant behaviours as the methylation is presented as whole genomic hypomethylation and 
as local promoter hypermethylation in critical tumour suppressor and growth regulator genes. 
[177] The methylation plays a vital role on the hormonal expression of tumours, for example, 
the methylation of hormonal genes has been proposed as a hormonal status predictor, using 
the methylation of the PR gene (PGR) for ER status and as a predictor of PR status the 
methylation of the ER gene (ESR1). [178] 
The peak located at 1640 cm-1 representing amide I band of proteins was identified by PC-3 
and showed the same trend intensity wise with peaks located at 1624, 1592, and 1571 cm-1 
which were identified with PC-4. This trend presented higher intensities in grade 3 luminal 
cases followed by grade 2 and 1. These peaks represent vibrations of amide I, C=N, and NH2 
from adenine and an increase in intensity in higher grades suggests higher contents of proteins 
and nucleic acids. [167] This overproduction of structural and genetic material behaviour is in 
agreement with the aggressive behaviour representative of higher grades.  
In addition, the peak placed at 1659 cm-1 was also identified by PC-4. This peak correlates 
with the C=C cis conformation of fatty acids. [149] This peak presented greater contribution 
in grade 2 samples, which confirmed the highly active lipid metabolism previously discussed 
in the higher wavenumber region.  
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5.2.1.3. FINGERPRINT REGION (1,450-600 CM-1) ANALYSIS OF LUMINAL SAMPLES ALL 
GRADES 
Principal component analysis of the fingerprint region revealed an unclear separation but 
relatively good grouping of the different grades of luminal samples as presented in Figure 44. 
PC-1 identified the following bands and assignments as differentiators of grade 1 luminal 
samples: 1383 cm-1 representing C-N and N-H deformations, 1227 cm-1 associated with 
phosphate I asymmetric PO2- stretching, 1165 cm-1 representing the C-O stretching mode of 
C-OH groups of serine, threonine, and tyrosine of proteins, 1062 cm-1 and 964 cm-1 which 
correlate with C-O stretching of phosphodiester and ribose. [167] Grade 1 samples presented 
absorbance closer to the average whereas grade 2 and 3 showed variable intensities with 
higher and lower than the average intensities. 
On the contrary, a better separation was achieved using PC-4. Grade 3 luminal samples 
showed higher intensities in the peak representing CH3 symmetric bending vibrational modes 
of lipids located at 1464 cm-1. [149] This behaviour suggests that biochemical changes occur 
in later grades in cancer cells in the lipid component probably associated with lipid 
peroxidation. [174]  
In addition, the bands located at 1237 and 1070 cm-1 representing phosphate I PO2- 
asymmetric stretchings and C-O vibration in disordered DNA structures [167] presented 
higher intensities in grade 2 samples while lower absorbance was found in a fraction of grade 
3 samples. DNA methylation reported at the beginning of this section suggested changes in 
nucleic acids at early grades. The affectations on DNA detected through the peaks suggested 
by PC-4 might be responsible for the changes detected in grade 2. 




Figure 42. Principal component analysis of the higher wavenumber region (3,500-2,550 cm-1). (A) Score plot using PC-1 and PC-6 accounting for 80% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for luminal samples grade 1,2, and 3. Dotted 
lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-6 loading. 




Figure 43. Principal component analysis of the amide region (1,700-1,500 cm-1). (A) Score plot using PC-3 and PC-4 accounting for 2% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for luminal samples grade 1,2, and 3. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-3 Loading, (D) PC-4 loading. 




Figure 44. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-1 and PC-4 accounting for 84% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for luminal samples grade 1,2, and 3. Dotted lines 
represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-4 loading. 
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5.2.2. TNBC SAMPLES ALL GRADES 
The average spectral profile of TNBC samples representing grade 1, 2, and 3 showed 
differences enough to see with the naked eye, as presented in Figure 45 and Figure 46. 
Different trends were detected in the different areas of the spectra, for example overall higher 
intensities can be appreciated for grade 3 TNBC samples in the higher wavenumber area, 
whereas in the amide and FP region the grade 3 TNBC spectral profile showed the lowest 
average intensities. In the amide region, grade 2 samples showed the most dominant spectra 
while grade 1 had the highest intensities in the spectral profile of the fingerprint region.  
A complete analysis of these three regions will be included to identify biochemical changes 
associated with the cancer progression of triple negative breast cancer cases. 
 
Figure 45. FTIR average spectral profile of TNBC samples representing grade 1, grade 2, and grade 3 cases, 
variance is represented with grey shadow. 
5.2.2.1. HIGHER WAVENUMBER (3,500-2,550 CM-1) ANALYSIS OF TNBC SAMPLES ALL 
GRADES 
The principal component analysis of the higher wavenumber region revealed a good grouping 
of grade 1 and 2 cases. On the contrary, a clear dispersion of grade 3 TNBC cases was identified 
using PC-1 and PC-5 as it can be appreciated in Figure 47.  
PC-1 identified the following peaks as responsible for the grade 2 grouping: 3026 cm-1 
representing aromatic C-H stretchings, 2896 cm-1 accounting for CH3 symmetric stretchings, 
2867 cm-1 representing aliphatic C-H stretching, and 2831 cm-1 which correlates with the N-
H stretching vibration. [149] Most of the grade 2 TNBC samples were distributed on the 
positive PC-1 axis, therefore lower intensities associated with the peaks previously reported 
can be suggested. Grade 3 TNBC samples were distributed among both axes showing a split 
behaviour which suggests important differences among grade 3 cases. The few grade 1 TNBC 
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cases reported in our cohort showed lower than the average intensities for peaks reported 
based on the PC-1 axis. However, this group showed intensities closer to the average for the 
peaks identified with PC-5. 
 
 
Figure 46. FTIR average spectral profile of TNBC samples representing grade 1, grade 2, and grade 3 cases. (A) 
General region (4,000-675 cm-1), (B) High wavenumber region (3,500-2,550 cm-1), (C) Amide region (1,700 -1,500 
cm-1), and (D) Fingerprint region (1,450-600 cm-1). 
PC-5 identified peaks associated with proteins represented by 3297 cm-1 representative of 
amide A and 3038 cm-1 correlating with Amide B (both representing N-H stretching), and 
fatty acids characterised by 2936 cm-1 and 2861 cm-1 which represent aliphatic and fatty 
acid vibrations. [149].  
Grade 2 and 3 TNBC samples showed variable intensities including lower and higher than the 
average behaviour without showing a clear trend regarding these biochemical components. 
However, grade 1 samples kept intensities closer to the average which suggests a steady 
protein and fatty acid content in early grades of TNBC. 
5.2.2.2. AMIDE REGION (1,700-1,500 CM-1) ANALYSIS OF TNBC SAMPLES ALL GRADES 
Principal component analysis of the amide region showed a nice grouping and clear separation 
of grade1,2, and 3 of TNBC as can be appreciated in Figure 48. The analysis of the amide region 
revealed important overproduction of nucleic acids in grades 1 and 2 of the TNBC samples. 
The overproduction of this material is characterised by higher intensities in the peak located 
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at 1606 which represent adenine vibrations in DNA. [164]The overproduction of cell 
components is characteristic of cell division and proliferation processes which are expected in 
early grades of cancer.  
The previous trend was also confirmed for C=C vibrations in fatty acids (1662 cm-1). These 
increased intensities suggested that the fatty acids fuelled and were needed for the synthesis 
of membranes and signalling molecule[173] decreasing its content in higher grades. Greater 
content of fatty acid has been suggested as part of the carcinogenesis process and cancer 
progression, in fact, de novo lipogenesis in cancerous tissue has been accepted as a symbol of 
aggressive behaviour. [179] However, a decline in content has been suggested in advanced 
cases as a result of lipid peroxidation and oxidative stress [175]. In addition, structural 
conformations changed to facilitate certain malignant processes. [102]  
In addition, grade 2 and 1 TNBC cases showed higher intensities for vibrations representing β-
sheet conformations of amide II in proteins (1534 cm-1) in comparison with grade 3 samples. 
These conformational changes from dominant α-helical structures to β-sheet conformation 
has been previously reported as transitions to malignant tissue. [102], [105] An important 
change in intensity and slightly change in shape can be appreciated in the spectral profile 
presented in Figure 48B. Considering the intensities and spectral profile, structural changes in 
proteins can be proposed in initial grades of the TNBC cases to facilitate invasive processes.  
On the contrary, overall overproduction and content of proteins can be assumed in grade 3 
TNBC cases thanks to the peaks located at 1625 cm-1 which represent amide I vibrations. [74] 
5.2.2.3. FINGERPRINT REGION (1,450-600 CM-1) ANALYSIS OF TNBC SAMPLES ALL 
GRADES 
The fingerprint region principal component analysis showed a good grouping for grade 1 and 
2 while grade 3 TNBC samples were dispersed as can be appreciated in Figure 49. Grade 1 
TNBC samples seem to group based on their absorbance of the following peaks: 1382, 1225, 
1158, 1114, and 1060 cm-1. These peaks presented higher than the average intensities.  These 
peaks were identified by PC-1. 
The band located at 1384 cm -1 represent the deformation of CH3, C-H, and N-H [149]which 
serves as the first indication of active modifications at cellular level. The 1225  and 1114 cm-
1  peaks are representative of phosphate stretching in the phosphodiester linkages in DNA and 
RNA. [170] All grades presented samples with higher intensities than the average. However, 
grade 2 and 3 showed a split behaviour with half of the samples showing lower than the 
average intensities. In addition, similar changes were identified at 1158 and 1060 cm-1 
associated with C-O of proteins and carbohydrates and the stretching of C-O characteristic of 
the nucleic acid triad respectively. The peak located at 1101 identified with PC-2 correlates 
with the symmetric stretching of P-O-C in nucleic acids. [167] Half of the grade 3 TNBC 
presented higher contributions of this component. These differences in intensity suggested 
that changes in the nucleic acids are dynamic among the different grades. 
The PC-2 identified three peaks located at 1390, 1236, and 1101 cm-1. The 1390 cm-1 
assignments correlate with the CH2 asymmetric bending and COO- stretching presented in 
proteins and fatty acids. [149] Grade 3 samples showed higher intensities for this peak 
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followed by grade 2 and 1 TNBC samples suggesting accumulation of structural cell contents 
(proteins) and cell membranes (fatty acids). The same trend was identified with the band 
located at 1236 cm-1 associated with phosphate I (PO2-) asymmetric stretching mainly from 
nucleic acids with the little contribution from phospholipids [121] [167]Dovbeshko et al., 
2000)Furthermore, the overproduction of fatty acids can also be correlated with increase 
signalling favouring and stimulating invasive processes [173] which is associated with the 
aggressive behaviour expected in higher grades.  
 
 




Figure 47. Principal component analysis of the higher wavenumber region (3,500-2,550 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 75% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for TNBC samples grade 1,2, and 3. Dotted 
lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-5 loading. 




Figure 48. Principal component analysis of the amide region (1,700-1,500 cm-1). (A) Score plot using PC-2 and PC-4 accounting for 11% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for TNBC samples grade 1,2, and 3. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-4 loading. 




Figure 49. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 93% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for TNBC samples grade 1,2, and 3. Dotted lines 
represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loading. 
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5.2.3. HER2+ ALL GRADES 
The average spectral profile of HER2+ samples representing grade 1, 2, and 3 showed visible 
differences in intensity, shifts and peak shapes as presented in Figure 50 and Figure 51. 
Different trends were detected in the different areas of the spectra, for example, overall 
higher intensities can be appreciated for grade 3 HER2+ samples in the higher wavenumber 
and fingerprint area. Similar average intensities to grade 2 were appreciated in the amide 
region whereas grade 1 HER2+ samples showed the lowest average intensities in all regions.  
A complete analysis of these three regions will be included to identify biochemical changes 
associated with the cancer progression of HER2+ breast cancer cases. 
 
Figure 50. FTIR average spectral profile of HER2+ samples representing grade 1, grade 2, and grade 3 cases, 
variance is represented with grey shadow. 
5.2.3.1. HIGHER WAVENUMBER (3,500-2,550 CM-1) ANALYSIS OF HER2+ SAMPLES ALL 
GRADES 
Good grouping and separation were achieved using PC-1 and PC-2 in the higher wavenumber 
area, as can be seen in Figure 52. Five peaks were identified as responsible for the separation 
and grouping of HER2+ samples of all grades. The first peak was located at 3168 cm-1 as has 
been associated with N-H symmetric stretching. The second peaks were identified at 3041 
cm-1 representing the N-H amide B stretching. Additionally, a third band located at 2869 cm-
1 was identified in PC-1 representing the CH3 symmetric stretching mainly from proteins and 
lipids with little contribution from carbohydrates and nucleic acids. [149] These 3 peaks 
showed higher absorbance in grade 3 samples followed by grade1 and 2. This behaviour 
suggested higher protein content. Moreover, the increased content of proteins indicates a 
higher cell density in the high-grade samples.  




Figure 51. FTIR average spectral profile of HER2+ samples representing grade 1, grade 2, and grade 3 cases. (A) 
General region (4,000-675 cm-1), (B) High wavenumber region (3,500-2,550 cm-1), (C) Amide region (1,700-1500 
cm-1), and (D) Fingerprint region (1,450-600 cm-1). 
PC-2 confirmed the differences in the N-H stretching among different grades by identifying 
the peak at 3336 cm-1 which represents the asymmetric stretching of the N-H bond. [102] 
Most of the HER2+ samples grade 1 and 2 were located in the axis representing higher 
absorbance than the average. These differences in absorbance on all grades had an impact on 
the peak shape as it can be seen in the spectral profiles presented in Figure 52B. The same 
trend was recognised for the 2968 cm-1 peak which represents the CH3 asymmetric stretching 
identified in lipids and fatty acids. [149] Both bands suggested higher contents of these 
components in lower grades. Fatty acids in lower grades might indicate the need for cellular 
building blocks for membrane formation, energy storage, and the production of signalling 
molecules which is required in early stages of cancer. [173] 
5.2.3.2. AMIDE REGION (1,700-1,500 CM-1) ANALYSIS OF HER2+ SAMPLES ALL GRADES 
Principal component analysis of the amide region resulted in good grouping and separation of 
HER2+ samples with different grades. The following peaks were identified by principal 
component 1 and 2. HER2+ samples grade 1 and 2 showed higher intensities in the peaks 
located at 1692, 1667, and 1543 cm-1.  
The 1692 cm-1 band represents the vibration of an antiparallel β-sheet of amide I, this vibration 
is caused by the in-plane C=O stretching, the weak coupling of C-N, and in-plane bending[149] 
The decrease in α-helix conformation and increase of β-sheet structures has been reported as 
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a biomarker for cancer identification. [102], [106] The differences in the contents are 
important and affect the width and shape of the amide I peak as can be seen in the spectral 
profiles presented in Figure 53B.  
The contribution of β-turns represented by the peak located at 1667 cm-1 was also higher for 
grade 1 and 2 supporting the decrease in α-helix conformations and promoting β- structures. 
These changes represent structural fluctuations in proteins associated with its biochemical 
function and might be caused by mutations occurring at early steps of carcinogenesis. [169] A 
similar intensity trend was identified for the peak located at 1543 cm-1 representing an amide 
II stretching arising from the C-N stretching and the CHN bending vibrations. [149] However, 
a downshift of 10 cm-1 has been identified in the grade 3 HER2+average spectral profile 
suggesting a lower contribution of this assignment in high-grade samples.  
Grade 3 HER2+samples showed a higher contribution of carbonyl stretch and ring breathing 
vibrations associated with nucleic acids [149] represented by the peak located at 1617 
followed by grade 2 and grade 1 samples. This behaviour has been previously reported to 
increase in intensity as the grade increases as a result of higher cell density and poor 
differentiator of grade 3 cancer cells. [106] 




Figure 52. Principal component analysis of the higher wavenumber region (3,500-2,550 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 98% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for HER2+ samples grade 1,2, and 3. Dotted 
lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loading. 




Figure 53. Principal component analysis of the amide region (1,700-1,500 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 93% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for HER2+ samples grade 1,2, and 3. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loading. 
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5.2.3.3. FINGERPRINT REGION (1,450-600 CM-1) ANALYSIS OF HER2+ SAMPLES ALL 
GRADES 
The fingerprint principal component analysis of HER2+ samples showed good separation and 
grouping when PC-3 and PC-4 were used as presented in Figure 54. The CH3 bending mode of 
proteins presented at 1404 cm-1 and the CH2 wagging of phospholipids, fatty acids, 
triglycerides, and amino acid chains represented by 1342 cm-1 [149]showed higher 
intensities in grade 1 and 2.Grade 3 samples presented a split behaviour with half of the 
samples showing similar intensities to lower grade, but also intensities lower than the 
average. The increased intensity in low and intermediate HER2+ grade might indicate changes 
in proteins and accumulation of cellular material to promote proliferation. [106]  
Grade 1 samples also showed high contributions of phosphate vibrations represented by 
1241 cm-1 (asymmetric stretching of nucleic acid phosphate) and 1085 cm-1 (phosphate 
from nucleic acids, phospholipids and partially amide III in proteins).[149] This trend was 
shared with half of the grade 3 HER2+ samples, which can be explained by the downshift 
presented in the grade 3 spectral profile at those specific assignments. The downshift of 10 
and 15 cm-1 for these peaks could have been caused by the alterations on the structural 
conformation of proteins previously discussed and the alteration of the membrane fluidity 
changes in invasive and aggressive cases. [158] 
Grade 3 HER2+ samples showed higher absorbance in the peaks located at 1161 cm-1, also 
recognised at 1155 cm-1 in PC-3, and 954 cm-1. These two bands are representative of C-O 
stretching mode of C-OH groups of serine, threonine, and tyrosine, and the C-O vibration in 
deoxyribose. [149] The increased contribution of these bands in grade 3 is caused by the 
higher cell density and the higher cell material available for poor differentiation and 
accelerated proliferation characteristic of high-grade samples.  
 
 




Figure 54. Principal component analysis of the fingerprint region (1,450-600 cm-1). (A) Score plot using PC-3 and PC-4 accounting for 7% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the higher wavenumber region for HER2+ samples grade 1,2, and 3. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-3 Loading, (D) PC-4 loading.




CHAPTER 6. RAMAN ANALYSIS OF NORMAL BREAST AND BREAST CANCER 
 
The results presented in this chapter include the Raman spectral analysis of 6 tissue 
microarrays containing African breast tumours from similar tribal origins in Nigeria including 
different grades and subtypes and one TMA containing normal breast sections. 
Twenty spectra were collected from the epithelial tissue of each sample. A total of 499 
cancerous tumours and 79 normal breast sections were studied with Raman spectroscopy. 
The average spectra of the cancerous epithelia named cancerous area and the normal 
epithelia called normal breast are presented in Figure 55 and Figure 56. 
 
Figure 55. Raman average spectra of cancerous area and normal breast. (A) General region (3600-400 cm-1), (B) 
Lipid region (3,100-2,680 cm-1), (C) Fingerprint region (1,800-500 cm-1), (D) Amides region (1,800-1,140 cm-1) 
indicating: Amide I (1,800-1,510 cm-1), Amide II (1,510-1,390 cm-1) and Amide III (1,390-1,140 cm-1) regions. (E) 
Amino acid and nucleic acids regions (980-600 cm-1), and (F) Hydroxyproline and proline region (810-960 cm-1). 
The spectral profile of both tissue types showed subtle differences in intensity and peak 
location. Nonetheless, the differences were clear to the naked eye and suggested the 
presence of vital molecules such as carbohydrates, lipids, proteins, and nucleic acids on both 
tissue types. The spectral profile of breast cancer showed lower overall intensity (Figure 
55A&C) except on the lipid area (Figure 55B) and the peaks located at 1667 and 1295 cm-1. 




Furthermore, noticeable changes in peak shapes and ratios can be appreciated in the amide 
region (Figure 55D) while subtle peak shifts are present on the amino and aminoacid region 
(Figure 55E).  
 
Figure 56. Raman average spectra of Breast cancer (CA) and normal breast (NB), variance is represented with 
grey shadow. 
The main spectral features of both spectra are reported in Table 21 with the assignments 
taken from Rehman et al, Talari et al, and Lazaro-Pacheco et al unless otherwise specified. 
[148], [180], [181] As stated on this table, each peak represents the vibration of a functional 
group from a molecule. Vibrations corresponding to biomolecules such as proteins, lipids and 
carbohydrates were found as expected. Special attention should be paid to assignments 
related with carotenoids and cancer specific assignments such as ceramides. However, a 
proper comparison of the cancerous and normal breast tissue can only be achieved including 
the several readings obtained with Raman spectroscopy and the use of multivariate analysis. 
Table 21. Raman spectral bands of cancerous area (CA) and normal breast (NB) spectra averages with 









3298 Attributed to OH stretch 3316 
3061 CH stretch in lipids 3061 
2934 Chain end CH3 symmetric band 2935 




3100-2800 CH, CH2, and CH3 symmetric and antisymmetric stretching 
2881 
2881 CH2 and CH of lipids and proteins 
3300-2700 
2764, 2726 




C=C stretching band 
α-Helical structure of amide I 
Structural protein modes of tumours 
Carbonyl stretch (C=O) 
DNA 
Proteins, including collagen I 
C=C (amide I (C=O stretching mode of proteins, α-helix 
conformation)/C=C lipid stretch 
1616 




C=C in-plane bending mode of phenylalanine and tyrosine 
1604 
Ring C-C stretch of phenyl 
Cytosine (NH2) 
Ring C-C stretch of phenyl 
Phenylalanine, tyrosine, C-C (protein) 




ν (CN) and δ (NH) amide II (protein assignment) 
ν(C C) porphyrin 






C-H vibration (proteins and lipids) 
Lipids 
1418 
C=C stretching in quinoid ring 
1424 
A, G (ring breathing modes of the DNA/RNA bases) 
CH deformation (DNA/RNA and proteins and lipids and 
carbohydrates) 
1337 
CH3CH2 wagging, collagen (protein assignment) 
1339 
CH3CH2 wagging, nucleic acid 
CH3CH2 wagging mode of collagen and polynucleotide chain 
(DNA purine bases) 
CH3CH2 twisting and wagging in collagen 
Cellular nucleic acids 
CH3CH2 deforming modes of collagen and nucleic acids  
1317 
G (ring breathing modes of the DNA/RNA bases); C H 
deformation (protein) 1317 









1280 Differences in collagen content 1274 
1267 Triglycerides (fatty acids) 1266 
1260 




Amide III (β sheet and random coils) 
1247 
Asymmetric phosphate [PO2− (asym.)] stretching modes 
(phosphate stretching modes originate from the 
phosphodiester groups of nucleic acids and suggest an 
increase the in nucleic acids in the malignant tissues). 
Phospholipids do not contribute to these bands 
1209 Hydroxyproline, tyrosine (collagen assignment) 1208 
1173 
Cytosine, guanine 
1174 Tyrosine (collagen type I) 
δ(C H), tyrosine (protein assignment) 
1157 
C-C, C-N stretching (protein) 
1157 
Carotenoids (absent in normal tissue) 





ν(C-C) skeletal of acyl backbone in lipid (trans conformation) 
C-N stretching vibration (protein vibration) 
ν(C-O)+ ν(C-C), disaccharides, sucrose 
ν(C-N) 




Symmetric PO2−  stretching vibration of the DNA backbone; 
phosphate backbone vibration as a marker mode for the DNA 
concentration; C-N of proteins 
1064 
Skeletal C-C stretch of lipids 
Acyl chains 
ν(C C) trans 
Fatty acid 1066 
C N stretching 
Ceramide 
1032 
δ(C-H), phenylalanine (protein assignment) 
1032 
C-H in-plane bending mode of phenylalanine 
Carbohydrate residues of collagen 
Phenylalanine, C-N stretching of proteins 
C-H in-plane bending mode of phenylalanine  
1003 Phenylalanine (collagen assignment) 1002 
959 Hydroxyapatite, carotenoid, cholesterol 958 
938 
Proline, hydroxyproline, ν(C C) skeletal of collagen backbone 
938 
C C stretch backbone 
922-921 
C- C stretch 
923 
Proline ring/glucose/lactic acid/praline ring 
Monosaccharides (β-glucose), (C-O- C) skeletal mode 900 





Disaccharide (maltose), (C-O-C) skeletal mode 
Adenine 
878 Tryptophan, δ(ring) 877 
875 
Antisymmetric stretch vibration of choline group N+(CH3)3,  
Characteristic of phospholipids  
Phosphatidylcholine, sphingomyelin  
870 
Most probably due to single bond stretching vibrations for 
the amino acids proline and valine and polysaccharides 870 
C-C stretching, hypro (collagen assignment) 
853 




Out-of-plane ring breathing, tyrosine/O-P-O stretch DNA 
829 
Phosphodiester 
O-P-O stretchings DNA/RNA 
Ring breathing tyrosine 
782 Cytosine/uracil ring breathing (nucleotide) 782 
758 
Symmetric breathing of tryptophan (protein assignment) 
758 Ethanolamine group 
Phosphatidylethanolamine 
746 T (ring breathing mode of DNA/RNA bases) 745 
727 
C-S (protein), CH2 rocking, adenine 
725 C C stretching, proline (collagen assignment) 
Lipid 
665 
G, T (ring breathing modes in the DNA bases); tyrosine-G 
666 
backbone in RNA 
643 C-C twisting mode of tyrosine 643 
621 C- C twisting mode of phenylalanine (proteins) 621 
598 Phosphatidylinositol 603 




ν(S-S) gauche-gauche-trans (amino acid cysteine) 
522 




S-S disulfide stretching band of collagen 
518 
ν(S-S) gauche-gauche-gauche (amino acid cysteine) 
496 Glycogen 498 
422 Cholesterol 421 
411 Glucose  412 
 
The fingerprint region comparison of both average spectral profiles showed higher intensities 
in the peaks located at 2881, 1667, and 1295 cm-1 These peaks are representative of CH2 and 
CH asymmetric stretch of lipids and proteins, the C=O stretching characteristic of α-helix 
structural proteins , and ceramide vibrations respectively. [148], [180]  




The first peak (2881 cm-1) serves as a first indication of differences in the protein and lipid 
content of both tissue types. The peak located at 1667 cm-1 suggested that a higher content 
of proteins are found in the cancerous area in comparison with the normal breast confirming 
the differences stated by the first peak.  
The peak placed at 1295 cm-1 represent ceramides and was only visible in the breast cancer 
spectral profile. Ceramides form part of the structural components of sphingolipids. 
Ceramides are form by fatty acids and sphingosine. Sphingolipids play an essential role in 
carcinogenesis as they are membrane lipids and work as signalling molecules that are involved 
in cell growth and differentiation, apoptosis, senescence and proliferation.[182] Therefore, 
sphingolipids participate and regulate various cellular processes linked to cancer 
development, progression, metastasis and therapy resistance. Ceramide synthases and 
ceramide levels are statistically significantly increased in breast cancer tissue in comparison 
with benign tumours and normal breast. When calculated, a 12-fold higher of the total 
ceramide level was identified in breast cancer samples in comparison with normal breast 
tissue. [183] 
Frank et al proposed more than two decades ago the use of the I1667/I1449 ratio as first 
differentiator of breast cancer over normal breast.[85] This ratio compares the protein to lipid 
content being represented by the C=C stretch in amide I and the CH2 scissoring in lipids. When 
this ratio was calculated, the normal breast had a lower ratio than the breast cancer tissue 
(0.86 vs 0.93), confirming a higher content of lipids on the breast cancer sections. Lipid 
transformations during cancer have been widely reported, for example, a decrease of 65% 
triglycerides in cancerous breast compared to normal breast and a 4-fold increase in the 
phospholipid content for malignant tissue with a consistent increase in unsaturated fatty 
acids. [184] 
Samples of 6 TMA containing cancerous samples and 1 normal breast tissue were analysed 
obtaining 11,560 spectra. The breast cancer cohort represents a diverse group of cases, thus, 
a comparison of numerous spectra for both cases can offer a better insight of the malignant 
behaviour and all the biochemical changes associated with the cancer development and 
progression. For this end, the results of the multivariate analysis are presented on the next 
sections.  
Comparison of breast cancer and normal breast tissue in the general region, fingerprint, 
amides (I, II, III), lipids, aminoacid and nucleic acid, hydroxyproline and proline regions were 
performed using principal component analysis. Different scores and loadings are produced as 
PCA results. Both are complementary to each other in order to interpret the data. The scores 
show the dispersion of the samples based on the variance percentage along the analysed area. 
The loadings are a representation of the contribution of the Raman assignments, therefore it 
can be assumed that the higher the intensity the higher the contribution of that specific peak 
for the classification.  
The PCA model created was validated using Linear discriminant analysis with a sensitivity of 
90% and a specificity of 78%. 




6.1 GENERAL REGION (4,000-400 CM-1) ANALYSIS OF NORMAL BREAST AND BREAST 
CANCER 
Principal component analysis was applied to the general spectral region. A clear separation 
and grouping was achieved with the PC-1 and PC-2 accounting for 57% of the variance as it 
can be seen in Figure 57. The loadings associated with these principal components identified 
the following peaks as responsible for the grouping and separation: 2884, 1583, 1450, 1336, 
1245, 1159, 1122, and 1004 cm-1. 
The peak located at 2884 cm-1 has been assigned to the CH2 and CH stretching of lipids and 
proteins[180] and was identified to contribute more in the cancer area in comparison with the 
normal breast. This difference in content might be cause by the accelerated and active cell 
component production characteristic of cancer development and progression.  
The peak at 1583 cm-1 has been associated with tryptophan and the C=C bending mode of 
phenylalanine[185] and presented greater intensities on the cancer samples. This component 
form part of proteins and its contribution might be associated with the structural components 
in highly dense samples. This behaviour was confirmed by the peak at 1450 cm-1 also 
presenting higher intensities than the normal counterpart and which is representative of the 
CH2 bending characteristic of malignant tissues. [180] 





Figure 57. Principal component analysis on the general region (4,000-400 cm-1). (A) Score plot using PC-1 and PC-2 accounting for 57% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average Raman spectral profile for breast cancer and normal breast. Dotted lines represent the peaks found as 
responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-2 loading. 




Breast cancer samples presented higher intensities in the peak located at 1336 cm-1. This 
peak has been assigned to different components, and provide important information on the 
biochemical changes associated with the carcinogenesis process. This band is associated with 
the amide III, and polynucleotide chains, and CH2 wagging vibrations from glycine backbone 
and proline side chain in collagen.[181] Higher intensities in this peak suggest higher content 
of proteins, nucleic acids, and collagen in the cancerous samples. The 1245 cm-1 peak 
representing an amide III assignment was identified by the PC-2 and also presented higher 
intensities in the cancerous samples.  
The normal breast samples presented higher intensities than the average on the 1159 cm-1 
peak. This band is associated with the C=C stretch mode characteristic of carotenoids and β-
carotenoids. In addition, the peak at 1122 cm-1 representing C-C stretch on carotene and 
breast lipids also presented the same trend. Carotenoids play a vital role in different processes 
at cellular level; they offer oxidative damage protection, upregulate connexion junctional 
communication and prevent the lipid oxidation. Gap junctional communication (GJC) has been 
suspected to participate in carcinogenesis. Moreover, normal breast tissue proved to present 
a higher quantity of carotenoids than cancerous tissue, acting as a fatty acids reservoir. [112] 
Carotenoids role in normal breast tissue suggests protection against cancer development. 
[186] Normal tissue spectra had similarities with oleic acid, linoleic acid, and docosahexaenoic 
acid. Furthermore, carotenoids, oleic acid, and docosahexaenoic acid are well-known to play 
a protective role in breast cancer. [187] The decrease intensity of carotenoids peaks suggested 
a lower content of these components in the malignant tissue. Brożek-Płuska’s publications 
suggested that the oxidation of aging-related pigments might be the reason of the carotenoids 
reduction.[188] Furthermore, the carotenoids reduction has been also explained through the 
oxidation of lipofuscin material, and the lipid reduction was attributed to lipid 
peroxidation.[88]  
Furthermore, the peak at 1000-1004 cm-1 presented greater contributions in cancerous 
samples and was assigned to phenylalanine. [180] Different authors focus on this peak as a 
collagen specific assignment. The literature has reported collagen fibre deposition, 
rearrangement of fibres and overproduction occurring when tumours develop and grow. 
[189] Consequently an increase of intensity in peaks associated with stromal overproduction 
were expected as classifiers of cancerous samples. Nonetheless, stromal components were an 
important and dominant part of the normal breast sections and they could have been included 
in the Raman acquisition. Besides, a phenylalanine assignment can be correlated to proteins 
and structural components of the epithelial cells. 
6.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF NORMAL BREAST AND BREAST 
CANCER 
The analysis of the spectral region was narrowed down to the fingerprint region resulting in a 
good separation and grouping of the cancer and normal breast as seen in Figure 58. The 
following peaks were identified as responsible for the separation and grouping of samples: 
1668, 1586, 1451-1449, 1275, 1090, 1004, 784, and 546 cm-1. Some of the listed peaks were 
already discussed on the general region findings and will not be discussed if repeated. The 
new peaks are identified in Figure 58B with dotted lines.  




The peak located at 1586 cm-1 is assigned to a phenylalanine and hydroxyproline vibrations. 
Both biological component suggests that this peaks is caused by the collagen content. The PCA 
suggested that the normal breast samples and the cancerous samples located on the negative 
axis of PCA presented higher intensities on this collagen peak. The cancerous epithelia were 
visibly denser than the normal epithelia, therefore the inclusion of collagen in stromal can be 
assumed in the normal breast data collection. The ECM plays an important role in tumour 
progression and metastasis. Talari et al reported collagen production and remodelling caused 
by hypoxia processes through their involvement in the transcriptional status of procollagen 
genes.[190] On the other hand, collagen content changes, have a close relationship with 
stromal desmoplasia, which is a malignancy response.[80]  
Representing nucleic acids bands, the peaks located at 1090 and 784 cm-1 representing 
symmetric phosphate stretching vibrations and ring  breathing modes in DNA and RNA 
bases[148], [191] showed higher intensities in cancerous areas. This fact suggests that the 
nucleic acids are present in greater quantity in the malignant tissue. Higher cell density and 
the overproduction of genetic material is characteristic of early stages of carcinogenesis. In 
addition, the phosphate band can also serve as indicator of higher metabolic activity.[74] 
The peak found at 1275 cm-1 represent an amide III contribution and is a protein 
characteristic vibration including collagen.[180]. This band presented higher contributions in 
the normal breast due to the higher content of collagen suggested previously. Amide III 
represents α helix conformations [192] providing information of the structural conformation 
of proteins and collagen. The lower intensity in α helix characteristic peaks suggested 
conformational changes in the cancerous tissue. This finding is in agreement with our FTIR 
results where higher relative quantity of α-helix conformation was proposed in the normal 
breast in comparison with cancerous tissue. These changes indicate modifications in the 
number of hydrogen intermolecular bonds in the secondary structural conformation in the 
cancerous samples.[102]  
A cholesterol related peak located 546 cm-1 presented greater contributions in the normal 
breast readings. Higher content of oxidize and modified cholesterol has been reported as sign 
of histological progression from normal epithelium to hyperplasia. [193] However, a starting 
stable cholesterol content is expected in normal breast. [194] 
 





Figure 58. Principal component analysis on the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-5 and PC-7 accounting for 3% of the variance, (B) Average 
Raman spectral profile for breast cancer and normal breast. Dotted lines represent the peaks found as responsible for the separation based on the loadings presented 
in C&D, (C) PC-5 Loading, (D) PC-7 loading.




6.3 AMIDES REGION (1,800-1,510 CM-1) ANALYSIS OF NORMAL BREAST AND BREAST 
CANCER 
Principal component analysis of the amide spectral region resulted in a decent separation and 
good grouping of normal and cancerous breast samples when the PC-2 and PC-3 were used as 
shown in Figure 59. Peaks identified by the general and fingerprint region were also identified 
in this analysis as follow: 1615, 1590-1588. New peaks were found as responsible for the 
grouping of samples and are presented in Figure 59B. These bands are located at 1667, 1605, 
1448, 1291, 1243, and 1204 cm-1.  
The first peak located at 1667 cm-1 is cause by the vibrations of amide I. The amide I peak is 
the result of the carbonyl (C=O) stretching vibrations of the amide group, but it is also 
representative of the α-helix structures of proteins.[89] The first visible evidence of the 
change in this peak is a upshift in frequency from 1663 cm-1 in the normal breast to 1667 cm1 
in the cancerous area. Manoharan has previously reported this shift towards higher 
wavenumbers in addition to a widening of the peak. [80] In our case, a minimal widening can 
be appreciated in the spectral profile, but a higher intensity of this band is visible in the 
cancerous peak and has been confirmed by the score plot. Greater contribution of proteins 
with dominant α-helix structures is suggested by the higher intensities in breast cancer 
samples.  
Higher content of proteins suggested by increased intensity of phenylalanine and tyrosine 
peak located at  1605 cm_1 was also present in the malignant tissue. In the same form, 
changes linked to protein and lipid content was suggested by variable intensities in the band 
located at 1448, which is assigned to CH deformations.  
 Nucleic acids variation were also suggested in the amide analysis with the 1291 cm-1 peak. 
This peak  is linked to cytosine vibrations [148] and its dominance over the normal breast 
analogue peak can be appreciated with the naked eye in the spectral profiles (Figure 59B). 
Higher intensities than the average were confirmed for the cancerous areas in comparison 
with the normal breast. The production of genetic material and cellular content is expected 
as part of the cell division which form parts of the uncontrolled proliferation in malignancies.  
The bands found at 1243 and 1204 cm-1 are both related to collagen and proteins. These 
assignments represent the amide III vibration, which is caused by the CH2 wagging coupled 
with the C-N stretching and pyrimidine bases (C-T). [180]. These bands are considered collagen 
assignments as the CH2 wagging of the glycine backbone and proline side changes contribute 
considerably to the total intensity of this peak. Normal breast presented higher contributions 
of these peaks due to the inclusion of collagen in the Raman data collection. On the other 
hand, some cancerous samples presented considerable contributions of these two peaks. As 
previously discussed, the ECM present adaptation changes in order to prepare the cancer cells 
for further invasion and hypoxia survival. [107], [190] Among the adaptation changes, the 
overproduction of collagen is present by fibroblast stimulation.  




Further analysis focused on the amide I (1800-1510 cm-1), amide II (1510-1390 cm-1), and 
amide III (1390-1140 cm-1) regions resulting in partial separation and good grouping of normal 
and cancer samples as presented in Figure 60. 
The amide peaks as observed in proteins are characteristically broad as result of superposition 
of peptide contributions. 
The peaks identified in the loadings associated with the score plots presented in Figure 60A, 
C, and E are presented in the average spectral profiles in Figure 60B, D, and F. Some of these 
peaks have been discussed in the previous sections and only the new peaks found will be 
discussed. 
6.3.1 AMIDE I REGION (1,510-1,800 CM-1) 
Peaks in the amide I region are highly sensitive to conformational changes in the secondary 
structure of proteins.[89] The most important band representing amide I is formed by the 
overlapping of three bands. However, the amide I β-turn consists of two overlapping bands 
located around 1676 and 1652 cm-1. The former represent the antiparallel β-sheet 
structure, whilst the second band  represent the α-helix structure.[195] Conformational 
differences were responsible for the grouping of normal breast samples. The peak located 
at1648 cm-1 related to random coil vibrations presented higher intensities in comparison 
with breast cancer samples. Complementarily, the band placed at 1676 cm-1 caused by amide 
I β-sheet conformations showed higher intensities in the cancerous spectra. The change in 
conformational changes has been reported to be caused by ECM adaptation in hypoxia,[190] 
and differentiator of normal and cancerous cells in in-vitro studies [74] 
Also, the peak located at 1615 cm-1 had higher intensities in the cancerous area spectra. This 
band is caused by the tyrosine, tryptophan, and C=C vibrations in proteins.[148] This vibration 
indicates the overproduction of cellular components leading to abnormal proliferation. 
6.3.2 AMIDE II REGION (1,510-1,390 CM-1) 
The amide II region is less sensitive for conformational changes. Nucleic acids have 
representative bands in this region located at 1461 and 1489 cm-1. The first band is a 
deoxyribose vibration. However, it has also been reported as a CH2 wagging and CH3 
deformation of lipids and collagen. The later spectral peak is attributed to DNA vibrations. 
These two bands presented greater intensities in the cancerous samples. The dominant 
intensities in the cancerous area suggest an accelerated genetic material production leading 
to cell division.  
Normal breast samples presented higher intensities in the 1423 cm-1 band. This peak is caused 
by the N-H in plane deformation mainly representative of proteins. [180]. This deformation 
freedom might be caused by the vibrational modes found in strict strongly packed structures 
in normal breast in comparison with the much relaxed β-structures in cancerous areas. [196] 





Figure 59. Principal component analysis on the amide region (1,800-1,510 cm-1). (A) Score plot using PC-2 and PC-3 accounting for 25% of the variance, (B) Average 
Raman spectral profile for breast cancer and normal breast. Dotted lines represent the peaks found as responsible for the separation based on the loadings presented 
in C&D, (C) PC-2 Loading, (D) PC-3 loading.
















































































































































1667 1605 12431448 1291 1204





Figure 60. Principal component analysis of the amide region. (A) Score plot of the amide I region (1,800-1,510 
cm-1), (B) Average Raman spectral profile for breast cancer and normal breast with peaks responsible for the 
separation in the amide I region, (C) Score plot of the amide II region (1,510-1,390 cm-1), (D) Average Raman 
spectral profile for breast cancer and normal breast with peaks responsible for the separation in the amide II 
region, (E) Score plot of the amide III region (1,390-1,140 cm-1), (F) Average Raman spectra profile for breast 




cancer and normal breast with peaks responsible for the separation in the amide III region. Ellipses were drawn 
subjectively based on visual trends 
6.3.3 AMIDE III REGION (1,390-1,140 CM-1) 
The amide III region is associated with coupled C–N stretching and N–H bending vibrations of 
peptide groups.[196] The peaks found as responsible for the grouping of cancerous and 
normal breast were caused by ceramides (1295 cm-1), Amide III from a concerted ring 
mode(1234 cm-1 ), and tryptophan, phenylalanine, and amide III vibrations characteristic of 
proteins (1208 cm-1 ). All this peaks presented greater intensities in the cancerous areas in 
comparison with the normal breast. These differences suggested higher metabolic activity and 
cell density in the malignant tissue. In addition, the ceramide peak serve as an important 
biomarker due to its participation as structural component of sphingolipids. Sphingolipids are 
highly relevant in carcinogenesis as they are linked to various cellular processes such as cancer 
development, progression, metastasis and resistance to therapy.[183] 
6.4 AMINO ACIDS AND NUCLEIC ACIDS REGION (980-600 CM-1) ANALYSIS OF NORMAL 
BREAST AND BREAST CANCER 
Principal component analysis of the amino acids and nucleic acid region resulted in excellent 
grouping of the cancerous samples and relatively good separation of normal breast and breast 
cancer samples as presented in Figure 61.  Several new peaks were identified in this area 
responsible for the grouping of sample points.  
Among the identified peaks there were different collagen associated bands such as 921 cm1 
and 939 cm-1. The former band is cause by the C-C stretch of proline ring, while the later 
band represent the C-C stretch of the skeletal collagen backbone (proline and hydroxyproline). 
These peaks were presented in both sample types with important intensities, however, this 
can be explaining with the dominant stromal component in the normal breast samples and 
the overproduction and hyperactive activity of carcinoma-associated fibroblasts (CAFs) in the 
malignant tissue. The stromal microenvironment actively contributes to the development of 
breast tumours. Malignant cells recruit stromal cells, (inflammatory cells, vascular cells, and 
fibroblasts) into the tumour tissue, in order to promote its growth. Desmoplastic tumour 
stroma or reactive tumour stroma produce granulation tissue mainly composed by 
accumulated extracellular matrix. Desmoplastic stroma has been found in breast epithelial 
malignancies.[197] Besides, the fibroblasts in malignant masses have different biological 
characteristics in comparison with normal fibroblasts.  
Breast cancer samples presented more intense peaks located at 830 cm-1 produced by PO2- 
stretch of nucleic acids, 644 cm-1 caused by the C-C twisting mode of tyrosine and 
phenylalanine characteristic of proteins, and 691 cm-1 which represent cholesterol ester 
vibrations in comparison with normal breast. The dominant cancerous peaks in these 
assignments are caused by a higher metabolic activity as reported in previous works. [74], [89] 
Normal breast spectra showed greater intensities in the 719 cm-1 band that represents the 
C-N vibration in membrane phospholipid head. [180] A decrease in phospholipids in malignant 
breast tissue has been proposed by different authors. [84], [198]–[200] Different explanations 




such as synthesis and breakdown of choline phospholipids caused by specific genetic 
alterations and phospholipids alterations affecting the membrane fluidity.  
6.5 LIPID REGION (3,100-2,680 CM-1) 
Differentiation and grouping of normal breast and breast cancer samples could been seen 
when the lipid region was analysed (Figure 62). Several peaks constituting the 3 clear visible 
bands were responsible for the differentiation of normal and malignant tissue.  
Aromatic CH stretching modes characterised by the 3061 cm-1 peak and CH2 asymmetric 
stretching of lipids and fatty acids assigned to the band located at 2946 cm1 presented higher 
intensities in normal breast spectra. Different studies reported dominance of lipids, 
specifically fatty acids in normal tissue spectra. Whereas, protein dominates abnormal tissue, 
both benign and malignant.[74], [78], [79] The 2961 cm-1 band also showed important 
differences in the normal breast and cancer spectra. Out-of-plane chain end antisymmetric 
CH3 stretch band in lipids and fatty acids vibrations are responsible for this band.[180] 
Breast cancer spectra showed more intense bands associated with protein vibrations such as 
2928, 2881, and 2849 cm-1. These peaks were produced by the symmetric CH3 stretch due 
primarily to protein, CH2 asymmetric stretch of lipids and proteins, and symmetric stretch of 
C-H respectively. A greater contribution of proteins can be attributed to; uncontrolled and 
abnormal cell proliferation, cell division, and migration in the malignant tissue. [201], [202] 
6.6 HYDROXYPROLINE AND PROLINE REGION (960-810 CM-1) 
Hydroxyproline and proline region analysis was included due to its informative nature on the 
collagen component of the breast samples. Excellent grouping was achieved when PC-4 and 
PC-7 as presented in Figure 63. Normal breast samples showed dominant intensities in the 
bands located at 956 and 851 cm-1. The former band is assigned to carotenoids.[180] Oleic 
acid and carotenoids have been identified to dominate normal breast tissue. [186] 
Carotenoids have antioxidant properties reducing DNA damage and mutations, in addition to 
offering immune protection. Carotenoids play an important role in cellular processes that 
avoid the development of pathologies in the breast tissue. [112]  
The 851 cm-1 band is caused by proline, hydroxyproline and glycogen vibrations. Collagen is 
protein consisting of repetitive proline-rich tripeptide domains composed by three main 
amino acids: glycine, proline and hydroxyproline (Gly-X-Y). The fibre-like structure of collagen 
allows it to produce a highly interconnected network throughout the ECM, providing the 
structural integrity and biochemical properties of the connective tissue.[203] 
On the other hand, breast cancer samples presenter greater contribution of the following 
peaks: 941, 899, and 828 cm-1. The stretching of C-C skeletal backbone of collagen 
represented by the band located at 941 cm-1 represented adaptation in the ECM on the 
cancerous samples.[107] Collagen can go through structural rearrangement resulting in the 
exposure of proline and hydroxyproline amino acids affecting the intensities of this band. 
[203] The 828 cm-1 band had also being assigned to hydroxyproline and proline, however 
tyrosine vibrations and stretching of PO2- in nucleic acids also had been attributed to this peak. 




In combination with the adenine peak placed at 899 cm1 the nucleic acids vibrations are 
evidence of higher metabolic activity and cell density in the cancerous samples.  





Figure 61. Principal component analysis on amino acids and nucleic acids region (980-600 cm-1). (A) Score plot using PC-6 and PC-7 accounting for 2% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average Raman spectral profile for breast cancer and normal breast. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-6 Loading, (D) PC-7 loading. 





Figure 62. Principal component analysis on the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 55% of the variance, (B) Average 
Raman spectral profile for breast cancer and normal breast. Dotted lines represent the peaks found as responsible for the separation based on the loadings 
presented in C&D, (C) PC-1 Loading, (D) PC-5 loading. 





Figure 63. Principal component analysis on the hydroxyproline and proline region (960-810 cm-1). (A) Score plot using PC-4 and PC-7 accounting for 2% of the 
variance-ellipses were drawn subjectively based on visual trends, (B) Average Raman spectral profile for breast cancer and normal breast. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-4 Loading, (D) PC-7 loading.
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CHAPTER 7. RAMAN ANALYSIS OF BREAST CANCER 
7.1 COMPARISON OF THE SPECTRAL DATA OF DIFFERENT SUBTYPES WITHIN A SPECIFIC 
GRADE.  
The results and discussion presented in this section include the Raman spectral analysis of 6 
tissue microarrays containing African breast tumours from similar tribal origins in Nigeria 
comparing different grades and subtypes. 
A total of 499 cancerous samples were analysed with Raman spectroscopy. Two comparison 
types were performed, the first one comparing different subtypes within one grade and the 
second one comparing the spectral data of different grades within a specific subtype.  
7.1.1 GRADE 1 ALL SUBTYPES 
When compared, the average spectral profile of grade 1 samples presenting luminal, HER2+ 
rich and triple negative breast cancer (TNBC) subtypes showed differences enough to see with 
the naked eye as presented in Figure 64 and Figure 65. 
 
Figure 64. Raman average spectral profile of grade 1 samples presenting triple negative (TNBC), luminal and 
HER2+ subtypes, variance is represented with grey shadow. 
7.1.1.1 LIPID REGION (3,100-2,680 CM-1) ANALYSIS OF GRADE 1 SAMPLES ALL SUBTYPES 
The comparison of the different subtypes of grade 1 spectral profiles showed overall 
differences in intensity and peak ratios. A good trend showing decent grouping and partial 
separation was obtained when the lipid region was analysed in the grade 1 breast cancer 
samples as seen in Figure 66. 





Figure 65. Raman average spectra of breast cancer (grade 1) samples. (A) Lipid region (3,100-2,680 cm-1), (B) 
Fingerprint region (1,800-500 cm-1), (C) Amides region (1,800-1,140 cm-1) (D) Amino acid and nucleic acids 
regions (980-600 cm-1). 
The following bands were identified using the loadings presented in Figure 66C and D: 2987, 
2946, 2928, 2883, and 2844 cm-1.. These peaks showed differences according to the subtype 
they presented. The peak located at 2987 represents a cholesterol ester contribution and 
presented higher content on the luminal samples and HER2+ followed by the TNBC samples. 
The intratumour accumulation of cholesteryl ester is closely connected to proliferation and 
aggressive potential of breast cancer tumours.[204] 
The same trend was detected in the 2946 and 2883 cm-1 peaks. Both bands represented CH 
and CH2 vibrations in lipids and proteins.[180] Additionally, a downshift can be seen from 
2883 cm-1 in the luminal and triple negative breast cancer spectral profile to 2878 cm-1 in 
the HER2+ samples (Figure 66B). The 2880 cm-1 band has demonstrated sensitivity to identify 
intermolecular packing interactions and serve as indication of ordered lateral chain–chain 
interactions in lipids.[205], [206] Therefore, this shift might suggest rearrangement associated 
with lipids structural changes, which can be related to cell membrane adaptations.  
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The bands identified by PC-4 suggested greater contributions of the 2928 and 2844 cm-1 
peaks in the luminal samples with lower intensities in the TNBC and HER2+ samples. The first 
band is associated with the symmetric stretch caused primarily due to proteins.[180] Hence, 
the presence of higher content of proteins in positive hormonal breast cancer cases can be 
suggested. Analysing the similar trend of the band located at 2844 cm-1 caused by the 
symmetric stretching of CH2 in lipids especially fatty acids, lipid peroxidation seemed to have 
an early active participation in TNBC in comparison with its positive counterpart (Luminal 
subtype). 
7.1.1.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF GRADE 1 SAMPLES ALL 
SUBTYPES 
When the fingerprint region of grade 1 samples was analysed with principal component 
analysis it showed decent grouping for all three subtypes (Figure 67). Noticeable variations on 
peaks intensities and sharpness can be appreciated among all the spectral area. The bands 
responsible for the grouping of the subtypes are indicated in Figure 67B. 
Luminal grade 1 spectra presented more intensity in the bands located at 1668, 1333, 1312, 
1203, and 1000 cm-1. Therefore, it can be suggested that the biomolecules associated with 
those peaks are present in higher amounts in the luminal grade 1 samples in comparison with 
TNBC and HER2+. The only HER2+ grade 1 sample showed intensities closer to the average for 
all these assignments. On the contrary to the luminal subtype, the TNBC sample points were 
located on the opposite axis suggesting less contribution of the listed peaks. 
 




Figure 66. Principal component analysis of the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-2 and PC-4 accounting for 22% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the lipid region for grade 1 TNBC, luminal, and HER2+. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-4 loading. 




Figure 67. Principal component analysis of the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-4 and PC-7 accounting for 8% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the fingerprint region for grade 1 TNBC, luminal, and HER2+. Dotted lines represent the 
peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-4 Loading, (D) PC-7 loading.
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The 1668 cm-1 peak is caused by the stretching of the carbonyl group (C=O ) in the α-helical 
structure of proteins. Moreover, the next bands located at 1333  and 1312 cm-1 represent 
the CH3CH2 wagging and twisting of nucleic acids, and collagen. [180] 
In addition, the band placed at 1203 cm-1also represented a collagen and protein peak 
representing the amide III and CH2 wagging vibrations from glycine backbone and proline side 
chains. [180] Other collagen and protein assignment located at 1000 cm-1 representing the 
symmetric stretching of phenylalanine presented the same trend.  
The TNBC grade 1 samples presented greater contribution on the 1465 cm-1 peak assigned 
to lipid vibrations. Likewise, The peak placed at 1557 cm-1 representing the stretching of C-
N and deformation of N-H  which are representative of amide II also showed higher intensities 
than the luminal counterpart with the HER2+ only sample point placed closer to the average. 
This behaviour is consistent with the findings presented on the FTIR section. 
7.1.1.3 AMIDES REGION (1,800-1,140 CM-1) ANALYSIS OF GRADE 1 SAMPLES ALL 
SUBTYPES 
Clear but subtle differences can be appreciated in the different regions of the amide spectral 
range of the average spectral profile of grade 1 samples as presented in Figure 68. Variations 
in intensity, shape, sharpness, and ratios are reflections of changes occurring at the molecular 
level.  
 
Figure 68. (A) Average spectral profile of the amide region (1,800-1,140 cm-1) for grade 1 TNBC, luminal, and 
HER2+, (B) amide I region (1,800-1,510 cm-1), (C) amide II region (1,510-1,390cm-1), (D) amide III region (1,390-
1,140 cm-1). 




Figure 69. Principal component analysis of the amide region (1,800-1,140 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 58% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the amide region for grade 1 TNBC, luminal, and HER2+. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-5 loading. 
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The principal component analysis of the whole amide region showed a good grouping for the 
TNBC grade1 samples. However, the luminal subtype presented a scattered behaviour 
reflecting a dynamic behaviour. HER2+ only sample was found close to the average intensity 
of the peaks to be discussed as seen in Figure 69. 
The band located at 1662 cm-1 is considered an amide I vibration [180], however, it has also 
been reported as ceramide backbone [207] This band presented higher intensities and 
therefore contributions in the TNBC, followed by the luminal subtype and HER2+ samples. 
Besides, TNBC grade 1 samples also showed the highest contributions of nucleic acids and 
collagen bands located at 1448, 1334, 1320, 1243, and 1205 cm-1. The 1448 and 1334 cm-1 
bands correspond to the CH3CH2 deformation and wagging in collagen and polynucleotide 
chain.[180] The 1320 and1243 cm-1 peaks represent amide III vibrations. [148]The former 
band is caused by CH deformation in proteins and DNA and RNA, while the later bands 
characterise the CH2 wagging and C-N stretching in collagen and pyrimidine bases (C-T). Lastly, 
the 1205 cm-1 peak representing the hydroxyproline structural component in collagen [203] 
confirmed the ECM adaptation in the TNBC subtype.  Due to the increased intensity of these 
bands in the TNBC grade 1 samples it can be suggested a higher contribution and content of 
collagen and nucleic acids in comparison with luminal and HER2+ subtypes.  
The HER2+ grade 1 sample showed greater contribution in the 1467 cm-1 band which is 
assigned to lipid vibrations, and the 1294 cm-1 peak that is assigned to methylene twisting. 
[180], [208] The greater intensities on the HER2+ spectra suggest higher content of lipids, and 
methylation processes. Early carcinogenesis stages are characterised by DNA methylation. The 
methylation has effects on the genetic activity, but also oncogenic transformations. [176] Half 
of the luminal samples presented similar intensities, however the other half showed higher 
than the average intensities suggesting a split behaviour. On the contrary, the TNBC had the 
lowest contributions for these peaks in comparison with the other subtypes in grade 1 
samples.  
7.1.1.4 AMINO ACID AND NUCLEIC ACIDS REGIONS (980-600 CM-1) ANALYSIS OF GRADE 1 
SAMPLES ALL SUBTYPES 
The amino acid and nucleic acid principal component analysis revealed differences among the 
three subtypes in the grade 1 samples. Good separation and grouping of the samples was 
achieved (Figure 70A) The listed peaks were identified as differentiators of all three subtypes: 
963, 877, 849, 783, 717, 641, and 621 cm-1. 
The TNBC grade 1 samples grouped in the PC-2 positive and PC-4 negative quadrant in the 
score plot (Figure 70A). The location of this group indicated higher intensities on lipid 
vibrations represented by 963 cm-1, which agrees with our FTIR results. Furthermore, 
important and higher contribution of protein and nucleic acids vibrations were identified for 
this subtype in comparison with luminal and grade 1 HER2+ samples. These contributions 
were represented by the peaks located at se contributions were represented by the peaks 
located at se contributions were represented by the peaks located at 849 cm-1 caused by  




Figure 70. Principal component analysis of the amino acid and nucleic acid region (980-600 cm-1). (A) Score plot using PC-2 and PC-4 accounting for 28% of the 
variance-ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the amino acid and nucleic acid region for grade 1 TNBC, luminal, 
and HER2+. Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-4 loading. 
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tyrosine stretch, 641 cm-1 representing the C-S stretching and C-C twisting of proteins, and 
621 cm-1 which is assigned to C-C twisting mode of phenylalanine. [180] 
Luminal and HER2+ grade 1 samples showed a similar behaviour which was suggested by their 
same quadrant location in the score plot (Figure 70A). They both presented higher intensities 
in the peaks placed at 877 and 717 cm-1. Both peaks can be assigned to phosphodiester 
vibrations in nucleic acids. [180]However, the 717 cm-1 band has been suggested to represent 
C-N group vibrations in membrane phospholipid head [148] which might imply cellular 
membrane changes and affectation is membrane fluidity.  
7.1.2 GRADE 2 ALL SUBTYPES 
When compared, the average spectral profile of grade 2 samples presenting luminal, HER2+ 
rich and triple negative breast cancer (TNBC) subtypes showed subtle differences presented 
in Figure 71 and Figure 72. Grade 2 HER2+ and TNBC samples presented similar spectral 
profiles. 
 
Figure 71. Raman average spectral profile of grade 2 samples presenting triple negative (TNBC), luminal and 
HER2+ subtypes, variance is represented with grey shadow. 
7.1.2.1 LIPID REGION (3,100-2,680 CM-1) ANALYSIS OF GRADE 2 SAMPLES ALL SUBTYPES 
Relatively good grouping was identified when the lipid region was analysed with principal 
component analysis as presented in Figure 73. Four bands were identified as responsible for 
the grouping depending on subtype of the grade 2 breast cancer samples: 2944, 2933, 2880, 
and 2846 cm-1. 
 





Figure 72. Raman average spectra of grade 2 breast cancer samples. (A) Lipid region (3,100-2,680 cm-1), (B) 
Fingerprint region (1,800-500 cm-1), (C) Amides region (1,800-1,140 cm-1) (D) Amino acid and nucleic acids 
regions (980-600 cm-1). 
The first peak (2944 cm-1) represents the CH2 asymmetric stretch in lipids chains, especially 
fatty acids.[180] This band presented a split behaviour among the samples with half of the 
samples of each subtype presenting lower intensities than the average and the other half 
higher intensities.  
Principal component 5 showed the best separation for both hormonal subtypes. The luminal 
grade 2 samples presented higher intensities in the 2933, 2880, and 2762 cm-1 bands. The 
first band is cause by the CH2 asymmetric stretch, while the 2880 cm-1 peak is representative 
of CH2 and CH vibrations in lipids and proteins. [148]The band located at 2762 cm-1 is 
assigned to general C-H stretches. [180] Besides, the TNBC samples showed higher intensities 
of the peak located at 2843 cm-1 that suggest a higher lipid methylation (CH3). This suggestion 
was due to the CH3 symmetric stretch of lipids assigned to this peak.[180] However, HER2+ 
grade 2 sample points stayed the closest to the average suggesting a more consistent 
biochemical behaviour.  
 
 




Figure 73. Principal component analysis of the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-5 and PC-6 accounting for 3% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the lipid region for grade 1 TNBC, luminal, and HER2+. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-5 Loading, (D) PC-6 loading. 
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These increased intensities in the luminal and TNBC subtypes suggest that a more active lipid 
metabolism take place in the hormonal subtypes in grade 2 samples in comparison with the 
HER2+ subtype. The lipid changes are reflected in the intensity variations, and suggest fatty 
acid adaptations. Fatty acids support different mechanisms that can influence on breast 
cancer, as they might may control cell division. This processes include: membrane fluidity, 
macromolecule mobility, receptor availability, and prostaglandin and cAMP/cGMP 
biosynthesis. Moreover, unsaturated fatty acids might transform by being metabolised into 
epoxides and peroxides and act as initiators for cell proliferation. [209] Therefore, lipid 
transformations serve as evidence of biochemical adaptations during the cancer evolution.  
7.1.2.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF GRADE 2 SAMPLES ALL 
SUBTYPES 
The principal component analysis of the fingerprint region revealed a clear grouping of luminal 
and TNBC grade 2 sample points following opposite trends. In addition, HER2+ grade 2 
samples showed a good grouping. However, certain overlapping of groups was identified as it 
can be seen in Figure 74. 
Grade 2 HER2+ samples classification peaks were defined by PC-2. This subtype showed higher 
intensities than the average on the band located at 1243 cm-1 representing a higher 
contribution of Amide III vibrations, caused by CH2 wagging and C-N stretching.[180]. This 
particular assignment can correlate with collagen presence and with pyrimidine bases 
representing a nucleic acid vibration. Extensive changes and overproduction of genetic 
material in the HER2+ grade 2 samples can be suggested due to the increased 1243 cm-1  
band contribution. Furthermore, HER2+ grade 2 samples also showed lower intensities in 
peaks associated with C=C in plane bending mode of phenylalanine (1604 cm-1) and 
symmetric stretching of CH3 groups in phospholipids (1366 cm-1). The first band, 1604 cm-1, 
confirmed that the increased intensity in 1243 cm-1 was caused by nucleic acid dominant 
content instead of collagen overproduction, whereas the phospholipids band (1366 cm-1) 
suggest lipid peroxidation and changes in membrane fluidity.  
The separation among luminal and TNBC grade 2 samples was achieved using the PC-5. TNBC 
grade 2 spectra showed greater intensities in the bands located at 1669 (amide I), 1613 
(tyrosine), 1447(CH2 bending in proteins), and 1002 cm-1(phenylalanine) in comparison with 
luminal samples. All the listed bands represent protein related vibrations suggesting that 
TNBC grade 2 cases focus more on the overproduction of structural material to promote 
proliferation in comparison with the other subtypes. 
The analysed luminal grade 2 samples showed higher contribution of C=C olefinic stretch 
represented by the 1585 cm-1 peak. [196]This change translates to rearrangement of 
hydrogen bonds within proteins and collagen resulting in structural changes. [203] 
 
 




Figure 74. Principal component analysis of the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-2 and PC-5 accounting for 31% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the fingerprint region for grade 2 TNBC, luminal, and HER2+. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-5 loading. 
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7.1.2.3 AMIDES REGION (1,800-1,140 CM-1) ANALYSIS OF GRADE 2 SAMPLES ALL 
SUBTYPES 
Grade 2 breast cancer samples showed slight subtle differences in the different regions of the 
amide spectral range of the average spectral profile as presented in Figure 75. HER2+ samples 
seem to have a similar spectral profile to TNBC. In comparison with grade 1 samples the amide 
region of grade 2 cancerous samples had less evident differences. 
 
 
Figure 75. (A) Average spectral profile of the amide region (1,800-1,140 cm-1) for grade 2 TNBC, luminal, and 
HER2+, (B) amide I region (1,800-1,510 cm-1), (C) amide II region (1,510-1,390cm-1), (D) amide III region (1,390-
1,140 cm-1). 
Luminal grade 2 breast cancer samples were located in the positive PC-4 axis with the TNBC 
samples with the same grade following the opposite trend as shown in Figure 76. Three peaks 
associated with nucleic acids vibrations represented by the bands located at 1629, 1406, and 
1177 cm-1 showed greater contributions in the luminal samples in comparison with TNBC. 
Amide vibrations caused by C=O stretching for β-form of polypeptides (1629 cm-1)[180], 
histidine vibration (1406 cm-1)[210], and cytosine and guanine stretching (1177 cm-1)[148] 
were identified as responsible for these contributions. In addition, the majority of HER2+ 
grade 2 samples also presented greater contributions on the 1629 cm-1 band suggesting 
dominant β-form structural conformations. 
TNBC grade 2 samples presented more intense peaks at 1333, and 1313 cm-1.[180] The 
former band is caused by nucleic acids and phosphates vibrations which related to 
phospholipids, while the later peak is assigned to CH3CH2 twisting mode of collagen and lipids. 
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This finding suggests that a more active lipid metabolism take place in the negative hormonal 
subtypes in grade 2 samples in comparison with the HER2+ and luminal subtype. 
PC-6 helped to identify the peaks responsible for the HER2+ grouping. For example, lower 
intensities of 1467 and 1296 cm-1 were identified for this subtype representing lower 
contributions of lipids, and acyl chains in fatty acids respectively. On the contrary, HER2+ 
grade sample presented higher intensities in amide I α-helix conformations (1656 cm-1), and 
deformation of C=C in phenylalanine (1601 cm-1).[180] The clustering of HER2+ subtypes 
based on structural changes suggest structure alterations most possible due to the 
replacement of β-sheets with α- and random coils. [106] 
7.1.2.4 AMINO ACID AND NUCLEIC ACIDS REGIONS (980-600 CM-1) ANALYSIS OF GRADE 2 
SAMPLES ALL SUBTYPES 
The principal component analysis of the amino acid and nucleic acid region revealed groups 
but not a completely visible separation as can be seen in Figure 77. When the spectral profile 
of each subtype for grade 2 samples were compared similar intensities and peak shape were 
visible. Therefore, the PCA offered a better insight of the biochemical changes occurring on 
each subtype for the same breast cancer grade. 
Five peaks were detected as differentiator of HER2+ grade 2 samples. The peaks were located 
at 920, 858, 829, 786, and 756 cm-1. The band located at 920 and 858 cm-1 are associated 
with collagen assignments (ring and amino acid side chain vibrations of collagen backbone, 
proline and hydroxyproline)[180] and presented lower intensities than the average in the 
HER2+ spectra. Greater intensities were detected in nucleic acids related peaks located at 
829 and 756 cm-1 assigned to phosphodiester stretching in nucleic acids and symmetric 
breathing of tryptophan respectively. This dominant peaks suggest an active accumulation of 
genetic material leading towards cell proliferation and invasive processes.  
Luminal and TNBC grade 2 samples were group following opposite trends in PC-6. Luminal 
spectra showed more intense contributions of ring breathing mode of DNA/RNA bases (748 
cm-1), and C-N vibrations in membrane phospholipid heads (712 cm-1).[148] These 
contributions with increased intensities suggest changes in membrane fluidity and 
overproduction of cellular material. [150] Besides, TNBC grade 2 samples presented increased 
contributions of 837 cm-1 representing deformative vibrations of amide groups, 826 cm-1 
caused by phosphodiester stretch of nucleic acids, and 642 cm-1 assigned to C-S stretching 
and C-C twisting of proteins.[180] All these contributions suggests structural adaptations in 
proteins, and accumulation of cellular material, structural and genetic material, indicating 
higher metabolism and cell density. [74] 
 




Figure 76. Principal component analysis of the amide region (1,800-1,140 cm-1). (A) Score plot using PC-4 and PC-6 accounting for 3% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the amide region for grade 2 TNBC, luminal, and HER2+. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-4 Loading, (D) PC-6 loading. 




Figure 77. Principal component analysis of the amino acid and nucleic acid region (980-600 cm-1). (A) Score plot using PC-5 and PC-6 accounting for 2% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the amino acid and nucleic acid region for grade 2 TNBC, luminal, and HER2+. 
Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-5 Loading, (D) PC-6 loading. 
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7.1.3 GRADE 3 ALL SUBTYPES 
When compared, the average spectral profile of grade 3 samples presenting luminal, HER2+ 
rich and TNBC subtypes showed differences in intensity able to be seen with the naked eye as 
presented in Figure 78 and Figure 79. Grade 3 HER2+ rich subtypes seemed to have the most 
different spectral profile in comparison with the hormonal positive and negative grade 3 
spectral profiles. The differences among the three subtypes will be discussed in the following 
sections. 
 
Figure 78. Raman average spectral profile of grade 3 samples presenting triple negative (TNBC), luminal and 
HER2+ subtypes, variance is represented with grey shadow. 
7.1.3.1 LIPID REGION (3,100-2,680 CM-1) ANALYSIS OF GRADE 3 SAMPLES ALL SUBTYPES 
Clear grouping and mildly separation was achieved among the grade 3 samples, when the 
higher wavenumber region, representing lipids, was analysed with principal component 
analysis as presented in Figure 80A. PC-5 seems to differentiate luminal from TNBC samples 
by discriminating them on the positive axis. HER2+ grade 3 spectra points were located the 
closest to the average suggesting average concentrations of lipid component in comparison 
with the hormonal subtypes. 
The loadings associated with the score presented (Figure 80C&D) identified the following 
peaks as responsible for the separation of the hormonal subtypes: 2963, 2841, 2881, and 2848 
cm-1. For all these peaks, a higher contribution represented by higher intensities were 
identified in the TNBC placing the luminal in the opposite trend with the HER2+ samples lying 
in between. 




Figure 79. Raman average spectra of grade 3 breast cancer samples. (A) Lipid region (3,100-2,680 cm-1), (B) 
Fingerprint region (1,800-500 cm-1), (C) Amides region (1,800-1,140 cm-1) (D) Amino acid and nucleic acids 
regions (980-600 cm-1). 
The listed peaks represent out-of-plane end antisymmetric CH3 stretch (2963 cm-1), CH 
vibrations in lipids and proteins (2941 cm-1), CH3 vibrations in fatty acids (2881 cm-1), and 
symmetric stretching of lipids (2848 cm-1).[211] Differences in intensity and therefore 
content suggest the effect of lipid metabolism in cellular signalling, storage of energy, and 
building and maintenance of cellular membranes.  
7.1.3.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF GRADE 3 SAMPLES ALL 
SUBTYPES 
The principal component analysis of the fingerprint region revealed a clear grouping of sample 
points in all three subtypes. In addition, overlapping of luminal, HER2+, and TNBC grade 3 
samples can be seen in Figure 81A. 
Once again, the luminal and TNBC spectra points are spread on opposite axis following 
opposite trends with the HER2+ samples lying in between and closer to the average in the PC-
2 axis. Luminal grade 3 samples showed greater contribution of C=C bending in phenylalanine 
(1582 cm-1) and phosphate stretching in guanine (1363 cm-1).[148]  
 
 




Figure 80. Principal component analysis of the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 55% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the lipid region for grade 3 TNBC, luminal, and HER2+. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-5 loading. 
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TNBC samples presented lower intensities than the average on both mentioned peaks. 
However, higher intensities of collagen-related peaks were present in the TNBC grade 3 
samples in comparison with the luminal subtype. These peaks represented CH2, CH3 bending 
modes of collagen and phospholipids (1032 cm-1)[180], rocking motions of methyl groups in 
carotenoids and ring breathing in phenylalanine (1005 cm-1)[212], and C-C stretch backbone 
mainly in proline and hydroxyproline [203]. These differences hinted to specific behaviours in 
the hormonal subtypes, with an accumulation of genetic and structural (proteins) material in 
the luminal subtype, while the TNBC subtype focuses not only on this, but also in lipid 
transformations and collagen overproduction.  The suggested lipid alterations include 
variations in phospholipids and carotenoids. The first one affects the membrane fluidity and 
therefore cell signalling,[158] while the carotenoid vibrations in neoplastic tissue correlates 
with carcinogenic mechanisms. Hormone activity and cell processes have a close relation with 
breast cancer and tumour growth. Hormone secretion and cell differentiation is regulated by 
the gap junction communication (GJC), which is upregulated by carotenoids.[187] 
Principal component 4, revealed peaks assigned to amide I (1669 cm-1), nucleic acids and 
phosphate vibrations (phospholipids)(1331 cm-1), amide III β-sheet and random coils (1242 
cm-1) , and uracil-based ring breathing mode (778 cm-1) [180] with variable intensities among 
the positive and negative hormonal subtypes. Furthermore, PC-4 offered the 1086 cm-1 band 
which presented higher intensities in the HER2+ samples. This assignment represents the C-C 
skeletal stretch of acyl backbone in lipid gauche conformation.[213] A weak band was 
observed in the 1080-1088 cm-1 region and was assigned to a random liquid-like conformation, 
which suggest lipid conformational adaptations. [214] Akhtar et al described from a model 
phospholipid systems reflecting intramolecular trans/gauche conformational changes within 
the hydrophobic acyl chain matrix of the bilayers of the aforementioned region.  




Figure 81. Principal component analysis of the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-2 and PC-4 accounting for 25% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the fingerprint region for grade 3 TNBC, luminal, and HER2+. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-4 loading. 
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7.1.3.3 AMIDES REGION (1,800-1,140 CM-1) ANALYSIS OF GRADE 3 SAMPLES ALL 
SUBTYPES 
Slight, but noticeable differences were identified in the three different regions of the amide 
spectral range as presented in Figure 82. The amide I spectral region showed greater contrast 
between TNBC and luminal spectra. Amide II average spectral profile suggest similarities 
between HER2+and luminal grade 3 samples, while amide III seems to differentiate the best 
the HER2+ spectral profile.  
 
Figure 82. (A) Average spectral profile of the amide region (1,800-1,140 cm-1) for grade 3 TNBC, luminal, and 
HER2+, (B) amide I region (1,800-1,510 cm-1), (C) amide II region (1,510-1,390cm-1), (D) amide III region (1,390-
1,140 cm-1). 
Principal component analysis of the amide regions showed good grouping for all three 
subtypes of grade 3 samples as presented in Figure 83A where PC-2 and PC-7 were used. PC-
2 offered the identification of peaks responsible for the differentiation of luminal and TNBC 
samples. Luminal grade 3 spectra showed greater contributions of C=C bending mode of 
phenylalanine represented by the peak located at 1583 cm-1. [180] Phenylalanine vibrations 
indicate protein overproduction leading to proliferation of cancerous cells or collagen 
overproduction. Either way, both processes have important roles leading to more aggressive 
behaviour and invasion to surrounding tissues. TNBC spectra presented greater contributions 
of amide III vibrations according with PC-2 loading (Figure 83C). The first peak representing 
CH2 wagging vibrations from glycine backbone and proline side chains (1204 cm-1), while the 
second band represented CH2 wagging and C-N stretching on collagen and pyrimidine bases 
(C and T).[180] The identified peaks suggest accumulation of genetic material and ECM 
production confirming a higher metabolism and targeting higher cell densities through 
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proliferation.[74] The same principal component revealed intensities closer to the average for 
the aforementioned bands in the HER2+ grade 3 samples.  
Besides, PC-7 identified a variety of bands mainly associated with proteins and nucleic acids 
overproduction suggesting proliferation, but also fatty acids content variations. The band 
located at 1667 cm-1 caused by amide I α-helical structure seemed to have more contribution 
in the majority of HER2+ and luminal samples. On the other hand, the peak located at 1609 
cm-1  assigned to cytosine (NH2),and  1470 cm-1 representing C=N stretching presented 
greater contributions in TNBC confirming the focus of this subtype in overproducing genetic 
content for replication and accelerated proliferation.  The band located at 1297 cm-1 caused 
by acyl chain and fatty acids [180], [211] also presented increased intensities in the TNBC 
grade 3 spectra. Good correlation with the FTIR results previously reported for grade 3 
reaffirm the suggestion of accumulation of fatty acids in TNBC to work as fuel for malignant 
activities. 
7.1.3.4 AMINO ACID AND NUCLEIC ACIDS REGIONS (980-600 CM-1) ANALYSIS OF GRADE 3 
SAMPLES ALL SUBTYPES 
The analysis of the amino acid and nucleic acid region revealed a decent grouping and unclear 
separation of different subtypes of grade 3 samples. The separation was avoided by 
overlapping of all three subtypes in the analysed spectral region as presented in Figure 84A. 
Principal Component 5 and 6 showed the best results accounting for 2% of the variance. 
Protein vibrations were responsible for most of the peaks identified with these two PCs. 
Luminal grade 3 samples were mostly distributed among the negative PC-6 axis which 
suggested a higher contribution of C-C skeletal stretch of collagen backbone, proline and 
hydroxyproline [203].  
HER2+ grade 3 spectral points location suggested higher intensities than the average in several 
peaks including; aminoacid side chain vibrations in collagen (857 cm-1 )[203], out-of-plane 
ring breathing in proteins (823 cm-1)[148], phosphodiester in nucleic acids (784 cm-1)[148], 
breathing of tryptophan and ring mode in DNA and RNA bases (754 and 745 cm-1 )[180], and 
C-S stretching and C-C twisting in proteins ( 640 and 618 cm-1).[180]. An active proliferation 
triggered by protein and nucleic acid content and ECM preparation for further invasive 
processes can be proposed as part of the HER2+ cancer progression. Furthermore, TNBC 
spectral points showed a good clustering closer to the average of both axis suggesting a 
dynamic behaviour on the protein and collagen overproduction represented by the 
aforementioned bands in this section.  
 




Figure 83. Principal component analysis of the amide region (1,800-1,140 cm-1). (A) Score plot using PC-2 and PC-7 accounting for 23% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the amide region for grade 3 TNBC, luminal, and HER2+. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-7 loading.  




Figure 84. Principal component analysis of the amino acid and nucleic acid region (980-600 cm-1). (A) Score plot using PC-5 and PC-6 accounting for 2% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the amino acid and nucleic acid region for grade 3 TNBC, luminal and HER2+. 
Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-5 Loading, (D) PC6 loading.
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7.2 COMPARISON OF THE SPECTRAL DATA OF DIFFERENT GRADES WITHIN A SPECIFIC 
SUBTYPE.  
7.2.1 LUMINAL SAMPLES ALL GRADES 
When compared, the average spectral profile of luminal samples representing grade 1, 2, and 
3 showed subtle differences in intensity as it can be appreciated in Figure 85 and Figure 86. In 
all regions, spectral profiles showed similitudes between grade 1 and 3. The discussion of 
these specific areas is presented in the following sections. 
 
Figure 85. Raman average spectral profile of luminal samples representing grade 1, grade 2, and grade 3 cases, 
variance is represented with grey shadow. 
7.2.1.1 LIPID REGION (3,100-2,680 CM-1) ANALYSIS OF LUMINAL SAMPLES ALL GRADES 
Principal component analysis in the lipid region of luminal samples showed good grouping and 
good separation of grade 2 and 3 samples as it can be seen in Figure 87. The group of peaks 
located at 2988, 2946, 2913, 2881, and 2844cm-1 were identified with PC-2 and PC-6. All 
these peaks are associated with lipid and protein vibrations caused by CH vibrations. 
Grade 2 and 1 luminal samples presented an increased intensities in the band located at 2881 
cm-1 and 2844 cm-1 which represent CH2 asymmetric stretch of lipids and fatty acids[180] in 
comparison with grade 3 samples. Moreover, the band placed at 2913 cm-1 representing CH 
band of proteins [180]showed higher intensities than the average in the majority of grade 2 
samples suggesting important protein overproduction in those cases.  





Figure 86. Raman average spectral profile of luminal samples representing grade 1, grade 2, and grade 3 cases. 
(A) Lipid region (3,100-2,680 cm-1), (B) Fingerprint region (1,800-500 cm-1), (C) Amides region (1,800-1,140 cm-1) 
D) Amino acid and nucleic acids regions (980-600 cm-1). 
Grade 3 luminal spectra showed greater contribution of cholesterol ester represented by the 
band located at 2988 cm-1 and CH vibration in proteins represented by the protein 
characteristic lower energy level band placed at 2946 cm-1. [180] Breast tumours rich in 
cholesterol ester have been associated with higher histologic grade in addition to be linked to 
proliferation and aggressive potential.[204] Cholesterol ester affect cellular activity, for 
example the stabilization and fluidity of the cell membrane as well as controlling the 
membrane permeability.[211] However, Cholesterol ester plays a relevant role when it comes 
to luminal breast cancer. A cholesterol metabolite presented as 27-hydroxycholesterol 
(27HC), has been proposed to function as oestrogen agonist, promoting and accelerating the 
proliferation of oestrogen receptor (ER)-positive (luminal) breast cancer cells.[215] 
7.2.1.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF LUMINAL SAMPLES ALL 
GRADES 
Principal component analysis of the fingerprint region revealed an unclear separation but 
relatively good grouping of the different grades of luminal samples as presented in Figure 88A.  
PC-6 identified the following bands and assignments as differentiations of grade 1 and 3 from 
grade 2: 1650, 1605, 1332, 1123, and 1002 cm-1. Grade 1 and grade 3 samples presented 
more intense peaks than grade 2. However, grade 2 luminal samples showed higher and lower 
intensities than the average.  
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The peak located at 1650 cm-1assigned to amide I with random coils conformations [180] 
suggest conformational changes in proteins as the histological grade increases. The bands 
located at 1605 and 1535 cm-1 associated with cytosine NH2 vibrations and CH2CH3 wagging 
mode of collagen and polynucleotide chains in DNA purine bases [148] had higher intensities 
in grade 1 and 3 cases. This fact suggests the accumulation of genetic material on abnormal 
and abhorrent poor differentiated cancer cells, which serves the invasive purpose of cancer.   
Following the same trend, grade 1 and grade 3 samples showed collagen related peaks with 
increased intensities including 1335, 1313, and 1000 cm-1. Fibroblasts play an important role 
in cancer progression, due to their production of growth factors, chemokines and extracellular 
matrix which assists the angiogenic recruitment of endothelial cells and pericytes.[216] 
Elevated collagen density rises tumorigenesis, local invasion, and metastasis, which translates 
in higher content of stromal collagen affecting tumour formation and progression. [217] Thus, 
the active production of fibroblast products serves as an indication of cancer progression 
through poor differentiation of the cancer cells.  
 




Figure 87. Principal component analysis of the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-2 and PC-6 accounting for 28% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the lipid region for luminal samples grade 1,2, and 3. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-6 loading. 




Figure 88. Principal component analysis of the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-1 and PC-6 accounting for 56% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the fingerprint region for luminal samples grade 1,2, and 3. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-6 loading.
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7.2.1.3 AMIDES REGION (1,800-1,140 CM-1) ANALYSIS OF LUMINAL SAMPLES ALL GRADES 
The different regions within the amide spectral range showed visible differences in intensity 
as it can be appreciated in Figure 89. Grade 1 and 3 in the luminal cases showed similar 
intensity behaviours in the average spectral profiles with more noticeable differences in 
comparison with grade 2. 
Principal component analysis was applied to the amide region of luminal samples representing 
grade 1,2, and 3 giving as a result a good grouping and differentiation using PC-4 and PC-7 as 
shown in Figure 90. Grouping and differentiation among grades was achieved using PC-7 as 
reference. Five peaks were identified with this principal component: 1669, 1586, 1438, 1295, 
and 1243 cm-1.PC-4 helped identified bands were grade 1 samples presented dominant 
contributions. These peaks included amide I random coils (1650 cm-1), tyrosine (1614 cm-1), 
guanine (1333 cm-1), and CH3CH2 twisting mode in collagen (1312 cm-1).[180]  
 
 
Figure 89. (A) Average spectral profile of the amide region (1,800-1,140 cm-1) for luminal samples grade 1,2, and 
3, (B) amide I region (1,800-1510 cm-1), (C) amide II region (1,510-1,390 cm-1), (D) amide III region (1,390-1140 
cm-1). 
Greater contributions of amide I with α-helix configuration (1669 cm-1), phenylalanine and 
hydroxyproline vibrations (1586 cm-1), and amide III vibrations linked to asymmetric 
phosphate stretching modes in nucleic acids (1243 cm-1)[181] were identified in grade 3 
luminal samples followed by grade 1 and grade 3. This behaviour suggested that higher 
luminal breast cancer grades focus on the proliferation though generation of cellular 
component and stimulation of the ECM. [89] 
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On the other hand, grade 2 spectra presented a dominant contribution of lipid related bands 
presented at 1438 cm-1 (CH2 deformation and scissoring in lipids) and 1295 cm-1(CH2 
deformation and ceramide vibrations)[180]. Grade 2 presented higher intensities for the 
aforementioned peaks followed by grade 1 and grade 3 samples respectively.  Ceramides are 
a family of lipid molecules and are product of sphingolipid synthesis. Ceramides participate in 
several cellular signalling processes such as regulation of differentiation, proliferation, and 
programmed cell death (PCD) of cells.[218] The active lipid transformation occurring in grade 
2 samples suggest de novo lipogenesis focusing on sphingolipids components as an essential 
part of cancer development and dedifferentiation towards higher histological grades.  
7.2.1.4 AMINO ACID AND NUCLEIC ACIDS REGIONS (980-600 CM-1) ANALYSIS OF LUMINAL 
SAMPLES ALL GRADES 
Relatively good grouping and overlapping of cluster was obtained when the amino acid and 
nucleic acid region was analysed with principal component analysis as presented in Figure 
91A. Within the PC-5 axis grade 2 and grade 3 samples were clustered following opposite 
directions with grade 1 laying in between. As result of the peak identification using PC-5 
loading the following bands were assigned as responsible for the samples grouping:  783, 
754, 746, 715, and 704 cm-1.  
The band located at 783 cm-1 showed greater contribution in grade 3 spectra of luminal 
samples followed by grade 2 and 1. This peak is assigned to phosphodiester vibrations and 
therefore corresponds to nucleic acids contributions. Its higher contribution and dominant 
behaviour as the histological grade goes up indicates a more active metabolism and cell 
density at higher grades. [74] 
Grade 2 luminal samples followed by grade 1 and 3 presented more intense peaks 
representing symmetric breathing of tryptophan (754 cm-1), ring breathing modes of DNA 
and RNA bases (746 cm-1), CN+(CH3)3 lipid vibrations (715 cm-1), and cholesterol ester (704 
cm-1). All these bands represent a wide collection of biomolecules including proteins, nucleic 
acids, and lipids. Grade 2 seemed to behave more dynamically during the abnormal 
production of cellular components leading to cell division in comparison with the lower and 
higher histological grade. Additionally, once again and correlating with the presented FTIR 
results, adaptations of the lipid components possibly affecting membrane fluidity, and energy 
storage reservoirs have been identified. 
 
 




Figure 90. Principal component analysis of the amide region (1,800-1,140 cm-1). (A) Score plot using PC-2 and PC-7 accounting for 23% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the amide region for luminal samples grade 1,2, and 3. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-7 loading. 




Figure 91. Principal component analysis of the amino acid and nucleic acid region (980-600 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 56% of the 
variance-ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the amino acid and nucleic acid region for luminal samples grade 
1,2, and 3. Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC5 loading. 
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7.2.2 TNBC SAMPLES ALL GRADES 
The average spectral profile of TNBC samples representing grade 1, 2, and 3 showed 
differences enough to see with the naked eye as presented in Figure 93. In all of the spectral 
profile regions similitudes between grade 2 and 3 TNBC samples whereas the grade 1 showed 
more differences with the rest of the cases. The discussion of these specific areas is presented 
in the following sections. 
 
Figure 92. Raman average spectral profile of TNBC samples representing grade 1, grade 2, and grade 3 cases, 
variance is represented with grey shadow. 
7.2.2.1 LIPID REGION (3,100-2,680 CM-1) ANALYSIS OF TNBC SAMPLES ALL GRADES 
Principal component analysis of the lipid region revealed an unclear separation but acceptable 
grouping of the different grades of TNBC samples as presented in Figure 94. PC-1 and PC-5 
were used as they presented the best separation and clustering.  
PC-1 achieved the best separation identifying the following bands and assignments as 
responsible for the clustering of all three TNBC cases: 2947 cm-1 assigned to asymmetric 
stretch of CH2 in lipids, 2881 cm-1 caused by CH2 asymmetric stretch of lipid and proteins, 
and 2849 cm-1 representing CH3 symmetric stretch of lipids.[180] All these bands presented 
greater contribution in grade 2 samples followed by grade 1 and 3. Grade 1 samples were 
clustered in the origin of the score plot, which confirm average intensities for the previously 
listed peaks.  
As discussed before, the evolution of breast cancer is characterised by lipid peroxidation. [88] 
Therefore, a worst differentiated cancer cell is suggested to have a lower content of lipids. 
Additionally, grade 3 cancer cells are associated with more aggressive behaviour, which might 
Chapter 7. Raman analysis of breast cancer 
181 
 
indicate hypoxic events in advanced cases. The lack of oxygen supply in hypoxic areas in breast 
tumours lead to higher rates of oxidative stress, resulting in considerable lipid peroxidation 
and oxidative degradation of lipids. [190] 
 
 
Figure 93. Raman average spectral profile of TNBC samples representing grade 1, grade 2, and grade 3 cases. (A) 
Lipid region (3,100-2,680 cm-1), (B) Fingerprint region (1,800-500 cm-1), (C) Amides region (1,800-1,140 cm-1) (D) 
Amino acid and nucleic acids regions (980-600 cm-1). 
Besides, PC-5 revealed higher intensities in the 2925 cm-1 band in grade 3 samples, followed 
by grade 2 and 1. This band is assigned to the CH3 symmetric stretch due primarily to 
proteins.[89] This situation confirms the varying protein contents with respect to the grades. 
7.2.2.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF TNBC SAMPLES ALL GRADES 
The fingerprint region principal component analysis showed a good grouping for grade 3 TNBC 
cases while grade 1 and 2 samples were dispersed as can be appreciated in Figure 95. Grade 
1 TNBC samples were spread equally in the PC-4 axis. The grade 3 cluster was identified in the 
positive axis of PC-4, while grade 2 samples were mainly dispersed in the negative axis of the 
same principal component.  
The peaks located at 1669, 847, 780 cm-1 presented higher intensities in the grade 3 TNBC 
samples. These bands were assigned to amide I with α-helix conformation, C-O-C skeletal 
mode in monosaccharides, and uracil-based ring breathing mode respectively. [180]. The 
greater contribution of proteins and nucleic acids in grade 3 samples might indicate higher 
metabolic activity, but also higher cell density in the collection volume.  
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Furthermore, lower intensities of the 1605 and 1108 cm-1 peaks in the grade 3 TNBC samples. 
These two band are representative of collagen assignments.[180]. This fact suggests a lower 
content of collagen in grade 3 samples in comparison with the lower histological grades.  
The spreading of grade 1 and grade 2 samples of TNBC cases between both axes in both 
principal components suggest highly dynamic behaviours in this subtype in the less aggressive 
histological grades.  
7.2.2.3 AMIDES REGION (1,800-1,140 CM-1) ANALYSIS OF TNBC SAMPLES ALL GRADES 
The spectral average of all three histological regions presenting TNBC subtype showed visible 
differences in the three amide regions as presented in Figure 96. Grade 1 samples showed the 
most differences with grade 2 and 3 that showed similar profiles.  
Principal component analysis of the amide region showed a nice grouping and partial 
separation of grade1,2, and 3 of TNBC as can be appreciated in Figure 97A. A clear clustering 
for grade 1 and grade 2 were achieved with partial clustering of grade 3 samples. PC-3 was 
responsible for the separation of all samples.  
The analysis of the amide region revealed important overproduction of nucleic acids and 
proteins in grade 3, followed by grade 2 and 1 of the TNBC samples. The overproduction of 
proteins and nucleic acids was characterised by higher intensities in the bands located at 
1669, 1247, and 1236 cm-1 which represent amide I α-helix conformation, amide III , and a 
combination of amide III and CH2 wagging vibrations from nucleic acids and glycine backbones 
and proline chains respectively.[180] The first finding complemented the presented FTIR 
results which suggest a higher β-sheet conformation in grade 1 and 2 in TNBC.  The 
overproduction of cell components is characteristic of cell division and proliferation processes 
which is expected with more contributions in more aggressive and higher grades of cancer 
Grade 1 samples showed greater contributions of the following bands found at 1589 and 
1557 cm-1 which are considered collagen characteristic peaks (phenylalanine and 
hydroxyproline vibrations).[148]  
7.2.2.4 AMINO ACID AND NUCLEIC ACIDS REGIONS (980-600 CM-1) ANALYSIS OF TNBC 
SAMPLES ALL GRADES 
The amino acid and nucleic acid region principal component analysis showed a good 
dispersion and overlay of the grade 1 ,2, and 3 TNBC partial clusters as can be appreciated in 
Figure 98. Grade 1 TNBC samples seem to cluster on the positive PC-3 axis. This indicate a 
greater contribution of collagen represented by  the 940 and 624 cm-1 peaks assigned to 
collagen backbone vibrations and C-C twisting mode of phenylalanine.[203] In agreement with 
previously reported results lower histological grades seem to present higher collagen and ECM 
components.  
Other protein related bands were identified with greater contributions in the grade 3 samples 
followed by grade 2 TNBC. These peaks were located at 921 and 750 cm-1 representing 
proline ring vibrations and breathing modes of tryptophan.[196] This elevated content of 
proteins reflect higher metabolism and cell density in the most abnormal cancer cells, which 
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is expected in breast cancer cells with aggressive behaviours. However, the overlay of cluster 
suggested a variety of biochemical changes among different histological grades. Therefore, 
and overproduction of proteins and nucleic acids characterised by 853 and 830 cm-1 assigned 









Figure 94. Principal component analysis of the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-1 and PC-5 accounting for 60% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the lipid region for TNBC samples grade 1,2, and 3. Dotted lines represent the peaks found 
as responsible for the separation based on the loadings presented in C&D, (C) PC-1 Loading, (D) PC-5 loading. 




Figure 95. Principal component analysis of the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-3 and PC-4 accounting for 12% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the fingerprint region for TNBC samples grade 1, 2, and 3. Dotted lines represent the 
peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-3 Loading, (D) PC-4 loading. 





Figure 96. (A) Average spectral profile of the amide region (1,800-1,140 cm-1) for TNBC samples grade 1,2, and 
3, (B) amide I region (1,800-1,510 cm-1), (C) amide II region (1,510-1,390 cm-1), (D) amide III region (1,390-1,140 
cm-1). 
 




Figure 97. Principal component analysis of the amide region (1,800-1,140 cm-1). (A) Score plot using PC-3 and PC-6 accounting for 5% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the amide region for TNBC samples grade 1, 2, and 3. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-3 Loading, (D) PC-6 loading. 




Figure 98. Principal component analysis of the amino acid and nucleic acid region (980-600 cm-1). (A) Score plot using PC-3 and PC-6 accounting for 7% of the variance-
ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the amino acid and nucleic acid region for TNBC samples grade 1, 2, and 3. 
Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-3 Loading, (D) PC-6 loading. 
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7.2.3 HER2+ SAMPLES ALL GRADES 
When compared, the average spectral profile of grade 1, 2, and 3 HER2+ displayed clear 
differences as presented in Figure 99 and Figure 100. In comparison with other subtype’s 
analysis the HER2+ spectral profile showed more differences among all histological grades. 
The discussion of these specific areas is presented in the following sections. 
 
Figure 99.  Raman average spectral profile of HER2+ samples representing grade 1, grade 2, and grade 3 cases, 
variance is represented with grey shadow. 
7.2.3.1 LIPID REGION (3,100-2,680 CM-1) ANALYSIS OF HER2+ SAMPLES ALL GRADES 
Good grouping and separation was achieved in the lipid region using PC-1 and PC-4 as it can 
be seen in Figure 101. Six bands were identified as responsible for the separation and grouping 
of HER2+ samples of all grades. The only grade 1 sample with histological grade 1 presented 
a more intense peak at 2977 cm-1 which suggests a higher asymmetric vibration and content 
of CH3 coming from lipids, specially fatty acids.[211] This fact correlates with our FTIR results, 
and can be explained by a less active lipid transformation, by peroxidation, degradation and 
active novo-lipogenesis creation, in lower grades.   
PC-4 was responsible for the grade 2 and grade 3 separation. Higher contribution of CH 
vibrations in proteins (2916) was presented in grade 3 followed by grade 2 and 1 suggesting 
higher cell density and metabolism in higher grades. Additionally, lipid related bands located 
at 2993 cm-1 (cholesterol ester), and 2880 and 2847 cm-1 (CH2 symmetric and asymmetric 
stretch in lipids) presented increased intensity in grade 2 samples.  
 




Figure 100. Raman average spectral profile of HER2+ samples representing grade 1, grade 2, and grade 3 cases. 
A) Lipid region (3100-2680 cm-1), B) Fingerprint region (1800-500 cm-1), C) Amides region (1800-1140 cm-1) D) 
Amino acid and nucleic acids regions (980-600 cm-1). 
7.2.3.2 FINGERPRINT REGION (1,800-500 CM-1) ANALYSIS OF HER2+ SAMPLES ALL 
GRADES 
The fingerprint principal component analysis of HER2+samples showed partial differentiation 
among grades and good grouping when PC-2 and PC-3 were used as presented in Figure 102. 
PC-2 identifies the following peaks as responsible for the clustering and separation of samples: 
1601, 1455, 1361, 939, and 850 cm-1.  
The first three bands were assigned to phenylalanine, deoxyribose, and tryptophan vibrations 
hinting accelerated and active production of cell components.[74] Grade 3 showed higher 
contribution of these components followed by grade 2 and 1. The other two bands, 939 and 
850 cm-1, were identified as collagen characteristic peaks (proline and hydroxyproline)[203] 
and presented the opposite trend to the aforementioned bands with higher intensities in 
grade 1, follow by higher histological grades in order.  
Moreover, the majority of peaks identified with PC-3 were associated also with collagen 
characteristic vibrations. As expected, grade 1 presented more intense band at those locations 
followed by grade 2 and 3. Both findings suggest that at early histological grades the collagen 
and ECM production remains the focus, while at higher and intermediate grades the 
proliferation of cellular material is priority.  
 




Figure 101. Principal component analysis of the lipid region (3,100-2,680 cm-1). (A) Score plot using PC-1 and PC-4 accounting for 53% of the variance, (B) Average 
spectral profile of the lipid region for HER2+ samples grade 1, 2, and 3. Dotted lines represent the peaks found as responsible for the separation based on the 
loadings presented in C&D, (C) PC-1 Loading, (D) PC-4 loading. 




Figure 102. Principal component analysis of the fingerprint region (1,800-500 cm-1). (A) Score plot using PC-2 and PC-3 accounting for 38% of the variance-ellipses 
were drawn subjectively based on visual trends, (B) Average spectral profile of the fingerprint region for HER2+ samples grade 1, 2, and 3. Dotted lines represent 
the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-2 Loading, (D) PC-3 loading. 
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7.2.3.3 AMIDES REGION (1,800-1,140 CM-1) ANALYSIS OF HER2+ SAMPLES ALL GRADES 
Important differences can be appreciated in the different amide regions of the average 
spectral profiles of all grades HER2+ breast cancer samples (Figure 103). These differences 
include intensity, sharpness and shape of the Raman peaks, which is particularly noticeable in 
the amide III region.  
Principal component analysis of the amide region resulted in good grouping and identification 
of HER2+ samples with different grades as presented in Figure 104.  Grade 1 and 3 HER2+ 
samples showed higher intensities in the peaks located at 1367 and 1179 cm-1. The former 
band is assigned to the symmetric stretch of CH3 groups in phospholipids, while the later 
corresponds to cytosine and guanine vibrations.[180] These contributions suggest that 
ongoing changes through grade 1 and 3 are occurring in the cellular membranes and the 
content of nucleic acids. However, only a single tumour sample was available with this subtype 
representing grade 1.   
Grade 2 samples location in the score plot suggested more contribution of tyrosine and 
phenylalanine ring vibrations (1603 cm-1), methylene deformation in biomolecules (1450 
cm-1), and ceramide deformation (1295 cm-1) [180] in comparison with grade 1 and 3. These 
changes indicate adaptations in protein production, as well as methylation processes. The 
hyper-methylation in breast cancer has been investigated and has demonstrated affectation 
in the activity of genes in charge of steroid receptors, cell adhesion and matrix 
metalloproteinases inhibitors. [176]  
 
Figure 103. (A) Average spectral profile of the amide region (1,800-1,140 cm-1) for HER2+ samples grade 1,2, and 
3, (B) amide I region (1,800-1,510 cm-1), (C) amide II region (1,510-1,390 cm-1), (D) amide III region (1,390-1,140 
cm-1). 
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The only grade 1 sample presented important contribution in bands associated with DNA 
bases (1483 cm-1)[148], and CH2 deformation and scissoring in lipids and acyl chains (1436 
and 1419 cm-1)[211]. Therefore, active transformation in the lipid content can be assumed in 
early HER2+ grades.  
7.2.3.4 AMINO ACID AND NUCLEIC ACIDS REGIONS (980-600 CM-1) ANALYSIS OF HER2+ 
SAMPLES ALL GRADES 
The amino acid and nucleic acid region principal component analysis showed a good 
separation and clustering of the grade 1 ,2, and 3 HER2+ samples as can be appreciated in 
Figure 105. Grade 3 HER2+ samples seem to cluster on the positive PC-7 axis. This indicate a 
greater contribution of nucleic acids and proteins represented by the 780 and 647 cm-1 peaks 
assigned to uracil-based ring breathing mode and C-C twisting mode of tyrosine.[180]  
Other protein related bands were identified with greater contributions in the grade 2 and 1. 
These peaks were located at 887, 856, 849, and 620 cm-1. However, some of these bands 
(856 and 620 cm-1) are characteristic of collagen vibrations which suggest changes in the 
tumour bed and its ECM to promote invasive processes and angiogenesis.[217] The rest of the 
listed peaks are associated with conformational changes favouring β-sheet conformations 
(887 cm-1), and regular protein vibrations such as tyrosine (849 cm-1).  
Furthermore, lipid characteristic peaks were also identified with higher intensities in grade 2 
samples. These bands were 955 cm-1 representing carotenoids and cholesterol and 877 cm-
1 representative of C-C-N+ symmetric stretch in lipids.[180], [211]The importance of 
cholesterol and lipid adaptations in breast cancer has attracted attention in the past decades. 
Prior studies have proposed as hallmark of tumorigenic cells alterations in the cholesterol 
content of cellular plasma membranes. In similar studies, the regulation of the cholesterol-
synthesis pathway has been indicated to also affect cellular proliferation in breast tumours. 
[219] On the other hand, increased novo lipogenesis has been associated with accelerated 
membrane formation caused by fast proliferation representing a hallmark of metastatic or 
invasive processes.[179], [220] 
 




Figure 104. Principal component analysis of the amide region (1,800-1,140 cm-1). (A) Score plot using PC-5 and PC-7 accounting for 2% of the variance-ellipses were 
drawn subjectively based on visual trends, (B) Average spectral profile of the amide region for HER2+ samples grade 1, 2, and 3. Dotted lines represent the peaks 
found as responsible for the separation based on the loadings presented in C&D, (C) PC-5 Loading, (D) PC-7 loading. 




Figure 105. Principal component analysis of the amino acid and nucleic acid region (980-600 cm-1). (A) Score plot using PC-4 and PC-7 accounting for 2% of the 
variance-ellipses were drawn subjectively based on visual trends, (B) Average spectral profile of the amino acid and nucleic acid region for HER2+ samples grade 1, 
2, and 3. Dotted lines represent the peaks found as responsible for the separation based on the loadings presented in C&D, (C) PC-4 Loading, (D) PC7 loading.
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CHAPTER 8. CONCLUSIONS AND FUTURE WORK 
Vibrational spectroscopy has proven to be an excellent technique for breast tissue analysis. 
The use of FTIR and Raman micro-spectroscopy on ex vivo breast samples provided excellent 
results containing important biochemical information. A combination of FTIR, Raman 
spectroscopy and chemometric methods was used for the first time in the study of African 
breast cancer in a relatively large cohort. This work contributes significantly to the field of 
cancer research by identifying key biochemical changes from normal breast to breast cancer 
as well as identifying chemical changes associated with different subtypes and grades of 
breast cancer.  
The differentiation of normal breast and breast cancer was successfully achieved with both 
FTIR and Raman micro-spectroscopic techniques. The PCA model created with Raman 
spectroscopy presented a sensitivity of 90% and a specificity of 78%. The PCA model created 
with FTIR spectroscopy reached a sensitivity of 92% and specificity of 86%.  
Although these numbers are promising and would provide good results in a screening test, in 
a definitive test at the time of surgery the presented prediction models will result in a 22% 
(Raman) and a 14% (FTIR) false positive rate. It is important to note that in a surgical context 
these false positives could result in women having unnecessary breast lumpectomies or 
mastectomies. As a consequence of removing healthy tissue there is the risk of tissue trauma 
and psychological impact. If these techniques are to be applied at the time of surgery, the 
protocols need to be optimised. For example, the incorporation of prediction protocols that 
consider analysing several points in odd numbers (n=2k+1) and the determination of the 
sample nature considering the majority of the predictions (k+1) could be used to improve the 
sensitivity of the presented models. This approach has been reported in protocols for glioma 
diagnosis in the UK. [221] 
Progression of cancer comprises a wide variety of mechanisms where stroma, angiogenesis, 
inflammation, immune system, hormones, and xenobiotic play an important role. All these 
processes and mechanism will cause biochemical changes at tissue level. The importance of 
identifying the chemical pathway to the progression of the disease relies on the valuable 
predictive information which allows the clinician to take decisions to improve the treatment 
course and to give the patient a better chance against the disease. Hence, the biochemical 
changes identified in this research can facilitate the assessment of potential metastasis as well 
as the aggressiveness at different progression time-points. In clinical practice, tracking the 
progress of cancer supports several decisions, such as changes in therapy.  
8. 1 COMPARISON OF NORMAL BREAST VS BREAST CANCER 
This research established the lipid and protein contribution as main differentiators of normal 
breast and breast cancer. This study reported a dominance of lipids, specifically fatty acids, in 
the normal tissue Raman spectra. Whereas, protein dominated the malignant breast. The 
normal breast samples presented higher intensities of carotenoids, β-carotenoids, and 
cholesterol. In the breast cancer sections, the reduction of these components has been 
explained through lipid peroxidation. Complementarily, our FTIR results found lower content 
of lipids relative to the protein content for the cancer tissue, whereas the opposite trend was 
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true for the normal breast epithelia as confirmed by the Amide I/Lipids and Amide II/Lipids 
ratios.  
Furthermore, FTIR identified transformations in the breast cancer lipids. These changes were 
proposed to be due to the increment of trans- lipid conformations in the breast cancer 
samples. In addition, a higher content of acyl chains in the cancerous area was identified, 
suggesting affectations on cell adhesion molecules in the cell membrane, as well as 
interactions between cell adhesion molecules and lipid components in the membrane. 
Greater contributions of protein and nucleic acid bands were identified with Raman and FTIR 
spectroscopy in the cancerous samples in comparison with the normal breast samples. DNA 
methylation has been suggested as responsible for the reduction in the methylation ratio from 
normal to malignant tissue in the FTIR analysis.  
The FTIR spectral profile of the breast cancer samples suggested a lower content of collagen 
relative to protein content. Both techniques indicated that the normal breast samples were 
dominated by the presence of collagen, while a higher content of proteins constituting the 
malignant epithelia were present in the cancerous samples. 
When the FTIR results were compared with the Raman spectroscopy findings, the 
conformational differences in proteins were responsible for the grouping of normal breast 
samples. A lower intensity in α helix characteristic peaks confirmed conformational changes 
in the cancerous tissue. In addition, random coil vibrations presented higher intensities in the 
normal breast in comparison with the breast cancer samples. Amide I β-sheet conformations 
showed higher intensities in the Raman cancerous spectra. β-sheet cancer peaks in the FTIR 
breast cancer profile presented a higher intensity in comparison with the normal breast. The 
A1657/A1635 ratio showed a higher relative quantity of α-helix conformation in the normal breast 
in comparison with cancerous tissue. β-sheet structural proteins were more present in cancer 
tissue. FTIR highlighted that structural changes formed an important part of breast cancer 
evolution.  
Ceramide related peaks were only visible in the Raman breast cancer spectra. The ceramide 
peak served as an important biomarker due to its participation as a structural component of 
sphingolipids. Sphingolipids are highly relevant in carcinogenesis as they are linked to various 
cellular processes such as cancer development, progression, metastasis and resistance to 
therapy.  
The heterogeneity of our breast cancer cohort was confirmed by the cluster analysis. This 
analysis was performed for the cancerous area and normal breast FTIR spectra. The infiltration 
of normal samples into clusters, formed mainly by cancer samples, confirmed the variability 
among cases. The cancerous samples included in this study represented different grades, 
subtypes, and as a result presented different characteristics that might have resembled the 
normal tissue.  
8.2 COMPARISON OF BREAST CANCER GRADES AND SUBTYPES 
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The cancerous cohort represented a heterogeneous group of cases, therefore, a specific 
comparison based on grade and subtype provided a better insight of the biochemical changes 
associated with the cancer progression and evolution.  
Raman and FTIR spectroscopy have been demonstrated as a functional evaluation and 
characterisation tool for breast cancer allowing qualitative analysis. Additionally, the 
understanding of positive (luminal) and negative (TNBC) hormonal receptors as well as HER2+ 
rich subtypes has been enriched using vibrational spectroscopy. These findings contribute in 
several ways to our understanding of breast cancer and provide a basis for analysis with 
vibrational spectroscopy. The work presented in this document supports future clinical 
implementations of these techniques. 
8.2.1 GRADE 1 BREAST CANCER SAMPLES 
The Raman analysis revealed a higher cholesterol ester contribution (2987 cm-1) on the 
luminal and HER2+ samples than the TNBC samples. The intra-tumour accumulation of 
cholesteryl ester is highly relevant due to its close connection to cell proliferation. Luminal 
and HER2+ presented a higher order of lateral chain–chain interactions in lipids in comparison 
with TNBC, as indicated by the contribution of 2946 and 2883 cm-1.  
HER2+ Raman spectra presented a higher content of lipids and methylation processes, while 
the luminal grade 1 samples presented a split behaviour, and TNBC had the lowest 
contributions for these bands. Similar results were obtained with FTIR spectroscopy, however, 
the differences in intensity and shape of lipid peaks indicated varying content of fatty acids. 
These variations advocated the important role played by fatty acids in the early histological 
grades. A higher content of olefin =CH stretching was identified in HER2+ grade 1 than the 
TNBC and luminal grade 1 samples. In contrast with the Raman results, TNBC showed a higher 
overall contribution of lipids, and the grade 1 luminal and HER2+ samples presented a more 
dynamic trend. 
Higher absorbance of proteins and nucleic acids vibrations was detected on the samples 
representing the luminal and TNBC subtypes using both techniques. Guanine and deformation 
of N-H in-plane in the FTIR spectra evidenced similarities between luminal and TNBC grade 1 
samples. Whereas lipid peroxidation seemed to have an early active participation in TNBC in 
comparison with its positive counterpart (Luminal subtype). The similitude between the 
hormonal subtypes suggested a similar nucleic acid production at lower grades, and a slower 
overproduction of genetic material seemed to take place in the HER2+ grade 1 samples.  
Structural changes in the proteins presented on grade 1 cancer cases were responsible for the 
discrimination of samples. The contribution of β-sheet structures of amide I in the FTIR data 
was similar on the luminal and TNBC. HER2+ showed less content of β-sheet structures. The 
spectral profiles of grade 1 luminal and TNBC showed wider amide I bands in comparison with 
the grade 1 HER2+ as a result of the low contribution of the β-sheet shoulder. In the same 
way, the Raman data revealed that luminal grade 1 spectra presented more intensity in the 
α-helical structure of proteins.  
Ceramides play an important role in the breast cancer Raman profile of TNBC. The ceramide 
backbone vibrations provided higher contributions in the TNBC, than the luminal subtype and 
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HER2+ samples. In addition, TNBC grade 1 samples showed the highest contributions of 
nucleic acids and collagen.  
8.2.2 GRADE 2 BREAST CANCER SAMPLES 
TNBC grade 2 samples presented more intense Raman peaks at 1333, and 1313 cm-1 which 
were caused by nucleic acids and phosphates vibrations related to phospholipids and the 
twisting mode of collagen and lipids. Vibrations related to lipids, cholesterol and creatine were 
identified in the FTIR data presenting higher intensities in the luminal and TNBC subtype, 
whereas the HER2+ subtype samples were all located in the lower than average area. HER2+ 
data also presented lower contributions of lipids in the Raman analysis. Thus, more active lipid 
metabolism takes place in the hormonal subtypes in grade 2 samples in comparison with the 
HER2+ subtype. 
The C-H deformation and C-O stretching associated with glycogen presented higher FTIR 
intensities in the TNBC and lower intensities in luminal and HER2+ grade 2 samples. The higher 
contribution of glycogen on the TNBC grade 2 served as an indicator of accelerated 
proliferation suggesting a more aggressive behaviour, which is characteristic of the TNBC 
subtype.  In addition, the TNBC samples showed higher lipid methylation (CH3) while HER2+ 
samples showed a more standard biochemical behaviour. The luminal and TNBC spectra 
intensities suggested a more active lipid metabolism in comparison with the HER2+ subtype. 
Luminal and TNBC subtypes had higher protein production than HER2+ at grade 2 as indicated 
by the results of both techniques. The Raman analysis showed that HER2+ presented the 
lowest content of collagen among the grade 2 samples. Additionally, variations in the C-H 
stretching peak located at 2948 cm-1 were higher in the luminal and TNBC reflecting more 
biochemical activity on these subtypes in comparison with HER2+ cases. 
Overproduction of genetic material in the luminal and HER2+ grade, and changes in the cell 
membrane fluidity, were suggested by the PO2- asymmetric stretching in nucleic acids and 
cholesterol ester FTIR vibrations. The significant participation of lipids and phospholipids in 
luminal cases was also confirmed with Raman spectroscopy. The protein-related Raman 
contributions suggested that TNBC grade 2 cases focus more on the overproduction of 
structural material to promote proliferation than the other subtypes.  
Both spectroscopic analyses revealed conformational changes as part of the subtype 
differentiation. HER2+ grade 2 samples had greater contributions on the 1629 cm-1 Raman 
band suggesting dominant β-form structural conformations. HER2+ rich samples presented 
higher intensities of β-sheet FTIR bands indicating more of this secondary structure in 
comparison with the other subtypes. 
TNBC grade 2 cases focused on the overproduction of genetic material to promote 
proliferation as confirmed by both techniques, whereas luminal grade 2 samples presented 
considerable structural changes in their proteins. This change translated to the rearrangement 
of hydrogen bonds within proteins resulting in structural changes in luminal grade 2 samples.  
8.2.3 GRADE 3 BREAST CANCER SAMPLES 
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TNBC presented the highest Raman lipid contributions, followed by HER2+ and luminal 
respectively. Acyl chains and fatty acids also presented increased intensities in the TNBC grade 
3 spectra. The same behaviour was confirmed when the grade 3 samples were analysed with 
FTIR, and lipid-related bands (3023, 2971, 2896, and 2896 cm-1 ) presented a higher 
contribution in the TNBC than HER2+ and Luminal. Highly active lipid metabolism in TNBC 
grade 3 samples was proposed. The accumulation of fatty acids in TNBC suggested aggressive 
malignant activities that needed to be fuelled through these lipid components. 
The Raman results proposed the accumulation of genetic and structural (proteins) material in 
the luminal subtype, while the TNBC subtype focused not only on this, but also on lipid 
transformations and collagen overproduction. The suggested lipid alterations included 
variations in phospholipids and carotenoids. The FTIR data suggested that TNBC had lower 
contents of nucleic acids in comparison with the positive hormonal receptor subtype. 
However, the Cytosine (NH2), and C=N stretching presented in FTIR spectroscopy confirmed 
the overproduction of genetic content for replication and accelerated proliferation in TNBC. 
Luminal grade 3 Raman spectra showed greater contributions of the C=C bending mode of 
phenylalanine. TNBC spectra presented greater contributions of amide III vibrations. The 
identified peaks suggested an accumulation of genetic material and ECM production, 
confirming a higher metabolism. HER2+ grade 3 Raman spectral data had higher intensities in 
the peaks associated with: aminoacid side chain vibrations in collagen, out-of-plane ring 
breathing in proteins, phosphodiester in nucleic acids, breathing of tryptophan and ring mode 
in DNA and RNA bases, and C-S stretching and C-C twisting in proteins. Active proliferation 
triggered by protein and nucleic acid content and ECM activation was proposed as part of the 
HER2+ cancer progression.  
Luminal grade 3 samples presented structural changes suggesting adaptation towards β-sheet 
conformations according to the FTIR peak located at 1636 cm-1. HER2+ grade 3 samples 
presented the lowest contribution of this secondary structure, while TNBC showed no 
particular preference. Thus, a reduction of the α-helix structure and increase in β-sheet 
structure was assumed in the luminal cases. Luminal grade 3 samples presented consistent 
important contributions in the C=N guanine FTIR vibration, followed by TNBC and finally 
HER2+ samples. These particular differences hinted towards guanine conformation changes, 
which disturb the reparative mechanisms of the cell and tissue. 
8.2.4 LUMINAL BREAST CANCER SAMPLES 
Grade 1 and 2 luminal samples presented an increased intensity in the Raman bands 
representing CH2 asymmetric stretching of lipids and fatty acids in comparison with grade 3 
samples. Grade 2 spectra showed greater contributions of CH2 deformation, scissoring in 
lipids, CH2 deformation, and ceramide vibrations than grade 1 and grade 3 samples. These 
results were similar to those obtained with FTIR, where C=C cis conformation of fatty acid 
peaks had a greater contribution in grade 2 samples. Likewise, asymmetric stretching 
vibrations of CH2 of acyl chains, CH3 symmetric stretching, and stretching vibrations of CH2 and 
CH3 of phospholipids, cholesterol, and creatine, showed higher intensities and contributions 
in grade 2 cases. 
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By contrast, grade 3 luminal Raman spectra showed greater contribution of cholesterol ester 
and CH vibration in proteins. Breast tumours rich in cholesterol ester were associated with a 
higher histologic grade in addition to being linked to proliferation and aggressive potential. 
Grade 3 luminal cases also presented a higher contribution of the amide A, amide I, C=N, and 
NH2 from adenine bands in the FTIR analysis than grade 2 and 1. These vibrations suggested 
that a higher content of proteins and nucleic acids were present in grade 3 samples, probably 
representing the aberration and poor differentiation associated with higher grades.   
Grade 1 and 3 samples presented more intense Raman peaks than grade 2. However, grade 2 
luminal samples showed higher and lower intensities than the average suggesting variable 
behaviour. The peak located at 1650 cm-1assigned to amide I with random coils 
conformations suggested conformational changes in proteins as the histological grade 
increased.  
Greater contributions of amide I with α-helix configuration, phenylalanine, hydroxyproline, 
and amide III vibrations were identified in grade 3 with Raman spectroscopy. This behaviour 
suggested that higher luminal breast cancer grades focused on cell proliferation by generating 
cellular components and stimulating the ECM. Additionally, grade 1 and grade 3 samples 
showed collagen related peaks. Thus, the active production of fibroblast products served as 
an indication of cancer progression through poor differentiation of the cancer cells. 
FTIR spectroscopy detected the methylation of nucleotides in grade 1 luminal cases. 
Methylation modifies the genetic activity. Literature confirmed significant methylation in ER 
positive cell lines. 
8.2.5 TNBC BREAST CANCER SAMPLES 
Asymmetric stretching of CH2 in lipids, CH2 asymmetric stretching of lipids and proteins, and 
CH3 symmetric stretching of lipids presented greater Raman contribution in grade 2 samples 
than grade 1 and 3 in the TNBC subtype. Therefore, a higher histological grade was suggested 
to have a lower content of lipids. FTIR results confirmed this, with intensities of C=C vibrations 
in fatty acids decreasing in higher grades. 
Grade 1 samples kept intensities closer to the average in the FTIR spectra suggesting steady 
protein and fatty acid contents in early grades of TNBC. The analysis of the amide region 
revealed important overproduction of nucleic acids in grades 1 and 2 of the TNBC samples. 
The overproduction of this material was characterised by adenine vibrations in DNA.  
Grade 3 samples showed higher FTIR intensities for CH2 asymmetric bending and COO- 
stretching presented in proteins and fatty acids than grade 2 and 1 TNBC samples, suggesting 
accumulation of structural cell contents (proteins) and cell membranes (fatty acids). The same 
trend was identified with the band located at 1236 cm-1 associated with phosphate I (PO2-) 
asymmetric stretching, mainly from nucleic acids. Greater contributions of the Raman bands 
representing CH3 symmetric stretching (proteins), amide I α-helix conformation, amide III, and 
a combination of amide III and CH2 wagging vibrations (nucleic acids), glycine backbones, and 
proline chains were detected in grade 3 samples, in comparison with grade 2 and grade 1. 
Furthermore, in the grade 3 samples a lower content of collagen was identified using the 
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Raman collagen characteristic peaks (phenylalanine and hydroxyproline vibrations) in 
comparison with the lower histological grades. 
Grade 2 and 1 TNBC cases presented more β-sheet conformations of amide II in proteins 
(1534 cm-1) in comparison with grade 3 samples. Thus, structural changes in proteins were 
proposed in initial grades of the TNBC cases to facilitate invasive processes.  
8.2.6 HER2+ BREAST CANCER SAMPLES 
HER2+ grade 1 presented higher asymmetric Raman vibrations and CH3 content coming from 
lipids, especially fatty acids. This fact correlated with our FTIR results, and can be explained by 
a less active lipid transformation, peroxidation, degradation and active novo lipogenesis, in 
lower grades. 
Higher contributions of CH Raman vibrations in proteins (2916) and FTIR vibrations (N-H 
symmetric stretching, N-H amide B stretching, and CH3 symmetric stretching mainly from 
proteins and lipids) were present in grade 3 in comparison to grade 2 and 1, suggesting higher 
cell density and metabolism in higher grades. Grade 3 HER2+ samples had more significant 
contributions from vibrations associated with nucleic acids in both techniques, than grade 2 
and grade 1 samples. Additionally, lipid related bands located at 2993 cm-1 (cholesterol 
ester), and 2880 and 2847 cm-1 (CH2 symmetric and asymmetric stretch in lipids) presented 
increased intensity in grade 2 samples. 
Grade 1 and 2 showed high FTIR contributions of phosphate and important lipid vibrations 
(wagging of phospholipids, fatty acids, triglycerides). Moreover, Grade 2 samples showed 
more ceramide deformation (1295 cm-1) in comparison with grade 1 and 3.  
As the histological grade increased, the contribution of the Raman bands located at 939 and 
850 cm-1, identified as collagen characteristic peaks, increased. Therefore, early histological 
grades involved collagen and ECM production, while at higher and intermediate grades the 
proliferation of cellular material played the main role. 
8.3 FUTURE WORK  
This research listed and revised substantial changes caused by breast cancer and their 
different grades and subtypes using vibrational spectroscopy. The presented data highlights 
the importance of FTIR and Raman spectroscopy and their outstanding clinical potential. It is 
clear that more work is required to improve the technology and facilitate its clinical use and 
data processing. To accomplish this, multidisciplinary collaboration between researchers, 
companies, and clinicians is crucial. 
This research will be of significant value to new researchers exploring the use of vibrational 
spectroscopy to study breast cancer and help in understanding the chemical pathway to the 
progression of disease. It would be interesting to carry these findings further and focus some 
research on improving the sensitivity and specificity of the prediction model. This could be 
achieved using machine learning and taking advantage of the big cohort data. The use of 
artificial intelligence and machine learning can represent an import tool in the spectroscopic 
Chapter 8. Conclusion and future work 
205 
 
analysis of vibrational data. The combination of vibrational spectroscopy and these strategies 
and algorithms can offer an effective and low-cost solution to healthcare and diagnostics.  
Machine learning approaches consist of a combination of several classification systems. The 
use of several classifiers allows improving the accuracy of the classification. These algorithms 
are designed to maximise the number of accurate classification. Ideally, artificial intelligence 
(AI) and machine learning algorithms should be able to adapt to new data without retraining. 
AI and machine learning have been widely used in different fields using vibrational 
spectroscopy data, for example, the analysis of ovarian and breast cancer tissue, cervical 
cytology, food analysis, drugs concentration, and soil analysis. [125], [222]–[225] 
The use of self-learning classifier would be an ideal next step for this research. In general 
terms, in the training stage, a model is created containing several rules. These rules 
encompass relevant information that is characteristic of specific classes, for example, the 
relevant database of the normal and malignant breast tissue biochemical behaviour identified 
in this work.  When new data is included in this model, it should evolve and produce more 
accurate classification rates, adapting and improving the robustness of the final model.  
Additionally, once the new and improved algorithm has been improved, the new classification 
algorithm could be tested in different fixated samples. These systems will then provide the 
opportunity of immediate feedback to clinicians and pathologists, significantly improving 
patient care. This will help in increasing confidence among the clinicians and rapidly bringing 
these techniques to the armoury of surgeons, oncologists, and pathologists. 
Vibrational spectroscopy has the potential to offer a real-time analysis in preserved breast 
samples with excellent accuracy and is capable of maintaining this accuracy after several 
years. Moreover, FTIR and Raman spectroscopy can provide practitioners and researchers 
with chemical information reflecting changes at tissue level. In clinical practice, these changes 
influence the treatment strategies. In practical research, these insights help to understand 
carcinogenesis and invasive progressions, accelerating the development of new treatments. 
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